Unnamed: 0,title,date,stock,sentiment
585568.0,4 Analysts On Why The Rumored AstraZeneca-Gilead Deal Is Unlikely To Materialize,2020-06-08 18:26:00-04:00,GSK,neutral
585569.0,GSK Says Science Does Not Link Pandemic H1N1 Flu Vaccine to Sleep Disorder,2020-05-28 06:19:00-04:00,GSK,negative
585570.0,Clinical Research and Development Efforts Booming in Midst of COVID-19 Health Crisis,2020-05-20 09:51:00-04:00,GSK,negative
585571.0,"GlaxoSmithKline To Present New Data At ASCO 2020 May 29-31, Will Highlight 26 Abstracts Across 8 Tumor Types",2020-05-20 09:23:00-04:00,GSK,negative
585572.0,Moncef Slaoui To Divest Moderna Stake As He Joins White House Vaccine Accelerator,2020-05-19 09:00:00-04:00,GSK,neutral
585573.0,"These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley",2020-05-18 12:07:00-04:00,GSK,positive
585574.0,"GSK, Pfizer Owned ViiV Healthcare Announces Long-acting Injectable Formulation of Cabotegravir Dosed Every Two Months Shows Higher Efficacy Than Daily Oral PrEP",2020-05-18 06:25:00-04:00,GSK,neutral
585575.0,Vir Biotechnology Announces  Identification and Characterization of a Potential Therapeutic COVID-19 Antibody by Vir Biotechnology Published in Nature,2020-05-18 06:14:00-04:00,GSK,neutral
585576.0,Shares of several healthcare companies are trading lower amid market weakness following US unemployment data and recent cautious comments from the WHO. Sentiment is also negative following cautious comments from Fed Chair Powell and bearish outlook from some major US investors on Wednesday. Negative investor sentiment has affected stocks across sectors for the session.,2020-05-14 11:18:00-04:00,GSK,negative
585577.0,GlaxoSmithKline Says Starts Clinical Trial To Test Experimental Rheumatoid-arthritis Drug Otilimab As Treating For Severe Coronavirus Related Pulmonary Disease; Expects Initial Results Towards End Of Year,2020-05-07 08:51:00-04:00,GSK,negative
585578.0,UPDATE: Sanofi Says Has Started To Discuss Advance Purchases With Several Countries Including US,2020-05-05 17:46:00-04:00,GSK,neutral
585579.0,UPDATE: Sanofi Says Trials Will Enroll Thousands Of Patients Globally,2020-05-05 17:45:00-04:00,GSK,neutral
585580.0,Sanofi Says Has Trials Of Coronavirus Vaccine Candidate In Development With GlaxoSmithKline,2020-05-05 17:45:00-04:00,GSK,neutral
585581.0,GlaxoSmithKline Option Alert: May 8 $41 Calls at the Ask: 1000 @ $0.5 vs 372 OI; Earnings 5/12 Before Open [est] Ref=$40.805,2020-05-01 14:18:00-04:00,GSK,positive
585582.0,Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions.,2020-05-01 12:35:00-04:00,GSK,positive
585583.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,GSK,positive
585584.0,GlaxoSmithKline Press Release Confirms Zejula (Niraparib) Approved By FDA,2020-04-29 16:22:00-04:00,GSK,positive
585585.0,FDA Approves GlaxoSmithKline's Niraparib For First-Line Maintenance Of Advanced Ovarian Cancer,2020-04-29 14:17:00-04:00,GSK,negative
585586.0,GlaxoSmithKline Q1 Adj. EPS 37.7 Pence; Reaffirms FY20 Guidance For Adj. EPS To Be Down 1-4%,2020-04-29 07:11:00-04:00,GSK,neutral
585587.0,Glaxo Plans Sale of $3.7B Stake in Unilever India,2020-04-29 06:14:00-04:00,GSK,neutral
585588.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,GSK,negative
585589.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,GSK,positive
585590.0,How The COVID-19 Pandemic Could End,2020-04-20 16:33:00-04:00,GSK,neutral
585591.0,Shares of several healthcare companies are trading higher. Strength could potentially be related to the increased demand in medical products stemming from the coronavirus pandemic.,2020-04-16 12:38:00-04:00,GSK,positive
585592.0,"GlaxoSmithKline, Sanofi Collaborate On COVID-19 Vaccine Development: What You Should Know",2020-04-14 09:31:00-04:00,GSK,neutral
585593.0,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",2020-04-14 07:59:00-04:00,GSK,negative
585594.0,GlaxoSmithKline shares are trading higher after the company announced a coronavirus vaccine collaboration with Sanofi.,2020-04-14 07:17:00-04:00,GSK,positive
585595.0,"Sanofi And GlaxoSmithKline Announce Coronavirus Vaccine Collaboration, Expected To Start Trials In 2H 2020",2020-04-14 07:02:00-04:00,GSK,neutral
585596.0,Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.,2020-04-09 09:58:00-04:00,GSK,positive
585597.0,"Collaboration with AstraZeneca, GSK and University of Cambridge to support UK national effort to increase COVID-19 testing",2020-04-08 05:23:00-04:00,GSK,positive
585598.0,GlaxoSmithKline And Vir Biotechnology Enter Collaboration To Find Coronavirus Solutions; GlaxoSmithKline To Make $250M Equity Investment In Vir,2020-04-06 08:05:00-04:00,GSK,positive
585599.0,President Trump Says U.S. is Very Far Down the Line on Developing Vaccines for Coronavirus; Trump Says 'We're Starting to See Light at the End of the Tunnel',2020-04-05 19:21:00-04:00,GSK,neutral
585600.0,"What's The Difference Between Coronavirus, SARS-CoV-2 and COVID-19?",2020-04-03 16:22:00-04:00,GSK,neutral
585601.0,"GlaxoSmithKline Reports Will Collaborate With Xiamen Innovax Biotech To Evaluate Coronavirus Vaccine Candidate XWG-03, Co. Will Provide Xiamen With Its PAndemic Adjuvant System",2020-04-03 06:05:00-04:00,GSK,neutral
585602.0,Amarin Shares Drop 67% As Court Invalidates Its Heart Drug Patent For Vascepa,2020-03-31 03:21:00-04:00,GSK,neutral
585603.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 09:22:00-04:00,GSK,positive
585604.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,GSK,positive
585605.0,"Shares of several healthcare companies are trading higher as equities gain amid hopes of a US stimulus agreement. Additionally, the coronavirus outbreak has increased demand for certain medical supplies.",2020-03-24 12:20:00-04:00,GSK,positive
585606.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,GSK,negative
585607.0,GlaxoSmithKline Shares Unaffected As Hearing FDA To Postpone AdCom Meeting For Trelegy Ellipta,2020-03-23 14:18:00-04:00,GSK,positive
585608.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,GSK,negative
585609.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,GSK,negative
585610.0,18 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-23 07:50:00-04:00,GSK,neutral
585611.0,Shares of several healthcare companies are trading higher as the market rebounds from coronavirus-related selloffs.,2020-03-20 09:43:00-04:00,GSK,positive
585612.0,"The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company",2020-03-20 07:44:00-04:00,GSK,negative
585613.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-19 10:49:00-04:00,GSK,negative
585614.0,"Shares of several healthcare companies are trading higher, rebounding from Monday's crash. Stocks may also potentially be getting a boost from expectations of further stimulus proposals.",2020-03-17 09:10:00-04:00,GSK,positive
585615.0,8 Biotechs With Coronavirus Vaccines In Development,2020-03-16 10:42:00-04:00,GSK,neutral
585616.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,GSK,negative
585617.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,GSK,negative
585618.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,GSK,negative
585619.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,GSK,neutral
585620.0,How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?,2020-03-10 17:24:00-04:00,GSK,neutral
585621.0,Agenus Highlights Triggering Of $15.1M Milestone Payment From HealthCare Royalty Partners,2020-03-10 09:16:00-04:00,GSK,neutral
585622.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,GSK,positive
585623.0,"GlaxoSmithKline's ViiV Healthcare Issues Press Release With Highlights From Long-Term Data From Phase III Study Of Cabotegravir, Rilpivirine",2020-03-09 14:30:00-04:00,GSK,neutral
585624.0,"GlaxoSmithKline's ViiV Healthcare Reports 5-Year, $20M Renewal Of Partnership With Pfizer, Shionogi, University Of North Carolina For HIV Cure",2020-03-09 10:01:00-04:00,GSK,neutral
585625.0,Shares of several healthcare-related companies are trading higher after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:16:00-05:00,GSK,positive
585626.0,Pfizer Works On Compounds That May Help Stop Coronaviruses,2020-03-03 06:53:00-05:00,GSK,positive
585627.0,How The COVID-19 Outbreak Is Benefiting Biotech Investors,2020-03-02 14:27:00-05:00,GSK,neutral
585628.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as it rebounds from a selloff caused by coronavirus fears.,2020-03-02 11:18:00-05:00,GSK,positive
585629.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,GSK,negative
585630.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,GSK,positive
585631.0,GlaxoSmithKline Reports Supplemental New Drug Application For Zejula Being Reviewed Under FDA's Real-Time Oncology Review Pilot Program,2020-02-24 09:04:00-05:00,GSK,neutral
585632.0,Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies,2020-02-20 05:33:00-05:00,GSK,positive
585633.0,FDA Approves GSK's Voltaren Arthritis Pain for Over-the-counter Use in the United States,2020-02-17 10:02:00-05:00,GSK,positive
585634.0,GlaxoSmithKline shares are trading lower on continued weakness after the company reported worse-than-expected Q4 financial results on Wednesday.,2020-02-06 10:58:00-05:00,GSK,negative
585635.0,GlaxoSmithKline shares are trading lower after the company reported worse-than-expected Q4 financial results.,2020-02-05 09:16:00-05:00,GSK,neutral
585636.0,"GlaxoSmithKline Earlier Reported Q4 EPS $0.33 May Not Compare To $0.73 Estimate, Sales $11.836B Miss $12.14B Estimate",2020-02-05 09:16:00-05:00,GSK,negative
585637.0,"Earnings Scheduled For February 5, 2020",2020-02-05 04:26:00-05:00,GSK,neutral
585638.0,CEPI and GSK Announce Collaboration to Strengthen Global Effort to Develop Vaccine for 2019-nCoV Virus,2020-02-02 19:41:00-05:00,GSK,positive
585639.0,Stocks That Hit 52-Week Highs On Friday,2020-01-24 10:41:00-05:00,GSK,neutral
585640.0,"GlaxoSmithKline Reports FDA Grants Priority Review Of Belantamab Mafodotin For Patients With Relapsed, Refractory Multiple Myeloma",2020-01-21 09:01:00-05:00,GSK,positive
585641.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,GSK,neutral
585642.0,"The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics",2020-01-16 07:22:00-05:00,GSK,neutral
585643.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-15 13:14:00-05:00,GSK,neutral
585644.0,ViiV Healthcare Says EMA's Committee For Medicinal Products For Human Use Has Granted An Accelerated Assessment For Fostemsavir Marketing Authorization Application,2020-01-10 08:20:00-05:00,GSK,positive
585645.0,"ViiV Healthcare Submits Regulatory Application To The European Medicines Agency For Fostemsavir, An Investigational, First-in-class Attachment Inhibitor For The Treatment Of HIV In Adults With Few Treatment Options Available",2020-01-10 08:18:00-05:00,GSK,positive
585646.0,34 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-03 07:45:00-05:00,GSK,neutral
585647.0,Drugmakers Kick Off 2020 With Margin-Expanding Price Hikes,2020-01-02 10:41:00-05:00,GSK,neutral
585648.0,"Drugmakers Including Pfizer, GlaxoSmithKline, Sanofi, To Hike US Prices On More Than 200 Drugs In January; Median US Drug Price Increase For Jan. 1 2020 Is Around 5%, According To Healthcare Research Firm",2019-12-31 15:56:00-05:00,GSK,positive
585649.0,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus",2019-12-29 18:38:00-05:00,GSK,neutral
585650.0,Stocks That Hit 52-Week Highs On Friday,2019-12-27 11:27:00-05:00,GSK,neutral
585651.0,31 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-12-27 08:13:00-05:00,GSK,neutral
585652.0,UK Retailer Tesco Suspends Supplier As Girl Discovers Secret Letter Alleging Prison Labor Abuse,2019-12-23 01:44:00-05:00,GSK,negative
585653.0,550 Cases Confirmed of H1N1 Virus with 26 Deaths Reported in Past 3 Weeks in Sana'a Yemen,2019-12-22 11:54:00-05:00,GSK,neutral
585654.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,GSK,neutral
585655.0,GlaxoSmithKline Announces Belimumab Demonstrated Statistical Significance Compared To Placebo Across All Four Major Secondary Endpoints,2019-12-18 09:13:00-05:00,GSK,positive
585656.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,GSK,positive
585657.0,GlaxoSmithKline shares are trading higher. Not seeing any news to justify the price action.,2019-12-16 09:27:00-05:00,GSK,positive
585658.0,8 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-12-13 06:52:00-05:00,GSK,neutral
585659.0,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",2019-12-12 07:38:00-05:00,GSK,positive
585660.0,Stocks That Hit 52-Week Highs On Wednesday,2019-12-11 10:49:00-05:00,GSK,neutral
585661.0,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",2019-12-11 07:21:00-05:00,GSK,negative
585662.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-10 14:27:00-05:00,GSK,neutral
585663.0,"Glaxo, Pfizer's ViiV Healthcare Reports Submission Of New Drug Application To FDA For Fostemsavir For Treatment Of HIV",2019-12-05 07:44:00-05:00,GSK,neutral
585664.0,10 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-02 07:24:00-05:00,GSK,neutral
585665.0,"Benzinga's Top Upgrades, Downgrades For November 21, 2019",2019-11-21 09:44:00-05:00,GSK,positive
585666.0,"GSK's ViiV Healthcare Announces Exclusive Licensing Agreement With The National Institutes of Health For Investigational ""bNAb"" With Potential For Long-acting HIV Treatment And Prevention",2019-11-21 09:10:00-05:00,GSK,positive
585667.0,UBS Upgrades GlaxoSmithKline to Buy,2019-11-21 06:13:00-05:00,GSK,neutral
585668.0,30 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-15 08:14:00-05:00,GSK,neutral
585669.0,19 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-14 07:35:00-05:00,GSK,neutral
585670.0,"Argus Research Maintains Buy on GlaxoSmithKline, Raises Price Target to $50",2019-11-11 09:29:00-05:00,GSK,neutral
585671.0,AstraZeneca Named The Most Innovative Global Pharma Company,2019-11-06 11:20:00-05:00,GSK,positive
585672.0,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",2019-11-01 07:38:00-04:00,GSK,neutral
585673.0,"The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut",2019-10-31 08:08:00-04:00,GSK,positive
585674.0,GlaxoSmithKline PLC shares are trading higher after the company reported better-than-expected Q3 sales results.,2019-10-30 12:45:00-04:00,GSK,positive
585675.0,"GlaxoSmithKline Q3 Adj. EPS 38.6 Pence, Pharma Sales £4.5B, Consumer Sales £2.5B, Vaccines Sales £2.3B, Shingrix Sales £535M",2019-10-30 08:02:00-04:00,GSK,neutral
585676.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-30 07:32:00-04:00,GSK,neutral
585677.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,GSK,negative
585678.0,GlaxoSmithKline Says Intravenous Benlysta Is First Biologic Treatment To Be Approved For Children With Lupus In Europe,2019-10-29 12:15:00-04:00,GSK,positive
585679.0,"The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug",2019-10-25 07:12:00-04:00,GSK,positive
585680.0,FDA Investigating Whether Heartburn Drug Zantac Causes Carcinogens To Form In The Bodies Of Patients,2019-10-24 17:06:00-04:00,GSK,neutral
585681.0,Zai Lab Highlights Recent FDA Approval Of Partner GSK's Zejula For Late-Line Treatment For Women With Recurrent Ovarian Cancer,2019-10-24 08:32:00-04:00,GSK,negative
585682.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,GSK,neutral
585683.0,GlaxoSmithKline Reports FDA Approval Of Added Indication For Zejula For Late-Line Treatment For Women With Recurrent Ovarian Cancer,2019-10-23 17:48:00-04:00,GSK,negative
585684.0,Bavarian Nordic Announces Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline for ~€796M,2019-10-21 03:28:00-04:00,GSK,neutral
585685.0,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict",2019-10-20 08:08:00-04:00,GSK,positive
585686.0,"Benzinga's Top Upgrades, Downgrades For October 16, 2019",2019-10-16 14:57:00-04:00,GSK,positive
585687.0,New Street Upgrades GlaxoSmithKline to Hold,2019-10-16 10:08:00-04:00,GSK,neutral
585688.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,GSK,positive
585689.0,"Benzinga's Top Upgrades, Downgrades For October 11, 2019",2019-10-11 10:10:00-04:00,GSK,positive
585690.0,Cantor Fitzgerald Upgrades GlaxoSmithKline to Buy,2019-10-11 07:33:00-04:00,GSK,neutral
585691.0,Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15.,2019-10-08 10:36:00-04:00,GSK,positive
585692.0,GlaxoSmithKline Announces 5-Yr Collaboration With Lyell Immunopharma To Develop New Technologies To Improve Cell Therapies For Cancer Patients,2019-10-08 09:32:00-04:00,GSK,negative
585693.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week.,2019-10-02 10:33:00-04:00,GSK,negative
585694.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-02 08:54:00-04:00,GSK,neutral
585695.0,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",2019-10-01 08:10:00-04:00,GSK,negative
585696.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2019-09-30 16:32:00-04:00,GSK,neutral
585697.0,Stocks That Hit 52-Week Highs On Monday,2019-09-30 11:10:00-04:00,GSK,neutral
585698.0,"GSK Announced Phase 3 Prima Trial of Zejula is the First Study to Show a Parp Inhibitor Significantly Improves Pfs, Regardless of Biomarker Status, When Given as Monotherapy in Women With First-line Platinum Responsive Advanced Ovarian Cancer",2019-09-28 18:32:00-04:00,GSK,positive
585699.0,GSK Presents New Data Showing Promising Anti-tumour Activity With Gsk3359609 in Combination With Pembrolizumab in Head and Neck Squamous Cell Carcinoma at ESMO 2019,2019-09-28 18:17:00-04:00,GSK,positive
585700.0,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",2019-09-27 07:56:00-04:00,GSK,positive
585701.0,GlaxoSmithKline shares are trading higher. Some analysts have noted that impeachment measures against Trump could derail Democratic drug price reform efforts.,2019-09-26 10:29:00-04:00,GSK,neutral
585702.0,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",2019-09-25 17:32:00-04:00,GSK,neutral
585703.0,The Week Ahead In Biotech: Spotlight On ESMO Conference,2019-09-22 16:22:00-04:00,GSK,neutral
585704.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,GSK,negative
585705.0,15 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-09-20 08:24:00-04:00,GSK,neutral
585706.0,GlaxoSmithKline Receives Positive CHMP Opinion For Intravenous Benlysta In Children With Lupus Aged Five Years And Above,2019-09-20 07:03:00-04:00,GSK,positive
585707.0,GlaxoSmithKline Reports CHMP Opinion For Intravenous Benlysta Follows Recent Approval By FDA In April 2019,2019-09-20 07:02:00-04:00,GSK,positive
585708.0,FDA Panel Votes 9-6 To Support Approval Of Glaxo's OTC Nicotine Oral Spray,2019-09-18 16:29:00-04:00,GSK,positive
585709.0,FDA Panel Votes 8-7 Backing Effectiveness Of Glaxosmithkline's Over-the-counter Nicotine Oral Spray,2019-09-18 15:44:00-04:00,GSK,neutral
585710.0,Notable Insider Buys In The Past Week: Coty And Sunrun,2019-09-15 11:20:00-04:00,GSK,neutral
585711.0,"The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck",2019-09-15 11:18:00-04:00,GSK,positive
585712.0,Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal,2019-09-13 08:14:00-04:00,GSK,neutral
585713.0,Springworks Therapeutics IPO: What You Need To Know,2019-09-12 17:22:00-04:00,GSK,neutral
585714.0,Glaxosmithkline Received FDA Approval For Nucala For Use In Children As Young As 6 Years Old With Severe Eosinophilic Asthma,2019-09-12 15:51:00-04:00,GSK,positive
585715.0,Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed bill would set US drug prices based on prices in other wealthy countries.,2019-09-10 10:30:00-04:00,GSK,positive
585716.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-10 09:02:00-04:00,GSK,neutral
585717.0,GlaxoSmithKline shares are trading lower after VBI Vaccines announced it will collaborate with GlaxoSmithKline to clinically evaluate the combination of VBI-1901 and GSK's AS01Badjuvant system.,2019-09-10 07:19:00-04:00,GSK,neutral
585718.0,VBI Vaccines Announces Collaboration With GlaxoSmithKline  To Clinically Evaluate VBI-1901 Cancer Vaccine Candidate With GSK's Adjuvant System I Recurrent Glioblastoma Patients,2019-09-10 07:04:00-04:00,GSK,negative
585719.0,"Perrigo Reports Purchase Of Prevacid 24hr, No Terms Disclosed",2019-09-05 08:37:00-04:00,GSK,negative
585720.0,Societe Generale Upgrades GlaxoSmithKline to Buy,2019-09-03 12:07:00-04:00,GSK,neutral
585721.0,"Jim Cramer Weighs In On GlaxoSmithKline, Wynn Resorts And More",2019-08-28 12:20:00-04:00,GSK,neutral
585722.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,2019-08-28 08:02:00-04:00,GSK,neutral
585723.0,Ionis Pharmaceuticals Licenses Hepatitis B Program TO GSK; Co. Eligible To Receive License Fees And Milestone Payments Of Up To $262M,2019-08-27 07:09:00-04:00,GSK,neutral
585724.0,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",2019-08-22 07:18:00-04:00,GSK,positive
585725.0,"ViiV Healthcare Reports Atlas-2M Study Met Its Primary Endpoint, Showing Similar Efficacy of Cabotegravir and Rilpivirine Administered Every Eight Weeks Compared to Four-week Administration",2019-08-22 04:00:00-04:00,GSK,neutral
585726.0,JP Morgan Reinstates Neutral on GlaxoSmithKline,2019-08-13 08:48:00-04:00,GSK,positive
585727.0,"GlaxoSmithKline Pres Of US Pharma Unit, Jack Bailey, To Step Down At Year End",2019-08-12 10:34:00-04:00,GSK,neutral
585728.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,GSK,negative
585729.0,New Equities that Broke Through 52-Week Highs Monday Morning,2019-07-29 10:13:00-04:00,GSK,negative
585730.0,"GlaxoSmithKline Q2 Adj. EPS £0.305, Sales £7.8B; Sees FY19 Adj. EPS Guidance Down 3-5%",2019-07-24 07:05:00-04:00,GSK,neutral
585731.0,GlaxoSmithKline Names Jonathan Symonds Non-Exec Chair,2019-07-24 07:04:00-04:00,GSK,neutral
585732.0,"Earnings Scheduled For July 24, 2019",2019-07-24 04:00:00-04:00,GSK,neutral
585733.0,GlaxoSmithKline Option Alert: Aug 16 $43 Calls Sweep (40) near the Ask: 1341 @ $0.151 vs 1915 OI; Ref=$41.44,2019-07-23 13:55:00-04:00,GSK,positive
585734.0,GlaxoSmithKline Announces Positive Results in Phase 3 PRIMA Study of ZEJULA in Ovarian Cancer,2019-07-15 04:05:00-04:00,GSK,negative
585735.0,GSK in Talks to Name HSBC's Symonds as Next Chairman,2019-07-14 21:15:00-04:00,GSK,neutral
585736.0,Study: ViiV Healthcare's 2-Drug HIV Regimen As Effective As 3,2019-07-10 10:15:00-04:00,GSK,positive
585737.0,"The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV",2019-07-10 07:17:00-04:00,GSK,positive
585738.0,ViiV Healthcare Announces Phase III TANGO Study Meets Primary Endpoint,2019-07-10 04:23:00-04:00,GSK,neutral
585739.0,"The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief",2019-07-03 07:31:00-04:00,GSK,negative
585740.0,GlaxoSmithKline Announces ViiV Receives Dovato EU Marketing Authorization,2019-07-03 04:03:00-04:00,GSK,neutral
585741.0,Liquidia Restructures Collaboration Agreement With GSK;  Amended Collaboration Agreement Provides The Company With The Right To Develop And Commercialize Three Additional PRINT-Based Therapeutics Delivered Via Inhalation,2019-06-26 16:20:00-04:00,GSK,positive
585742.0,Genocea Biosciences Shares Spike Higher On Uptick In Volume Amid Filing Showing GlaxoSmithKline Purchased ~1.86M Shares Of Co.'s Common Stock,2019-06-26 10:51:00-04:00,GSK,positive
585743.0,GlaxoSmithKline Says the FDA Accepted its Application for Zejula in late Stage Ovarian Cancer with Priority Review,2019-06-24 07:11:00-04:00,GSK,negative
585744.0,GlaxoSmithKline Offered Concessions to Address EU Antitrust Concerns Over Planned JV With Pfizer's Consumer Health Business,2019-06-20 04:09:00-04:00,GSK,neutral
585745.0,"GlaxoSmithKline Launches Sale Of Two Portfolios Of Latam Consumer Health Drugs And Physiogel Skincare Drugs, Co. To Launch Sale Of A Third Portfolio Of European Health Drugs After The Summer; Aims To Raise Overall £1B From Portfolio Disposals",2019-06-19 13:27:00-04:00,GSK,neutral
585746.0,GlaxoSmithKline Option Alert: Fri $40 Calls Sweep (19) near the Ask: 646 @ $0.653 vs 2695 OI; Earnings 7/24 Before Open [est] Ref=$40.765,2019-06-19 13:25:00-04:00,GSK,positive
585747.0,VBI Shares Plunge On Mixed Late-Stage Hepatitis B Vaccine Trial Results,2019-06-17 12:02:00-04:00,GSK,positive
585748.0,Bicycle Therapeutics 13D Filing From GlaxoSmithKline Shows 10.8% Stake,2019-06-07 14:17:00-04:00,GSK,neutral
585749.0,GlaxoSmithKline shares are trading higher after the company announced that the FDA approved two new methods for administering Nucala for patients.,2019-06-07 09:50:00-04:00,GSK,positive
585750.0,Glaxosmithkline Says Nucala (Mepolizumab) Gains FDA Approval For Two New Self-Administration Options,2019-06-06 15:49:00-04:00,GSK,positive
585751.0,GlaxoSmithKline Expects To Increase Supply Of Shingrix Globally And Is Investing In Significant Capacity Expansion,2019-05-23 11:38:00-04:00,GSK,positive
585752.0,GlaxoSmithKline Announces Approval Of Shingrix In China For Prevention Of Shingles In Adults Aged 50 And Over,2019-05-23 11:36:00-04:00,GSK,positive
585753.0,"ACCC Says GSK, Novartis Misled Consumers With Voltaren Osteo Gel Claims",2019-05-17 04:46:00-04:00,GSK,neutral
585754.0,"UPDATE: Zymeworks Says If All Six Programs With GSK Are Developed, Commercialized, New Potential Value Of Collaboration $1.1B",2019-05-16 06:46:00-04:00,GSK,positive
585755.0,Zymeworks Reports Expansion Of Deal With GSK For Azymetric Bispecific Deal,2019-05-16 06:45:00-04:00,GSK,neutral
585756.0,"Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK for ~ €90M in Cash",2019-05-16 06:11:00-04:00,GSK,neutral
585757.0,GlaxoSmithKline shares are trading lower after the company said it expects 2019 EPS to fall by 5 to 9 percent compared to the previous year.,2019-05-01 09:56:00-04:00,GSK,neutral
585758.0,GlaxoSmithKline  Q1 Adj. EPS Up 22%,2019-05-01 07:05:00-04:00,GSK,neutral
585759.0,"Earnings Scheduled For May 1, 2019",2019-05-01 05:05:00-04:00,GSK,neutral
585760.0,Shares of several pharmaceutical companies are trading higher in sympathy with Pfizer and Merck after the companies reported strong Q1 earnings.,2019-04-30 09:34:00-04:00,GSK,positive
585761.0,"GSK Subsidiary ViiV Healthcare Submits New Drug Application to the FDA for the First Monthly, Injectable, Two-Drug Regimen of Cabotegravir and Rilpivirine for Treatment of HIV",2019-04-29 07:08:00-04:00,GSK,neutral
585762.0,GlaxoSmithKline Receives US Approval Of Benlysta For Intravenous Use In Children With Lupus Aged 5+,2019-04-26 14:57:00-04:00,GSK,positive
585763.0,GlaxoSmithKline Shares Unaffected As Traders Circulate Word EMA Panel Recommended Approval Of Co.'s 2-Drug HIV Treatment Dovato,2019-04-26 10:51:00-04:00,GSK,positive
585764.0,"GlaxoSmithKline Reports $100M Investment To Expand Long-Term Vaccine Manufacturing Capabilities In Hamilton, Montana",2019-04-24 08:36:00-04:00,GSK,positive
585765.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,GSK,positive
585766.0,Akorn Receives 2 Generic Nose Spray Approvals,2019-04-22 09:28:00-04:00,GSK,neutral
585767.0,Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices.,2019-04-16 15:34:00-04:00,GSK,negative
585768.0,"The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing",2019-04-09 08:10:00-04:00,GSK,neutral
585769.0,"Pfizer, GlaxoSmithKline Reports Its ViiV Healthcare Co. Received FDA Approval For Dovato Drug Regimen For Treatment-Naive HIV-1 Adults",2019-04-08 16:52:00-04:00,GSK,positive
585770.0,FDA Approves First Two-Drug Complete Regimen For HIV-Infected Patients Who Have Never Received Antiretroviral Treatment,2019-04-08 15:33:00-04:00,GSK,positive
585771.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2019-03-29 12:45:00-04:00,GSK,neutral
585772.0,GlaxoSmithKline Reports Reviewed Presentation Of Respiratory Product Sales Following Approval Of Generic Advair In US,2019-03-28 12:17:00-04:00,GSK,positive
585773.0,GlaxoSmithKline Announces Further Positive Data From Dreamm-1 Study Of Anti-Bcma Antibody-Drug Conjugate In Patients With Relapsed/Refractory Multiple Myeloma,2019-03-21 12:04:00-04:00,GSK,positive
585774.0,"Glaxosmithkline Announces Results Demonstrate Clinically Meaningful And Durable Response Rates Of Dostarlimab Monotherapy, In Msi-H And Mss Tumours",2019-03-19 13:47:00-04:00,GSK,positive
585775.0,Markets React Amid Report FDA Commish Scott Gottlieb Will Resign,2019-03-05 15:39:00-05:00,GSK,negative
585776.0,GlaxoSmithKline Reports Received Positive CHMP Opinion For Intravenous Zanamivir for Treatment Of Complicated Influenza,2019-03-01 08:38:00-05:00,GSK,positive
585777.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-02-15 16:31:00-05:00,GSK,positive
585778.0,GlaxoSmithKline Q4 EPS 24.7 Pence; Sees FY19 Adj. EPS Down 5-9% Year Over Year; Sees 80 Pence Dividend For 2019,2019-02-06 07:09:00-05:00,GSK,neutral
585779.0,A Peek Into The Markets: US Stock Futures Down Ahead Of Earnings,2019-02-06 06:29:00-05:00,GSK,neutral
585780.0,"13 Stocks To Watch For February 6, 2019",2019-02-06 04:48:00-05:00,GSK,neutral
585781.0,"Earnings Scheduled For February 6, 2019",2019-02-06 04:10:00-05:00,GSK,neutral
585782.0,Q4 Earnings Outlook For GlaxoSmithKline,2019-02-05 14:13:00-05:00,GSK,neutral
585783.0,"GlaxoSmithKline, Merck KGaa Report Global Alliance For M7824; Merck KGaa Will Receive Upfront Payment Of €300M; Deal Has Total Potential Value Of €3.7B",2019-02-05 07:04:00-05:00,GSK,positive
585784.0,Pharma Catches Another Case Of M&A Fever,2019-02-01 10:15:00-05:00,GSK,neutral
585785.0,Innoviva Shares Fall 5.8% Following FDA Approval Of Mylan's Generic Version Of Advair; Innoviva Is A Partner With GlaxoSmithKline For Competing Drug,2019-01-30 15:05:00-05:00,GSK,positive
585786.0,"Mylan Shares Spike ~3% Over Last Min., GlaxoSmithKline Shares Fall As Traders Circulate FDA.gov Alert On First Generic Drug Approvals",2019-01-30 15:01:00-05:00,GSK,positive
585787.0,GlaxoSmithKline shares are trading lower after Exane BNP Paribas downgraded the stock from Outperform to Neutral.,2019-01-14 10:28:00-05:00,GSK,neutral
585788.0,"Benzinga's Top Upgrades, Downgrades For January 14, 2019",2019-01-14 09:13:00-05:00,GSK,positive
585789.0,Exane BNP Paribas Downgrades GlaxoSmithKline to Neutral,2019-01-14 07:35:00-05:00,GSK,neutral
585790.0,4 Biotech Pipeline Areas To Keep An Eye On In 2019,2019-01-11 14:53:00-05:00,GSK,neutral
585791.0,"TD Ameritrade IMX Continued Its Dip In December, Falling To A More Than Two-Year Low",2019-01-08 13:39:00-05:00,GSK,negative
585792.0,GlaxoSmithKline CEO At JP Morgan Conference Says Co. Will Continue To Invest In Early-Stage HIV Treatments,2019-01-08 10:50:00-05:00,GSK,positive
585793.0,GlaxoSmithKline CEO Emma Walmsley AT JP Morgan Conference Says Shingles Vaccine SHINGRIX Expected To Be An Important Contributor For Many Years,2019-01-08 10:39:00-05:00,GSK,positive
585794.0,Hearing GlaxoSmithKline Discussing Cancer Portfolio At San Francisco Conference,2019-01-07 10:45:00-05:00,GSK,negative
585795.0,GlaxoSmithKline Extends Agreement With Exagen; Terms Not Disclosed,2019-01-02 11:56:00-05:00,GSK,positive
585796.0,"Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James",2019-01-02 10:21:00-05:00,GSK,neutral
585797.0,"GlaxoSmithKline shares are trading higher after announcing a consumer healthcare join venture with Pfizer, in which it will hold a 68% stake.",2018-12-20 08:36:00-05:00,GSK,positive
585798.0,"GlaxoSmithKline, Pfizer To Merge Consumer Health Care Businesses",2018-12-19 12:01:00-05:00,GSK,positive
585799.0,"GlaxoSmithKline shares are trading up after the company announced a consumer healthcare join venture with Pfizer, in which it will hold a 68% stake.",2018-12-19 11:29:00-05:00,GSK,positive
585800.0,22 Stocks Moving In Wednesday's Pre-Market Session,2018-12-19 08:07:00-05:00,GSK,neutral
585801.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,GSK,positive
585802.0,UPDATE: Pfizer to Hold 32% Stake in JV; GlaxoSmithKline 68%,2018-12-19 04:21:00-05:00,GSK,neutral
585803.0,"Pfizer, GlaxoSmithKline Announce JV to Create Premier Global Consumer Healthcare Company",2018-12-19 04:19:00-05:00,GSK,positive
585804.0,Epizyme Earns $8M Milestone Payment From GlaxoSmithKline For Initiation Of Clinical Development For PRMT1 Inhibitor,2018-12-18 06:34:00-05:00,GSK,negative
585805.0,Morgan Stanley Initiates Coverage On GlaxoSmithKline with Underweight Rating,2018-12-14 09:58:00-05:00,GSK,neutral
585806.0,"SunTrust Robinson Humphrey Initiates Coverage On GlaxoSmithKline with Hold Rating, Announces $38 Price Target",2018-12-14 08:58:00-05:00,GSK,neutral
585807.0,NeuroMetrix Modifies Agreement With GSK Healthcare On 2019 Quell Joint Development Program; The $13.8M To Be Paid By GSK Will Be Reallocated,2018-12-11 13:32:00-05:00,GSK,positive
585808.0,"Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate",2018-12-11 12:42:00-05:00,GSK,positive
585809.0,"Jefferies Assumes GlaxoSmithKline at Buy, Announces Price Target $45",2018-12-11 10:04:00-05:00,GSK,neutral
585810.0,"Jim Cramer Gives His Opinion On GlaxoSmithKline, Abbott Laboratories And More",2018-12-09 13:59:00-05:00,GSK,neutral
585811.0,"Benzinga's Top Upgrades, Downgrades For December 6, 2018",2018-12-06 09:15:00-05:00,GSK,positive
585812.0,GlaxoSmithKline shares are trading lower after Barclays downgraded the stock from overweight to equal-weight.,2018-12-06 08:31:00-05:00,GSK,negative
585813.0,Barclays Downgrades GlaxoSmithKline to Equal-Weight,2018-12-06 06:53:00-05:00,GSK,neutral
585814.0,Wedbush Moves To The Sidelines On Tesaro Following Glaxo Deal,2018-12-04 15:18:00-05:00,GSK,neutral
585815.0,56 Biggest Movers From Yesterday,2018-12-04 05:02:00-05:00,GSK,neutral
585816.0,Mid-Afternoon Market Update: Tesaro Climbs On Acquisition News; Tonix Pharmaceuticals Shares Slide,2018-12-03 14:30:00-05:00,GSK,positive
585817.0,46 Stocks Moving In Monday's Mid-Day Session,2018-12-03 12:37:00-05:00,GSK,neutral
585818.0,Mid-Day Market Update: Hexindai Falls After Q2 Results; Global Blood Therapeutics Shares Surge,2018-12-03 12:15:00-05:00,GSK,positive
585819.0,GlaxoSmithKline shares are trading lower after the company announced it will acquire Tesaro for $75 per share in cash.,2018-12-03 11:54:00-05:00,GSK,positive
585820.0,Mid-Morning Market Update: Markets Open Higher; Nexstar to buy Tribune Media for $46.50/Share,2018-12-03 10:13:00-05:00,GSK,neutral
585821.0,GlaxoSmithKline Strikes $5B M&A Deal With Tesaro In Quest To Boost Oncology Franchise,2018-12-03 10:07:00-05:00,GSK,positive
585822.0,Tesaro shares are trading higher after receiving a $75/share cash offer from GlaxoSmithKline.,2018-12-03 08:30:00-05:00,GSK,positive
585823.0,28 Stocks Moving In Monday's Pre-Market Session,2018-12-03 08:13:00-05:00,GSK,neutral
585824.0,"Clovis Oncology Shares Up 32% Premarket, Likely Trading Higher In Sympathy With 60% Upside Move In Tesaro Following $6B Deal For Glaxo To Buy Tesaro",2018-12-03 08:12:00-05:00,GSK,positive
585825.0,"GlaxoSmithKline to Acquire TESARO for $75/Share Cash, Deal Worth $5.1B Including the Assumption of Debt",2018-12-03 07:09:00-05:00,GSK,negative
585826.0,GlaxoSmithKline to Divest Horlicks to Unilever; Merger of GSK Consumer Healthcare Limited with Hindustan Unilever Limited for ~ £3.1B,2018-12-03 04:40:00-05:00,GSK,negative
585827.0,GlaxoSmithKline shares trading slightly higher after Crown Labs reported it has acquired distribution rights to five of GSK's consumer brands.,2018-11-30 12:11:00-05:00,GSK,positive
585828.0,"Crown Labs Reports Purchase Of GlaxoSmithKline's Select Consumer Healthcare Brands, No Terms Disclosed",2018-11-30 12:09:00-05:00,GSK,negative
585829.0,GlaxoSmithKline Offers Update On Horlicks Pursuit: Confirms Consideration Being Given For A Potential Deal Which Includes A Merger,2018-11-29 06:47:00-05:00,GSK,neutral
585830.0,Hearing Unilever Has Entered Exclusive Talks To Buy GlaxoSmithKline's Horlicks Unit,2018-11-27 16:41:00-05:00,GSK,positive
585831.0,GlaxoSmithKline and J&J's HIV Drug Juluca Received Approval In Japan,2018-11-27 14:43:00-05:00,GSK,positive
585832.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,GSK,positive
585833.0,GlaxoSmithKline Submits US Regulatory Filing To Expand Use Of NUCALA In Children With Severe Eosinophilic Asthma,2018-11-19 07:14:00-05:00,GSK,negative
585834.0,"Stocks Trading Ex Dividend For Thurs., Nov., 15, 2018",2018-11-15 11:33:00-05:00,GSK,neutral
585835.0,"GlaxoSmithKline Q3 Adj. EPS 0.355 Pence, Sales £8.1B",2018-10-31 08:02:00-04:00,GSK,neutral
585836.0,"Earnings Scheduled For October 31, 2018",2018-10-31 04:06:00-04:00,GSK,neutral
585837.0,GlaxoSmithKlein's and Pfizer's ViiV Gives an Update on its Two-Drug HIV Regimen,2018-10-29 06:24:00-04:00,GSK,neutral
585838.0,MorphoSys's Licensing Partner GSK has Reported Data on GSK3196165 from Phase 2 Study in RA to be Presented at the ACR Conference,2018-10-21 08:09:00-04:00,GSK,neutral
585839.0,"GlaxoSmithKline And Pfizer Joint Venture, ViiV, Submits HIV 2DR Regulatory Application To FDA",2018-10-18 11:03:00-04:00,GSK,neutral
585840.0,GlaxoSmithKline Publishes Results From Harmony Outcomes Study Of Albiglutide  In The Lancet; Results Shows Albiglutide Was Superior To Placebo With Respect To Major Adverse Cardiovascular Events,2018-10-02 06:49:00-04:00,GSK,positive
585841.0,"Analyst: Amarin's Vascepa Results Create Unicorn Potential, M&A Opportunity",2018-09-25 12:43:00-04:00,GSK,positive
585842.0,GlaxoSmithKline Experimental Vaccine Shows 54% Efficacy In Preventing Pulmonary TB After 2 Years,2018-09-25 12:01:00-04:00,GSK,neutral
585843.0,"Innoviva, GlaxoSmithKline Report Positive CHMP Opinion Supporting Expanded COPD Indication In Europe",2018-09-21 07:31:00-04:00,GSK,positive
585844.0,"GSK Shares Moving Higher Over The Last 5 Minutes; Late Monday, The Times Of India Said That Nestle And Univlever Are Among Suitors To Bid For GSK's Horlicks Unit",2018-09-18 12:14:00-04:00,GSK,positive
585845.0,Benzinga Pro's 5 Stocks To Watch Today,2018-09-07 09:36:00-04:00,GSK,neutral
585846.0,"The Daily Biotech Pulse: Amgen-AstraZeneca, Boston Scientific Opens Wallet, Advaxis Offering",2018-09-07 07:55:00-04:00,GSK,neutral
585847.0,REMINDER: GlaxoSmithKline Has FDA PDUFA Date Today for Mepolizumab,2018-09-07 05:13:00-04:00,GSK,neutral
585848.0,GlaxoSmithKline Plans To Eliminate About 650 Positions In The US,2018-09-05 17:05:00-04:00,GSK,neutral
585849.0,"The Week Ahead: Mr. Dorsey Goes To Washington, Employment And Wage Data On Tap",2018-09-04 12:18:00-04:00,GSK,neutral
585850.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2018-09-02 09:41:00-04:00,GSK,neutral
585851.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,2018-08-31 15:06:00-04:00,GSK,neutral
585852.0,"Barron's Picks And Pans: Electronic Arts, GlaxoSmithKline, Microsoft, Tesla And More",2018-08-25 18:16:00-04:00,GSK,neutral
585853.0,"FDA Approves Arakoda (Tafenoquire) For The Proyhylaxis Of Malaria In Patients Aged 18 Years And Older, Biosimilar to GlaxoSmithKline's Krintafel",2018-08-24 15:16:00-04:00,GSK,positive
585854.0,"Argus Maintains Buy on GlaxoSmithKline, Raises Price Target to $47",2018-08-20 07:57:00-04:00,GSK,neutral
585855.0,"Shares of GlaxoSmithKline are up 1.5% and shares of Pfizer are up 0.7% after ViiV Healthcare, a joint venture between the two companies, announced positive 48-week study results for HIV treatment regimen.",2018-08-15 11:38:00-04:00,GSK,positive
585856.0,"ViiV Healthcare Announces Positive 48-week Results for First Pivotal, Phase III Study for Novel, Long-acting, Injectable HIV-treatment Regimen",2018-08-15 04:34:00-04:00,GSK,positive
585857.0,"Stocks Trading Ex Dividend For Thurs., Aug. 9, 2018",2018-08-09 08:42:00-04:00,GSK,neutral
585858.0,"Stocks Which Will Trade Ex Dividend On Thurs., Aug. 9, 2018",2018-08-08 11:48:00-04:00,GSK,neutral
585859.0,GlaxoSmithKline Reports CHMP Recommended Mepolizumab For Treatment Of Severe Eosinophiliac Asthma For Pediatric Patients In Europe,2018-07-27 09:54:00-04:00,GSK,negative
585860.0,"GlaxoSmithKline, 23andMe Partner On DNA Data In Drug Development",2018-07-26 15:13:00-04:00,GSK,neutral
585861.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",2018-07-25 08:41:00-04:00,GSK,positive
585862.0,GlaxoSmithKline FDA AdCom Meeting Today 8am to 4pm ET For Mepolizumab sBLA,2018-07-25 07:13:00-04:00,GSK,neutral
585863.0,GalaxoSmithKline Q2 Adj. EPS 28.1P Beat 26.1P Consensus Est.,2018-07-25 06:27:00-04:00,GSK,neutral
585864.0,"Earnings Scheduled For July 25, 2018",2018-07-25 04:23:00-04:00,GSK,neutral
585865.0,GlaxoSmithKline's Earnings Preview,2018-07-24 14:56:00-04:00,GSK,neutral
585866.0,"UPDATE: Gemini Studies Show Two-drug Regimen of Dolutegravir and Lamivudine Has Similar Efficacy to a Three-drug Regimen in Treatment Naïve Hiv Patients, With No Emergence of Resistance",2018-07-24 04:45:00-04:00,GSK,negative
585867.0,GlaxoSmithKline Announces ViiV Healthcare Presents Juluca 100 Week Data at AIDS 2018,2018-07-24 04:28:00-04:00,GSK,neutral
585868.0,GlaxoSmithKline Says GEMINI 1 & 2 Studies of Two-Drug Combo HIV Treatment Met Primary Endpoint,2018-07-24 04:26:00-04:00,GSK,neutral
585869.0,"The Week Ahead: FANG Earnings Continue, Fox Vote On Disney Deal, More IPOs",2018-07-23 12:41:00-04:00,GSK,neutral
585870.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-07-22 17:03:00-04:00,GSK,neutral
585871.0,GlaxoSmithKline Shares Spike As Financial Times Reports Its Board Considering Spinning Off Consumer Division,2018-07-20 14:27:00-04:00,GSK,positive
585872.0,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares",2018-07-18 08:42:00-04:00,GSK,positive
585873.0,"Benzinga's Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial",2018-07-12 08:37:00-04:00,GSK,neutral
585874.0,"GlaxoSmithKline Issues Release Highlighting Roivant Sciences Subsidiary Dermavant Sciences Agreed To Buy Rights To Tapinarof For Treatment Of Psoriasis, Atopic Dermatitis For £250M",2018-07-12 07:23:00-04:00,GSK,positive
585875.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2018-07-08 19:16:00-04:00,GSK,neutral
585876.0,"UPDATE: GlaxoSmithKline Says Co.'s Wholly-Owned Indrect Subsidiary SR One Bought ~269K Shares Of Translate Bio At $13/Share On Jul. 2, 2018",2018-07-05 16:48:00-04:00,GSK,positive
585877.0,Translate Bio 13D Filing From GlaxoSmithKline Shows 8.3% Stake In Co.,2018-07-05 16:47:00-04:00,GSK,neutral
585878.0,Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates,2018-06-30 18:05:00-04:00,GSK,neutral
585879.0,GlaxoSmithKline Shares As Yet Unaffected By FDA Approval Of Glenmark Pharma's North Carolina Facility to Manufacture Generic Version of GSK's Malarone,2018-06-18 12:39:00-04:00,GSK,positive
585880.0,40 Biggest Movers From Yesterday,2018-06-15 04:56:00-04:00,GSK,neutral
585881.0,31 Stocks Moving In Thursday's Mid-Day Session,2018-06-14 12:26:00-04:00,GSK,neutral
585882.0,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",2018-06-14 08:11:00-04:00,GSK,negative
585883.0,GlaxoSmithKline Presents Results Showing Low Rates Of Organ Damage With Long-Term Use Of Benlysta,2018-06-13 09:18:00-04:00,GSK,negative
585884.0,Adaptimmune Therapeutics Reports Data From Pilot Study Of NY-ESO SPEAR T-Cells In Synovial Sarcoma Will Be Published In 'Cancer Discovery',2018-06-11 07:49:00-04:00,GSK,negative
585885.0,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",2018-06-08 16:33:00-04:00,GSK,neutral
585886.0,"Adaptimmune Therapeutics Presents Promising Updated Myxoid/Round Cell Liposarcoma Data with NY-ESO, Presented at #ASCO2018",2018-06-02 20:06:00-04:00,GSK,positive
585887.0,"GSK, Innoviva Announce Submission of Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD",2018-05-29 04:07:00-04:00,GSK,neutral
585888.0,GlaxoSmithKline Receives U.S. Approval Of Ellipta For Use In Children From 5 Years Old Who Suffer From Asthma,2018-05-21 11:52:00-04:00,GSK,negative
585889.0,'EU warns of possible birth defect link to GSK's HIV drug',2018-05-18 11:24:00-04:00,GSK,negative
585890.0,Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning,2018-04-30 11:58:00-04:00,GSK,neutral
585891.0,"Earnings Scheduled For April 25, 2018",2018-04-25 04:25:00-04:00,GSK,neutral
585892.0,"GlaxoSmithKline, Innoviva Report Once-Daily Trelegy Ellipta Gained Expanded Indication For COPD In US",2018-04-24 12:51:00-04:00,GSK,positive
585893.0,GlaxoSmithKline Says Study Published in NEJM Shows Benefits of Trelegy Ellipta Over Alternatives,2018-04-18 05:09:00-04:00,GSK,positive
585894.0,"GSK to Transfer Rare Disease Gene Therapy Portfolio to Orchard Therapeutics in Exchange for 19.9% Stake in Orchard, Seat on Board, Royalties, Milestones",2018-04-12 04:22:00-04:00,GSK,neutral
585895.0,Podcast: What All Investors Should Know About Trade Deficits and Recessions,2018-04-11 14:16:00-04:00,GSK,neutral
585896.0,"GlaxoSmithKline Announces Trellegy Ellipta Approved In Canada For COPD, Availability Expected June 2018",2018-04-05 10:49:00-04:00,GSK,positive
585897.0,"Teva, GlaxoSmithKline Shares Unaffected Following Earlier Circulation Of Court Ruling Which Showed Teva Won Reversal Of $235M Drug Patent Verdict",2018-03-28 15:22:00-04:00,GSK,positive
585898.0,30 Stocks Moving In Tuesday's Mid-Day Session,2018-03-27 12:31:00-04:00,GSK,neutral
585899.0,GlaxoSmithKline To Buy Novartis' Stake in Consumer Health Care JV For $13 Billion,2018-03-27 10:53:00-04:00,GSK,positive
585900.0,24 Stocks Moving In Tuesday's Pre-Market Session,2018-03-27 08:02:00-04:00,GSK,neutral
585901.0,Novartis to Sell Stake in Consumer Healthcare JV to GSK for $13B,2018-03-27 04:20:00-04:00,GSK,neutral
585902.0,GlaxoSmithKline Shares Up 4.7% After Co. Earlier Announced Winning Of Positive CHMP Opinion For Juluca HIV Treatment In Europe,2018-03-23 12:14:00-04:00,GSK,positive
585903.0,25 Stocks Moving In Friday's Pre-Market Session,2018-03-23 08:09:00-04:00,GSK,neutral
585904.0,"Glaxo, Pfizer's ViiV Healthcare Reports Winning Of Positive CHMP Opinion For Juluca In Europe Recommending Marketing Authorization",2018-03-23 07:32:00-04:00,GSK,positive
585905.0,GlaxsoSmithKline did Not Submit Final Bid for Pfizer's Consumer Healthcare Unit,2018-03-23 06:15:00-04:00,GSK,neutral
585906.0,"Pfizer Says Continues to Evaluate Potential Strategic Alternatives for Consumer Healthcare Business, Including Spin-off, Sale; Says Expects Decision in 2018",2018-03-23 04:56:00-04:00,GSK,neutral
585907.0,Reckitt Benckiser Ends Discussions with Pfizer over Purchase of Consumer Healthcare Business,2018-03-22 04:29:00-04:00,GSK,neutral
585908.0,GlaxoSmithKline Earlier Announced Positive EU Approval For Labeling Update To Relvar Ellipta In Patients with Asthma,2018-03-08 08:24:00-05:00,GSK,positive
585909.0,"GSK, Innoviva Announce Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma",2018-03-08 03:49:00-05:00,GSK,positive
585910.0,Height Casts 65% Odds That Congress Rolls Back Pharma Discounts,2018-03-07 11:31:00-05:00,GSK,neutral
585911.0,GSK  Says New Clinical Data Demonstrate High Vaccine Efficacy of Fluarix Tetra (Influenza Vaccine) in Children 6-35 Months of Age,2018-03-06 06:00:00-05:00,GSK,neutral
585912.0,"UPDATE: dolutegravir Was Well-Tolerated In Adults Receiving Rifampin-Based TB Therapy, Medication Was Effective When Administered Twice-Daily With Dual Nucleoside Reverse Transcriptase Inhibitors",2018-03-05 12:05:00-05:00,GSK,positive
585913.0,GlaxoSmithKline's VIIV Healthcare Announces New dolutegravir Data For Treatment Of People Living With HIV Co-Infected With Tuberculosis,2018-03-05 12:03:00-05:00,GSK,neutral
585914.0,Heartbreak And Desire: 11 Of Our Favorite Wall Street Love Stories,2018-02-14 12:10:00-05:00,GSK,positive
585915.0,GSK Submits Landmark IMPACT Data to EMA to Support Expanded Label for Trelegy Ellipta,2018-02-14 04:03:00-05:00,GSK,positive
585916.0,"CDC Still Recommends Sanofi, GlaxoSmithKline Vaccines As Flu-Related Deaths Rise",2018-02-12 16:26:00-05:00,GSK,positive
585917.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-02-08 08:03:00-05:00,GSK,neutral
585918.0,U.S. Regulators Delayed Approval of Generic Version of GSK's Advair by Novartis's Sandoz Unit,2018-02-08 04:43:00-05:00,GSK,positive
585919.0,GSK Says ‍ViiV Healthcare Launches New Two-Drug HIV Study,2018-02-08 04:42:00-05:00,GSK,neutral
585920.0,GSK Reports Q4 Core Operating Profit GBP$2.04B,2018-02-07 07:10:00-05:00,GSK,positive
585921.0,"Earnings Scheduled For February 7, 2018",2018-02-07 04:52:00-05:00,GSK,neutral
585922.0,GSK's Meningitis B Vaccine Bexsero Receives Breakthrough Therapy Designation from FDA for Prevention of Invasive Meningococcal Disease in children 2-10 Years Old,2018-02-07 04:39:00-05:00,GSK,neutral
585923.0,Attention Biotech Investors: February PDUFA Catalysts Come Calling,2018-01-31 15:30:00-05:00,GSK,neutral
585924.0,Jefferies On Gilead: 'We See Better Days Ahead',2018-01-26 13:48:00-05:00,GSK,positive
585925.0,GlaxoSmithKline 6-K Shows CHMP Gave Positive Opinion Recommending Label Update For Use Of Once-Daily Shingrix,2018-01-26 07:31:00-05:00,GSK,positive
585926.0,GSK Announces CHMP Positive Opinion for Labelling Update to Relvar Ellipta in Patients with Asthma,2018-01-26 04:35:00-05:00,GSK,positive
585927.0,"J&J No Longer Candidate For Purchase Of Pfizer's Consumer Unit; GlaxoSmithKline, Reckitt Benickser Working With Banks To Make A Bid",2018-01-25 09:34:00-05:00,GSK,negative
585928.0,"Novartis Incoming CEO Sees No Change to Co's Position on GSK JV, Roche Stake -Reuters",2018-01-24 05:10:00-05:00,GSK,negative
585929.0,Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings?,2018-01-19 12:48:00-05:00,GSK,neutral
585930.0,NeuroMetrix Shares Up 34.1% Following Earlier Announcement Of Collaboration With GlaxoSmithKline,2018-01-17 11:46:00-05:00,GSK,positive
585931.0,"NeuroMetrix, GlaxoSmithKline Consumer Healthcare Report Strategic Collaboration For Development, Expansion Of Access To Quell Wearable Pain Relief Technology",2018-01-17 07:11:00-05:00,GSK,negative
585932.0,"Friday U.S. CDC Announced America At Peak Of Flue Season With Flu Outbreak Across Entire Continental U.S. For First Time; Potential Positive For Flu Vaccine Manufacturers e.g. Sanofi, GlaxoSmithKline",2018-01-16 09:28:00-05:00,GSK,negative
585933.0,GSK Receives FDA Approval For Expanded Indication For FLUARIX QUADRIVALENT For Persons 6 Months And Older,2018-01-12 08:00:00-05:00,GSK,positive
585934.0,Morgan Stanley: Epizyme Has 'Blockbuster' Cancer Drug In The Making,2018-01-10 10:26:00-05:00,GSK,negative
585935.0,"GSK CEO On Pfizer Consumer Business, We Don't Need It, Wouldn't Overpay For It",2018-01-09 14:08:00-05:00,GSK,neutral
585936.0,"GSK CEO Says There's No Change To Dividend Policy Laid Out Last Year, No Expected Dividend In Near Term",2018-01-09 13:53:00-05:00,GSK,negative
585937.0,GSK CEO Says It'll Take Time TO Build Reimbursement For Shingrix Shingles Vaccine,2018-01-09 13:41:00-05:00,GSK,neutral
585938.0,"Barron's Picks And Pans: Chevron, Corning, GlaxoSmithKline And More",2017-12-31 11:48:00-05:00,GSK,neutral
585939.0,"GSK Announces FDA Approves US Label Update on ICS/LABA Combinations in Asthma, Based on Review of Safety Data",2017-12-21 04:41:00-05:00,GSK,positive
585940.0,"ASH 2017 Highlights: Gilead, Novartis, Juno, Bluebird Bio And More",2017-12-13 12:31:00-05:00,GSK,neutral
585941.0,GlaxoSmithKline Receives FDA Approval For Nucala (Mepolizumab),2017-12-12 11:57:00-05:00,GSK,positive
585942.0,GSK Says New Data from a Phase III Clinical Study Supports Safety and Efficacy of Shingrix in Immune-compromised Patients,2017-12-06 04:28:00-05:00,GSK,positive
585943.0,Reuters Reporting ACCC Institured Proceedings Against GlaxoSmithKline and Novartis Consumer Health In Australia,2017-12-05 17:33:00-05:00,GSK,neutral
585944.0,"REMINDER: Tuesday Is Estimated FDA PDUFA Date For: Johnson & Johnson for Rilpivirine and In Partnership with GlaxoSmithKline For Dolutegravir, and Novo Nordisk for Semaglutide",2017-12-04 15:49:00-05:00,GSK,neutral
585945.0,"The Week Ahead For December 4: The Biggest Catalysts, Conferences, And Investor Events",2017-12-04 11:23:00-05:00,GSK,neutral
585946.0,GlaxoSmithKline Begins Phase III Study On Injection To Prevent HIV,2017-12-01 12:38:00-05:00,GSK,neutral
585947.0,"Benzinga's Top Upgrades, Downgrades For November 27, 2017",2017-11-27 09:05:00-05:00,GSK,positive
585948.0,Adam Feuerstein Tweets: FDA approves Viiv Healthcare's $GSK HIV therapy Juluca. Two drugs (dolutegravir/rilpivirine),2017-11-21 14:00:00-05:00,GSK,positive
585949.0,"VBI Vaccines Could Nearly Triple In Value On New Drug Launches, According To BMO",2017-11-15 13:04:00-05:00,GSK,positive
585950.0,"13F Filing Shows Paulson & Co. Dissolves Stake In Glaxosmithkline, Increases Stake In DISH Network",2017-11-14 16:56:00-05:00,GSK,neutral
585951.0,Dynavax Awaits FDA Verdict On Hepatitis B Vaccine,2017-11-08 15:04:00-05:00,GSK,positive
585952.0,GlaxoSmithKline Highlights Safety Profile Observed In Bliss-76 Long-Term Study Consistent With Results Observed In Overall Bliss Trial For Belimumab,2017-11-08 12:29:00-05:00,GSK,positive
585953.0,"GlaxoSmithKline Shares Tick Higher As CEO Emma Walmsley Says Hiring Of Barron Is 'Highly Significant,' 'Exciting' And Underscores Her 'Absolute, Unequivocal Prioritization' On Improving Co.'s Pharma Unit",2017-11-08 10:04:00-05:00,GSK,positive
585954.0,GlaxoSmithKline Reports Submitted sBLA For Mepolizumab In COPD To FDA,2017-11-07 10:07:00-05:00,GSK,neutral
585955.0,GlaxoSmithKline's R&D Head Patrick Vallance Leaving Co to Become UK Government's Chief Scientific Adviser -Reuters,2017-11-03 05:14:00-04:00,GSK,neutral
585956.0,Novartis Buys French Radiopharmaceutical Company,2017-11-01 12:50:00-04:00,GSK,neutral
585957.0,"GlaxoSmithKline, Innoviva Report Study Showed 'Superiority of Anoro Ellipta to Stiolto Respimat in Improving Lung Function in Chronic Obstructive Pulmonary Disease'",2017-11-01 07:12:00-04:00,GSK,positive
585958.0,GSK's ViiV Healthcare Announces Positive Phase 3 Results from BRIGHTE Study of Fostemsavir in Heavily Treatment-experienced Patients with HIV,2017-10-27 04:28:00-04:00,GSK,positive
585959.0,Bank of America Downgrades GlaxoSmithKline PLC Common Stock to Neutral,2017-10-26 09:22:00-04:00,GSK,neutral
585960.0,"Wall Street's M&A Chatter From October 25: Sprint-T-Mobile, Trade Desk, Pfizer, Dynegy",2017-10-26 07:35:00-04:00,GSK,neutral
585961.0,"Pfizer Will Launch $15B+ Consumer Health Sale In Nov., Glaxo Has Hired Citi Related To Pfizer Unit Auction",2017-10-25 14:33:00-04:00,GSK,neutral
585962.0,GlaxoSmithKline Reports Q3 EPS Of 32.5 Pence vs 31.8 Pence,2017-10-25 07:14:00-04:00,GSK,neutral
585963.0,"Earnings Scheduled For October 25, 2017",2017-10-25 04:24:00-04:00,GSK,neutral
585964.0,The Week Ahead: Earnings Season Starts In Earnest,2017-10-23 09:00:00-04:00,GSK,positive
585965.0,Agenus +19% Premarket @$5.15; GSK's Shingle Vaccine Receives FDA Approval,2017-10-23 06:17:00-04:00,GSK,positive
585966.0,GSK's Shingle Vaccine Shingrix Receives US FDA Approval,2017-10-23 06:14:00-04:00,GSK,positive
585967.0,"Agenus Reports Health Canada Granted Marketing Authorization To Glaxo's Shingrix, Which Contains Co.'s Proprietary Immune Adjuvant QS-21",2017-10-13 14:12:00-04:00,GSK,positive
585968.0,GlaxoSmithKline Shingrix Has Been Approved In Canada For Prevention Of Shingles In People Over 50,2017-10-13 13:38:00-04:00,GSK,positive
585969.0,"Attention Biotech Investors, Here's Your PDUFA Primer For October",2017-09-28 10:51:00-04:00,GSK,neutral
585970.0,"Theravance Biopharma, GlaxoSmithKline and Innoviva Announce IMPACT Study Shows Trelegy Ellipta Met Its Primary Endpoint With Statistical Significance",2017-09-20 16:07:00-04:00,GSK,positive
585971.0,"GSK, Innoviva Announce Positive Headline Results from IMPACT Study Showing Single Inhaler Triple Therapy Trelegy Ellipta Reduced COPD Exacerbations",2017-09-20 04:04:00-04:00,GSK,positive
585972.0,GlaxoSmithKline Says it Received a Positive Opinion from CHMP for Self Injectable Benlysta,2017-09-15 07:04:00-04:00,GSK,positive
585973.0,"GSK, Innoviva Announce Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Receives Positive Opinion from CHMP in Europe for Appropriate Patients with COPD BW",2017-09-15 03:57:00-04:00,GSK,positive
585974.0,"FDA Panel Votes 11-0 Available Data For GlaxoSmithKline's Shingrix Shingles Vaccine In Adults Age 50, Older Supports Efficacy",2017-09-13 14:02:00-04:00,GSK,positive
585975.0,"GlaxoSmithKline, Innoviva Announce Positive Results from Pioneering Salford Lung Study in Asthma Published in The Lancet, and Presented at ERS",2017-09-11 04:03:00-04:00,GSK,positive
585976.0,What Pharmaceuticals Spend On Lobbying To Influence Trump,2017-09-09 16:28:00-04:00,GSK,negative
585977.0,"This Drug, An Alternative To Marijuana And Ketamine, Could Treat Suicidal Depression And PTSD",2017-09-07 13:02:00-04:00,GSK,negative
585978.0,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,2017-09-01 14:03:00-04:00,GSK,neutral
585979.0,GlaxoSmithKline Recent Pullback Delivers A Healthy Opportunity To Buy,2017-08-30 09:55:00-04:00,GSK,positive
585980.0,Where Does Zika Virus Vaccine Research Stand Now?,2017-08-12 14:51:00-04:00,GSK,neutral
585981.0,"Pfizer, Sanofi, Glaxo Shares Unaffected Amid Comment From Mexican Anti-Trust Agency Official Suggesting Drugs Sold By Those Cos. Do Not Face Competition From Generics Readily Available Elsewhere",2017-08-09 10:56:00-04:00,GSK,positive
585982.0,"United Therapeutics Shares Up 7.7% On M&A Chatter; GSK, Gilead, Novartis Said To Be Possibly Considering Deal For Co.",2017-08-04 09:40:00-04:00,GSK,positive
585983.0,"UK Evening Standard Reports GSK, Gilead, Novartis Could Pay Up to $200/Share for United Therapeutics",2017-08-04 08:00:00-04:00,GSK,positive
585984.0,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,2017-08-01 09:20:00-04:00,GSK,neutral
585985.0,8 Of The Biggest Whistles Ever Blown On Wall Street,2017-07-31 09:46:00-04:00,GSK,neutral
585986.0,GlaxoSmithKline Says 30+ Programs Will be Stopped,2017-07-26 06:22:00-04:00,GSK,negative
585987.0,"Earnings Scheduled For July 26, 2017",2017-07-26 04:22:00-04:00,GSK,neutral
585988.0,Hearing GlaxoSmithKline-Majority Owned Viiv Healthcare Announced Positive Interim Results From Dawning Trial,2017-07-25 08:36:00-04:00,GSK,positive
585989.0,GSK Submits U.S. Regulatory Filing Of Arnuity Ellipta In Children With Asthma,2017-07-24 08:22:00-04:00,GSK,neutral
585990.0,GlaxoSmithKline Gets FDA Approval for an Injectable Form of Benlysta,2017-07-21 15:19:00-04:00,GSK,positive
585991.0,GSK and Innoviva Submits EU Filing for Extended Use of Relvar Ellipta in Patients with Controlled Asthma on an ICS/LABA Combination,2017-07-21 09:02:00-04:00,GSK,neutral
585992.0,These Non-Tech Companies Are Investing In An AI Future,2017-07-20 15:20:00-04:00,GSK,neutral
585993.0,Emergent BioSolutions Reports Will Buy Raxibacumab From GSK For ~$130M,2017-07-19 16:20:00-04:00,GSK,neutral
585994.0,GlaxoSmithKline Intends To Sell Its MaxiNutrition Brand In UK,2017-07-19 08:08:00-04:00,GSK,neutral
585995.0,GSK Considering Sale of Horlicks Business- BBC,2017-07-19 06:00:00-04:00,GSK,neutral
585996.0,"8-K From OncoMed Shows Co. Received Letter From GlaxoSmithKline Indicating Co. Terminated R&D Collaboration, Option, License Deal",2017-07-10 16:38:00-04:00,GSK,neutral
585997.0,"Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks",2017-07-05 12:17:00-04:00,GSK,negative
585998.0,Attention Biotech Investors: Keep Your Date With July PDUFA Action-Days,2017-07-05 11:01:00-04:00,GSK,neutral
585999.0,"Benzinga's Top Upgrades, Downgrades For July 5, 2017",2017-07-05 09:25:00-04:00,GSK,positive
586000.0,Citigroup Downgrades GlaxoSmithKline PLC Common Stock to Neutral,2017-07-05 07:33:00-04:00,GSK,neutral
586004.0,GlaxoSmithKline Granted FDA Orphan Designation for Treatment of Multiple Myeloma,2017-06-25 19:52:00-04:00,GSK,positive
586005.0,How Altimmune Is Trying To Get Ahead Of A Potentially Fatal 'Flu Pandemic',2017-06-23 08:15:00-04:00,GSK,negative
586006.0,GlaxoSmithKline Shares Seem Largely Unaffected Amid Sky News Report Co. CEO Pursuing Sale Of MaxiNutrition Brand,2017-06-22 15:32:00-04:00,GSK,positive
586008.0,GlaxoSmithKline Offers Results From Phase 3 Revaccination Study Of Shingrix: Met Primary Objective,2017-06-21 09:12:00-04:00,GSK,neutral
586013.0,GlaskosmithKline Tafenoquine Study Met Primary Endpoint,2017-06-12 07:20:00-04:00,GSK,neutral
586015.0,Consult Your Doctor: FDA Thinks Big Pharma Might Be Intentionally Confusing You With Too Much Information,2017-06-01 08:40:00-04:00,GSK,negative
586016.0,Alternative Paths To The Public Markets: Nexeon MedSystems' Form 10 IPO And Capital Consciousness,2017-05-30 09:20:00-04:00,GSK,neutral
586017.0,"Nexeon CEO On The Brain Chip Targeting Parkinson's, Lou Gehrig's Disease And Other 'Cyborg' Technologies",2017-05-29 20:05:00-04:00,GSK,neutral
586018.0,"Meet The 37-Year-Old Prodigal, JD And Neuroscientist Who's Making Matrix's Thought-Downloading Brain Chip A Reality",2017-05-25 12:38:00-04:00,GSK,neutral
586019.0,"Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst",2017-05-23 14:09:00-04:00,GSK,positive
586020.0,Citi Prefers These 4 Stocks Over Pfizer On Bottom-Line Concerns,2017-05-16 11:15:00-04:00,GSK,neutral
586021.0,GlaxoSmithKline to Acquire Novartis's 36.5% stake in GSK Consumer Healthcare -UK Sunday Times,2017-05-15 04:03:00-04:00,GSK,neutral
586022.0,"Woodford Investment Management Says Sold Out Of GlaxoSmithKline, Citing Weak Pipeline, Lack Of Strategic Options -Reuters",2017-05-12 07:16:00-04:00,GSK,negative
586023.0,Turing Rejects $100 Million Offer For Daraprim,2017-05-10 11:32:00-04:00,GSK,negative
586024.0,"Innoviva Shares Indicated Higher Premarket as Co., GlaxoSmithKline Earlier Announced relvar Ellipta Significantly Improved Asthma Control in Salford Lung Study Patients",2017-05-05 08:25:00-04:00,GSK,positive
586025.0,Epizyme Reports Earned $10M Milestone Payment from GlaxoSmithKline Related to Initiation of GLP Toxicology Studies with Novel Methyltransferase Inhibitor,2017-05-04 06:48:00-04:00,GSK,positive
586026.0,How Ad Companies Have Responded To A Changing Media Landscape,2017-04-26 08:07:00-04:00,GSK,neutral
586027.0,"As Price Falls, Vetr Upgrades GlaxoSmithKline To Buy",2017-04-20 14:35:00-04:00,GSK,neutral
586028.0,What Would A $5.8 Billion NIH Cut Look Like? Devastation,2017-04-20 13:38:00-04:00,GSK,negative
586029.0,GSK Announces Regulatory Submission in Japan of Candidate Vaccine for Prevention of Shingles,2017-04-18 08:07:00-04:00,GSK,neutral
586030.0,UPDATE: Glaxo Says Intends to Vote for Innoviva's Board Nominees at '17 Annual Meeting,2017-04-13 17:15:00-04:00,GSK,neutral
586031.0,Amended 13D Filing from GlaxoSmithKline on Innoviva Shows Comment Glaxo 'support Innoviva's Board and management team's continuing effort to deliver significant shareholder value',2017-04-13 17:14:00-04:00,GSK,positive
586032.0,Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger,2017-04-06 16:01:00-04:00,GSK,neutral
586033.0,F-3 from GlaxoSmithKline Shows Registration for $10B Debt Securities Shelf Offering,2017-04-03 17:32:00-04:00,GSK,negative
586034.0,"50 Advertisers Boycott YouTube Advertising, And It Won't Mean More Than A 1% Dip In Google's Top Line",2017-04-01 08:45:00-04:00,GSK,negative
586035.0,GlaxoSmithKline Reports Initiation of Phase III Study with Mepolizumab in Patients with Severe Hypereosinophilic Syndrome,2017-03-31 06:20:00-04:00,GSK,negative
586036.0,GlaxoSmithKline Shares Move Higher as Mylan Shares Tumble Following News of CRL for Generic Advair Diskus,2017-03-29 13:18:00-04:00,GSK,positive
586037.0,"8-K from Pernix Therapeutics Shows Co., GlaxoSmithKline Have Agreed Current Outstanding Balance of Award is $21.45M",2017-03-21 16:23:00-04:00,GSK,positive
586038.0,GlaxoSmithKline Reports US Regulatory Submission Seeking Expanded Indication for Fluarix Quadrivalent for Infants 6 Months and Older,2017-03-15 11:14:00-04:00,GSK,neutral
586039.0,How The Ultra-Wealthy Are Helping Advance Health And Life Sciences,2017-03-10 15:58:00-05:00,GSK,positive
586040.0,"GlaxoSmithKline Reports MUSCA Study Showed Nucala Significantly Improved Quality of Life, Lung Function in Severe Asthma Patients with Eosinophilic Phenotype",2017-03-06 10:24:00-05:00,GSK,positive
586041.0,GlaxoSmithKline Reports Positive Results for Relvar Ellipta Lung Function Study in Patients with Well-controlled Asthma,2017-02-23 04:49:00-05:00,GSK,positive
586042.0,"Dysfunction, Heartbreak And Love: 11 Most Interesting Corporate Couples",2017-02-14 17:40:00-05:00,GSK,positive
586043.0,Q4 2016 Real-Time Call Brief,2017-02-08 10:36:00-05:00,GSK,neutral
586044.0,"GlaxoSmithKline Reports Q4 Core EPS 26.1p, Group Sales £7.586B",2017-02-08 07:23:00-05:00,GSK,neutral
586045.0,"Earnings Scheduled For February 8, 2017",2017-02-08 04:40:00-05:00,GSK,neutral
586046.0,Theravance Biopharma Says Royalties from 'Closed Triple' Expected as Early as 2018,2017-01-09 06:15:00-05:00,GSK,neutral
586047.0,Ionis Pharma's Target Lifted To $68 Following More Favorable Spinraza Ramp Estimates,2016-12-29 10:35:00-05:00,GSK,positive
586048.0,6 Worst Biotech Stocks Of 2016,2016-12-23 11:50:00-05:00,GSK,negative
586049.0,Positive Zika Vaccine Update May Ignite Inovio Short Squeeze,2016-12-21 11:05:00-05:00,GSK,positive
586050.0,Jefferies' 2017 Global Pharma Outlook,2016-12-19 10:56:00-05:00,GSK,neutral
586051.0,"GSK, Innoviva Announce Start of Phase III Study of Once-Daily Closed Triple Combination Therapy FF/UMEC/VI in Patients with Asthma",2016-12-19 05:58:00-05:00,GSK,neutral
586052.0,What We Know About Trump's Potential Pick To Head The FDA,2016-12-12 14:08:00-05:00,GSK,neutral
586053.0,"Pfizer, J&J, Other Big Pharma Names Dip Lower Just After the Open",2016-12-07 09:34:00-05:00,GSK,negative
586054.0,GSK Files Regulatory Submission in European Union for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD,2016-12-02 09:18:00-05:00,GSK,neutral
586055.0,"Glaxosmithkline Announces EU Regulatory Submission Of Shingles Vaccine, A Japan Submission Planned In 2017 - Reuters",2016-11-25 08:42:00-05:00,GSK,neutral
586056.0,Theravance Biopharma Highlights Filing of U.S. New Drug Application for the Closed Triple in COPD by GlaxoSmithKline and Innoviva,2016-11-21 16:38:00-05:00,GSK,neutral
586057.0,GSK receives FDA approval for expanded indication for FluLaval Quadrivalent for infants 6 months and older,2016-11-21 08:29:00-05:00,GSK,positive
586058.0,GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD,2016-11-21 07:04:00-05:00,GSK,neutral
586059.0,"GSK, Innovia Announce FDA Filing in US for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD",2016-11-21 04:13:00-05:00,GSK,neutral
586060.0,GSK Reports Positive Results In 4th Consecutive Pivotal Trial of Benlysta,2016-11-14 10:36:00-05:00,GSK,positive
586061.0,Why The Time Has Come To Buy Novartis,2016-11-10 10:57:00-05:00,GSK,neutral
586062.0,Senator Bernie Sanders Tweets: The business model of the drug industry is fraud. Glaxo put patients at risk to increase their profits.,2016-11-02 10:35:00-04:00,GSK,negative
586063.0,"GlaxoSmithKline Wins European Approval for Updated Boostrix, Boostrix Polio Label for Benefit to Pregnant Women",2016-11-01 10:05:00-04:00,GSK,positive
586064.0,"Glaxosmithkline Reports In SEC Filing An 8.3% Stake In Crispr Therapeutics, May Engage in Communications With Co's Board",2016-10-28 16:23:00-04:00,GSK,positive
586065.0,"GlaxoSmithKlein Q3 EPS $0.43 vs $0.74 est, Revenue $10.0B vs $8.9B est, May Not Compare",2016-10-26 07:15:00-04:00,GSK,neutral
586066.0,"Earnings Scheduled For October 26, 2016",2016-10-26 04:02:00-04:00,GSK,neutral
586067.0,6 Big Pharma Companies Left To Report September Quarterly Figures,2016-10-25 13:45:00-04:00,GSK,neutral
586068.0,Goldman Says These 25 Healthcare Stocks Are Immune To The Election,2016-10-24 10:55:00-04:00,GSK,positive
586069.0,Hearing SEC Has Said Glaxo Will Pay $20M to Settle Civil Foreign Bribery Charges,2016-09-30 14:11:00-04:00,GSK,negative
586070.0,Hearing Glaxo Has Said Intends to Sell Remaining Holding in Aspen,2016-09-28 11:20:00-04:00,GSK,neutral
586071.0,"vTv Therapeutics Shares Initiated With Buy Rating, $13 Target",2016-09-26 11:46:00-04:00,GSK,positive
586072.0,PiperJaffray Initiates Coverage on GlaxoSmithKline at Overweight,2016-09-23 06:46:00-04:00,GSK,negative
586073.0,"HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target",2016-09-22 10:45:00-04:00,GSK,neutral
586074.0,Epizyme Gets $6M Milestone Payment from GlaxoSmithKline,2016-09-15 06:30:00-04:00,GSK,neutral
586075.0,GlaxoSmithKline Reports Randomized Phase III Study of ZOE-70 Showed 90% Efficacy in Adults Aged 70+ Who Maintained Usage for At Least Four Years,2016-09-14 17:39:00-04:00,GSK,neutral
586076.0,"The Market In 5 Minutes: Huge FDA News, Major Mid-Week M&A",2016-09-14 09:17:00-04:00,GSK,positive
586077.0,Benzinga's Top Downgrades,2016-09-14 09:16:00-04:00,GSK,positive
586078.0,Exane BNP Paribas Downgrades GlaxoSmithKline to Underperform,2016-09-14 04:58:00-04:00,GSK,neutral
586079.0,EU Reports Regulatory Submission For Sirukumab In RA,2016-09-12 07:35:00-04:00,GSK,neutral
586080.0,Aspen Global to Acquire Portfolio of Anesthetics from GSK for Initial Payment of £180M Plus Milestone Payments of Up to £100M,2016-09-12 04:24:00-04:00,GSK,neutral
586081.0,"UPDATE: Theravance Says GSK's Regulatory Submissions On Track for Closed Triple in US, Europe by End of '16",2016-09-07 17:06:00-04:00,GSK,neutral
586082.0,UPDATE: Theravance Biopharma Says Will Be Entitled to Receive 85% Economic Interest in Closed Triple Royalties Paid by GSK as Part of Deal with Innoviva,2016-09-07 17:05:00-04:00,GSK,positive
586083.0,Theravance Bipharma Announces Clinically Meaningful Benefits For The Closed Triple,2016-09-07 17:05:00-04:00,GSK,positive
586084.0,GSK Presents Positive Results from Phase III FULFIL Study of Closed Triple Combination Therapy FF/UMEC/VI vs Symbicort Turbohaler in COPD at ERS International Congress,2016-09-06 09:53:00-04:00,GSK,positive
586085.0,Almost The Whole World In This ETF's Hands,2016-08-29 13:30:00-04:00,GSK,neutral
586086.0,"Waiting For Growth, Or A Better Valuation, Argus Stays Sidelined On Novartis Shares",2016-08-24 15:30:00-04:00,GSK,positive
586087.0,ViiV Healthcare Launches Phase III Program Evaluating Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment - PRN,2016-08-16 08:59:00-04:00,GSK,neutral
586088.0,"GSK, Alphabet's Verify to Establish Galvani Bioelectronics",2016-08-01 05:54:00-04:00,GSK,neutral
586089.0,"Legg Mason Introduces International High Dividend, Low Vol ETF",2016-07-29 15:27:00-04:00,GSK,negative
586090.0,GlaxoSmithKline Reports 1H Core EPS Up 12% to 44.3 Pence,2016-07-27 07:03:00-04:00,GSK,neutral
586091.0,GlaxoSmithKline Reports Shipping of '16-'17 Seasonal Flu Vaccines for US Market,2016-07-20 15:53:00-04:00,GSK,negative
586092.0,GlaxoSmithKline Announces Aria Study Shows Superior Efficacy of Triumeq For Treatment-NaÏve Women Living With HIV,2016-07-18 06:19:00-04:00,GSK,positive
586093.0,Jefferies Upgrades GlaxoSmithKline to Buy,2016-07-14 06:31:00-04:00,GSK,neutral
586094.0,Believe It: Brexit Isn't All Bad For U.K. ETFs,2016-07-11 08:41:00-04:00,GSK,positive
586095.0,5 Stocks Cut In Half In 2016,2016-07-05 11:26:00-04:00,GSK,negative
586096.0,Benzinga's Top Upgrades,2016-07-01 09:05:00-04:00,GSK,positive
586097.0,"Theravance Biopharma Highlights Positive Top-Line Results from Pivotal Phase 3 FULFIL Study of Closed Triple Announced by GlaxoSmithKline, Innoviva",2016-06-20 21:15:00-04:00,GSK,positive
586098.0,"GlaxoSmithKline, Innoviva Announce FULFIL Study  Met Two Co-primary Endpoints",2016-06-20 04:12:00-04:00,GSK,neutral
586099.0,Veeva Announces GSK Has Added Co.'s Commercial Cloud App as Part of Ongoing Program to Transform Customer Engagement Globally,2016-06-09 07:19:00-04:00,GSK,positive
586100.0,Supreme Court Rejects GlaxoSmithKline Bid to Throw Out Racketeering Lawsuits Over Diabetes Drug Safety Risks,2016-06-06 09:33:00-04:00,GSK,positive
586101.0,GSK Informed FivePrime that FDA had Imposed Partial Clinical hold on GSK's Phase 1b Trial of FP-1039/GSK3052230,2016-06-06 06:10:00-04:00,GSK,negative
586102.0,"OncoMed Presents Phase 1b Data for First-in-Class Treatments in Ovarian, Breast and Lung Cancer at #ASCO16",2016-06-05 09:32:00-04:00,GSK,negative
586103.0,GlaxoSmithKline And Innoviva Plan To File A NDA For Triple Combination Therapy,2016-06-02 14:45:00-04:00,GSK,neutral
586104.0,"GlaxoSmithKline, Innoviva Offer Regulatory Update on US Filing Plans for Closed Triple Combo Therapy FF/UMEc/VI for Patients with COPD",2016-06-02 11:02:00-04:00,GSK,neutral
586105.0,Proactive Investors Reports GSK Could be Buyer of Pacific Biosciences,2016-06-02 10:35:00-04:00,GSK,positive
586106.0,"GlaxoSmithKline, to File NDA for Closed Triple Combination Therapy FF/UMEC/VI in Patients With COPD",2016-06-02 05:11:00-04:00,GSK,neutral
586107.0,Regulus Reports Expansion of Trial Collab Deal with Glaxo; Phase II Study On Track to Report Interim Results by Yearend,2016-06-01 08:06:00-04:00,GSK,neutral
586108.0,BMO Downgrades Ionis Pharma After Platelet Concerns Spill Over To Volanesorsen,2016-05-27 15:28:00-04:00,GSK,neutral
586109.0,GlaskoSmithKlinke's Strimvelis Gets EMA To Treat Rare Disease,2016-05-27 10:51:00-04:00,GSK,positive
586110.0,Cowen Downgrades Ionis After Thrombocytopenia Issues,2016-05-26 13:33:00-04:00,GSK,neutral
586111.0,"GlaxoSmithKline Says Co, Innoviva Announced Positive Headline Results from Innovative Salford Lung Study in Chronic Obstructive Pulmonary Disease",2016-05-24 05:59:00-04:00,GSK,positive
586112.0,GSK Chairman Says Breakup of Group Not Being Considered at the Moment -Reuters,2016-05-05 10:54:00-04:00,GSK,neutral
586113.0,The Market In 5 Minutes: Do Or Die,2016-05-03 09:44:00-04:00,GSK,negative
586114.0,Benzinga's Top Upgrades,2016-05-03 08:57:00-04:00,GSK,positive
586115.0,Codexis Announces Completion CodeEvolver Technology Transfer to GSK; Earns $7.5M Milestone Payment,2016-05-02 07:04:00-04:00,GSK,neutral
586116.0,GlaxoSmithKline Reports Q1 Core EPS £0.198; Sees FY16 Core EPS Growth 10-12%,2016-04-27 07:10:00-04:00,GSK,positive
586117.0,"IIFL Capital Says GlaxoSmithKline's Consumer Business Structural Story Is Intact, Says Zubair Ahmed Interview Is 'being wrongly nuanced', Maintains Add Recommendation",2016-04-07 08:07:00-04:00,GSK,positive
586118.0,SocGen Picks New Favorites In Big Pharma,2016-04-06 13:44:00-04:00,GSK,positive
586119.0,Evidence Pfizer Could Revisit GlaxoSmithKline Or AstraZeneca Deals If Allergan Falls Through,2016-04-05 12:30:00-04:00,GSK,neutral
586120.0,"The Market In 5 Minutes: Tuesday, April 5, 2016",2016-04-05 10:38:00-04:00,GSK,neutral
586121.0,"GlaxoSmithKline Receives Positive CHMP Opinion For Strimvelis, Gene Therapy To Treat ADA-SCID",2016-04-01 10:09:00-04:00,GSK,positive
586122.0,GlaxoSmithKline Shares Higher in Premarket Following Upgrade at Citigroup from Neutral to Buy,2016-03-30 05:03:00-04:00,GSK,positive
586123.0,Citi Downgrades Novartis Following SAG Investigation,2016-03-29 10:10:00-04:00,GSK,neutral
586124.0,GlaxoSmithKline Receives Marketing Approval for Nucala in Japan,2016-03-29 05:05:00-04:00,GSK,positive
586125.0,Theravance Biopharma Holder GlaxoSmithKline Reports 24.3% Stake As Of March 14,2016-03-24 16:20:00-04:00,GSK,neutral
586126.0,Glaxo CEO Witty Says Massive Amount of Discounts on U.S. Drugs Creates Lack of Transparency in Drug Pricing -Reuters,2016-03-17 11:08:00-04:00,GSK,negative
586127.0,GSK Says Advair Diskus Achieves Primary Endpoint in LABA Safety Study of Children Aged 4-11 Years with Asthma,2016-03-17 04:51:00-04:00,GSK,positive
586128.0,GSK CEO Sir Andrew Witty to Retire in March 2017,2016-03-17 04:49:00-04:00,GSK,neutral
586129.0,"GlaxoSmithKline, Miltenyi Biotec to Collaborate on Cell and Gene Therapy",2016-03-16 07:25:00-04:00,GSK,neutral
586130.0,Glaxosmithkline Presents Data AAAAI on Efficacy of Nucala in Severe Asthma Patients Stratified by Eosinophil Levels; Study  Showed Severe Asthma Patients Who Received Nucala Had Significant Improvement in Exacerbation Rates vs Placebo,2016-03-07 12:57:00-05:00,GSK,negative
586131.0,25 Headlines Moving The Markets This Week,2016-02-29 12:36:00-05:00,GSK,neutral
586132.0,Benzinga's Top Initiations,2016-02-26 09:51:00-05:00,GSK,positive
586133.0,Cantor Fitzgerald Initiates Coverage on GlaxoSmithKline at Hold,2016-02-26 06:21:00-05:00,GSK,neutral
586134.0,"Viiv Healthcare Phase II Study, Says Comparable Viral Suppression Rates Btwn Injectable Regiment & 3 Drug Oral Regimen",2016-02-23 14:57:00-05:00,GSK,neutral
586135.0,"Dynavax, GlaxoSmithKline Battling In Same Industry: Who Will Win?",2016-02-23 12:30:00-05:00,GSK,positive
586136.0,"Lannet Company Announces FDA Approval Of Nasal Spray, Shares Tick Higher",2016-02-22 12:36:00-05:00,GSK,positive
586137.0,"VBI Vaccines, GlaxoSmithKline Partner On Research To Enhance Vaccine Stability",2016-02-09 08:31:00-05:00,GSK,neutral
586138.0,GSK CEO Says Not Wise to Make Definitive Choice On Consumer Spin-Off In Short Term,2016-02-03 07:29:00-05:00,GSK,negative
586139.0,GSK CEO Says Willing to have Standby Capability for Zika Vaccine,2016-02-03 07:29:00-05:00,GSK,neutral
586140.0,Hearing Glaxo Has Issued US Regulatory Submission for Expanded Indication for Flulaval for Infants 6+ Mos.,2016-02-02 09:03:00-05:00,GSK,neutral
586141.0,"Adaptimmune, GSK Expand Strategic Immunotherapy Collaboration That Creates 8 Combination Study Opportunities",2016-02-02 08:28:00-05:00,GSK,positive
586142.0,"EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4",2016-01-29 13:38:00-05:00,GSK,positive
586143.0,"Benzinga's M&A Chatter for Thursday January 28, 2015",2016-01-28 23:27:00-05:00,GSK,neutral
586144.0,Hearing Unconfirmed Market Chatter of Potential JNJ Deal to Acquire GlaxoSmithKline,2016-01-28 11:19:00-05:00,GSK,negative
586145.0,"GlaxoSmithKline Consumer Nigeria Plc Receives Offer from Suntory Beverage to Divest Bottling, Distribution Of Drinks Business -Reuters",2016-01-28 07:39:00-05:00,GSK,neutral
586146.0,Bryan Garnier Upgrades GlaxoSmithKline to Buy,2016-01-27 08:23:00-05:00,GSK,neutral
586147.0,"Bloomberg: GlaxoSmithKline, Qualcomm To Jointly Develop Medical Technology",2016-01-20 13:34:00-05:00,GSK,neutral
586148.0,"GlaxoSmithKline, Qualcomm Said to be in Talks for JV -Bloomberg",2016-01-20 12:54:00-05:00,GSK,neutral
586149.0,"Ionis Pharma. Reports GSK Begins Phase 1 Study Of IONIS-HBV-L Rx, To Receive $1.5M Milestone Payment",2016-01-13 07:07:00-05:00,GSK,neutral
586150.0,"Investment Fund Manager: GlaxoSmithKline Should Be Broken Up, Shares Tick Higher",2016-01-08 11:57:00-05:00,GSK,negative
586151.0,Woodford Investment Management Founder Neil Woodford Says GlaxoSmithKline Should be Separated into Two Companies -BBC,2016-01-08 05:30:00-05:00,GSK,neutral
586152.0,Napodano: Here Is Actinium's Place Among The CAR-T Hype & Radiopharma Busts,2016-01-07 14:11:00-05:00,GSK,neutral
586153.0,"Pacific Biosciences Shares Up ~2%, Traders Attribute Move To Chatter GSK May Seek To Buy Pacific Biosciences",2016-01-07 10:37:00-05:00,GSK,positive
586154.0,Why This Codexis Analyst Is Confident Stock Is Worth $6,2016-01-06 12:51:00-05:00,GSK,positive
586155.0,Watch Stocks of Co.'s with Flu-Related Solutions; Macquarie Note Earlier Highlighted 'Early Flu Results Lagging,2015-12-22 12:06:00-05:00,GSK,negative
586156.0,Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare for $350M Upfront Plus Milestone Payments,2015-12-18 04:17:00-05:00,GSK,neutral
586157.0,"Amgen Reports Reacquisition of All Product Rights to Prolia, No Terms Disclosed",2015-12-14 16:00:00-05:00,GSK,negative
586158.0,GSK  Receives Approval for Nucala in Canada to Treat Severe Eosinophilic Asthma -Reuters,2015-12-10 06:02:00-05:00,GSK,positive
586159.0,GSK Receives EMA Authorization for Nucala In 31 Countries,2015-12-02 11:43:00-05:00,GSK,neutral
586160.0,"EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And Biotech Picks",2015-11-25 09:53:00-05:00,GSK,positive
586161.0,GSK Announces Start of Phase III Study of Sirukumab in Giant Cell Arteritis -Reuters,2015-11-25 05:25:00-05:00,GSK,neutral
586162.0,"FBB Capital Partners Mike Bailey On Pfizer, Allergan Deal: ""Allergan good choice for [Pfizer], less risk of cultural clash compared to British company like GlaxoSmithKline""",2015-11-24 13:38:00-05:00,GSK,positive
586163.0,Idera to Collaborate With GSK to Identify 3rd Generation Antisense Molecules for Treatment of Renal Disease,2015-11-23 08:01:00-05:00,GSK,neutral
586164.0,"NIH Announces Initiative to Develop Long-Acting HIV Treatment,d Prevention Tools In Partnership With GlaxoSmithKline -Reuters",2015-11-18 10:48:00-05:00,GSK,neutral
586165.0,ISIS Pharma Called A 'Sleeper Awakening' At Piper Jaffray,2015-11-05 10:25:00-05:00,GSK,neutral
586166.0,FDA Approves Nucala for Use With Other Asthma Medicines for Maintenance Treatment of in Patients Age 12 and Older,2015-11-04 17:16:00-05:00,GSK,positive
586167.0,GSK CEO Says 'No Comment' to Report Pfizer Approached GSK Prior to Allergan Talks -Reuters,2015-11-03 07:26:00-05:00,GSK,negative
586168.0,Regulus Expands Development of RG-101 through Clinical Trial Collaboration with GSK,2015-11-03 07:16:00-05:00,GSK,positive
586169.0,"UPDATE: Glaxo Says ~80% of Medicines, Vaccines in New R&D Portfolio Have Chance to Be 'First In Class'",2015-11-03 06:59:00-05:00,GSK,positive
586170.0,"UPDATE: Glaxo Portfolio Includes 40 Potential New Medicines, Vaccines",2015-11-03 06:59:00-05:00,GSK,neutral
586171.0,GlaxoSmithKline Unveils Innovative R&D Portfolio to Investors,2015-11-03 06:58:00-05:00,GSK,positive
586172.0,"Pfizer Reports Collaboration Deal with GlaxoSmithKline Related to Next-Gen Design of PCMM Oral Solid Dose Development, Manufacturing Units",2015-10-29 08:11:00-04:00,GSK,positive
586173.0,"GlaxoSmithKline Reports Q3 EPS $0.11, Backs FY 2015 Guidance",2015-10-28 08:01:00-04:00,GSK,negative
586174.0,GSK's candidate Shingles Vaccine Containing Agenus' QS-21 Stimulon Shows 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Years and Older,2015-10-27 07:14:00-04:00,GSK,neutral
586175.0,GSK's Candidate Shingles Vaccine Demonstrates 90% Efficacy Against Shingles in People 70 Years of Age and Over,2015-10-27 06:54:00-04:00,GSK,neutral
586176.0,GSK's Advair Diskus Achieves Primary Endpoint in Laba Safety Study Of Patients With Asthma,2015-10-27 06:53:00-04:00,GSK,positive
586177.0,ISIS Pharmaceuticals Earns $5M from GSK for Initiation of Phase 1 Study of ISIS-GSK4-L Rx,2015-10-26 07:03:00-04:00,GSK,neutral
586178.0,"Barron's Recap: Barnes & Noble, DSW Could Skyrocket",2015-10-25 22:23:00-04:00,GSK,positive
586179.0,Benzinga's Top Upgrades,2015-10-20 09:11:00-04:00,GSK,positive
586180.0,GlaxoSmithKline Announces Positive Data For Incruse Ellipta Comparisons,2015-10-20 08:04:00-04:00,GSK,positive
586181.0,Credit Suisse Upgrades GlaxoSmithKline to Neutral,2015-10-20 07:34:00-04:00,GSK,positive
586182.0,The 15 Biggest Mergers Of All Time,2015-10-19 13:51:00-04:00,GSK,neutral
586183.0,Option Alert: $GSK Jan $43 Call; 8500 Contracts @Ask @$1.20,2015-10-16 12:00:00-04:00,GSK,positive
586184.0,GlaxoSmithKline Spike To HOD Following JP Morgan Upgrade To Neutral,2015-10-12 11:45:00-04:00,GSK,positive
586185.0,JP Morgan Upgrades GlaxoSmithKline to Neutral,2015-10-12 11:43:00-04:00,GSK,positive
586186.0,Liquidia Technologies And GlaxoSmithKline Advance Existing Collaboration; GlaxoSmithKline Exercises Option For Inhaled Therapeutics,2015-09-30 12:44:00-04:00,GSK,neutral
586187.0,Study for Glasko Drug Theravance Shows Reduced Risk For Clinically Imporant Pulmonary Disease Deterioration,2015-09-28 06:12:00-04:00,GSK,negative
586188.0,"GlaxoSmithKline Receives Positive CHMP Opinion In Europe FOr Novel Anti-IL5 Biologival Nucala, Treats Patients With Severe Refractory Eosinophlilic Asthma",2015-09-24 10:06:00-04:00,GSK,positive
586189.0,National Vaccine Info Center Releases Questions Related to FDA's Fast Track Designation of Glaxo's Squalene Flu Vaccine,2015-09-16 12:29:00-04:00,GSK,negative
586190.0,GlaxoSmithKline's 'Unexpected Disappointment',2015-09-12 13:33:00-04:00,GSK,negative
586191.0,"US Stock Futures Rise Ahead Of Jobless Claims, Wholesale Inventories Data",2015-09-10 08:06:00-04:00,GSK,neutral
586192.0,"Five Prime Therapeutics Announces Initial Data From Ongoing Phase 1b Trial of FP-1039 in Squamous NSCLC, Mesothelioma",2015-09-10 04:33:00-04:00,GSK,neutral
586193.0,Theravance Just Lost Its Catalyst,2015-09-09 13:45:00-04:00,GSK,negative
586194.0,GSK Shares Fall Following Announcement of No Statistically Significance SUMMIT COPD CV Survival Study Results,2015-09-08 14:55:00-04:00,GSK,positive
586195.0,"UPDATE: GSK, Theravance Report Results From the SUMMIT COPD CV Survival Study; Primary Endpoint Not Statistically Significant",2015-09-08 14:42:00-04:00,GSK,negative
586196.0,"GSK, Theravance Report Results From the SUMMIT COPD CV Survival Study; Primary Endpoint Not Statistically Significant",2015-09-08 14:41:00-04:00,GSK,negative
586197.0,"Probes Reporter's Latest Updates: Choice Hotels, GlaxoSmithKline, Itron, Kinross Gold And More",2015-09-04 14:27:00-04:00,GSK,neutral
586198.0,GlaxoSmithKline Holder Theravance Reports 24.5% Stake As Of Dec 31,2015-09-02 12:48:00-04:00,GSK,neutral
586199.0,UPDATE: GlaxoSmithKline Says Tianjin Explosion Strained Supply Of Hepatitis-B Treatment Marketed In Japan,2015-09-01 14:22:00-04:00,GSK,negative
586200.0,GlasxoSmithKlien Says It Holds Sales Rights To Tenozet In Japan/China And Formulates Drug At Tianjin Plant Which Exploded,2015-09-01 14:21:00-04:00,GSK,neutral
586201.0,Five Prime Therapeutics Announces Oral Presentation of Initial Data From Ongoing Phase 1b Trial of FP-1039/GSK3052230 in Squamous Non Small Cell Lung Cancer and Mesothelioma at World Conference on Lung Cancer,2015-08-24 04:20:00-04:00,GSK,negative
586202.0,"US Stock Futures Slide Ahead Of Deere, Foot Locker Earnings",2015-08-21 07:06:00-04:00,GSK,neutral
586203.0,EU Commission Clears Acquisition of Certain GSK Consumer Health Assets by Perrigo -Reuters,2015-08-21 06:08:00-04:00,GSK,positive
586204.0,"Novartis Acquires Rremaining Rghts to GSK's Ofatumumab to Develop Treatments for MS, Other Autoimmune Indications",2015-08-21 04:34:00-04:00,GSK,neutral
586205.0,GlaxoSmithKline Facing Corruption Charges in Romania -Reuters,2015-07-29 13:54:00-04:00,GSK,negative
586206.0,"GlaxoSmithKline Reports Q2 EPS 17.3pence, no estimates",2015-07-29 07:03:00-04:00,GSK,negative
586207.0,GSK's Malaria Vaccine With Agenus' QS-21 Stimulon Receives Positive CHMP Opinion for Prevention of Malaria in Young Children,2015-07-24 04:42:00-04:00,GSK,positive
586208.0,Benzinga's Volume Movers,2015-07-09 10:32:00-04:00,GSK,neutral
586209.0,U.S. CDC committee recommends physicians make individual decisions on the use of meningococcal group B vaccines,2015-06-24 13:33:00-04:00,GSK,positive
586210.0,5 NYSE Healthcare Stocks With The Highest ROE,2015-06-22 09:29:00-04:00,GSK,neutral
586211.0,"Pfizer To Acquire Nimenrix, Mencevax From GlaxoSmithKline  For ~$130M",2015-06-22 07:01:00-04:00,GSK,neutral
586212.0,"Chardan: Sell Axovant Sciences, RVT-101 Market Pricing Is 'Highly Irrational'",2015-06-18 09:37:00-04:00,GSK,negative
586213.0,"Jim Cramer Advises His Viewers On GlaxoSmithKline, American International Group, Caesars And Caesars Acquisition",2015-06-18 07:12:00-04:00,GSK,neutral
586214.0,Axovant Sciences' IPO Sparks Comment On 'Biotech Bubble',2015-06-12 10:34:00-04:00,GSK,neutral
586215.0,"FDA Approves Glaxosmithkline's Severe Asthma Drug Mepolizumab In Adults 18+, But Not In Children Age 12-17",2015-06-11 15:26:00-04:00,GSK,neutral
586216.0,Hedge Funds Buying Biotech IPO Operated By Ex-Fund Manager,2015-06-10 11:19:00-04:00,GSK,neutral
586217.0,Mylan Launches Sirdupla in the UK; Bioequivalent alternative to GlaxoSmithKline's Seretide Evohaler,2015-06-08 04:18:00-04:00,GSK,neutral
586218.0,Hearing Morgan Stanley Downgrades GlaxoSmithKline to Equalweight,2015-06-04 11:44:00-04:00,GSK,neutral
586219.0,GSK Shares Spike Lower,2015-06-04 11:36:00-04:00,GSK,neutral
586220.0,Perrigo to Acquire Portfolio of Leading OTC Brands from GSK,2015-06-02 06:34:00-04:00,GSK,neutral
586221.0,"Oppenheimer: Buy Five Prime Therapeutics, It's Worth $45/Share",2015-05-15 10:50:00-04:00,GSK,positive
586222.0,"GSK, NewLink Vaccine Trials May Not Produce Useful Efficacy Data as Ebola Disappears in W. Africa -Reuters",2015-05-12 08:36:00-04:00,GSK,negative
586223.0,"GlaxoSmithKline Buys 85,579 Shares Of Theravance @$16.00/Share -Form 4",2015-05-11 15:44:00-04:00,GSK,positive
586224.0,GlaxoSmithKline Reports Q1 Core Operating Profit GBP$1.31B Sales GBP$5.6B,2015-05-06 07:01:00-04:00,GSK,positive
586225.0,Glaxo Says Will Retain Existing Holding in VIIV Healthcare,2015-05-06 07:01:00-04:00,GSK,neutral
586226.0,GlaxoSmithKline Announce EU Regulatory Submission for Gene Therapy to Treat Rare Disease ADA-SCID -Reuters,2015-05-05 05:16:00-04:00,GSK,positive
586227.0,"Glaxo, Theravance Announces BREO ELIPTA Approved by FDA for Treatment of Adults with Asthma in US",2015-04-30 16:37:00-04:00,GSK,positive
586228.0,GSK's Nigerian Unit Says Q1 Pretax Profit Fell 52.7% vs Year Ago,2015-04-30 12:25:00-04:00,GSK,positive
586229.0,142 HIV Cases Linked to Indiana Outbreak -DJ,2015-04-24 13:47:00-04:00,GSK,neutral
586230.0,GSK's Malaria Vaccine Phase 3 Study Containing Agenus' QS-21 Published in The Lancet,2015-04-24 07:05:00-04:00,GSK,neutral
586231.0,SocGen Initiates Big Drug/Pharma Names,2015-04-15 12:07:00-04:00,GSK,neutral
586232.0,7 Trends Drug Investors Should Know,2015-04-13 16:32:00-04:00,GSK,neutral
586233.0,FDA Says High-Dose Influenza Vaccine Significantly More Effective Than Standard Dose in Elderly -Reuters,2015-04-08 09:49:00-04:00,GSK,positive
586234.0,Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE,2015-04-06 04:46:00-04:00,GSK,positive
586235.0,"Experimental Ebola Vaccines from Glaxo, Newlink Genetics, Being Tested in Liberia Appear Safe -Reuters",2015-03-26 17:29:00-04:00,GSK,positive
586236.0,"Cold Spring Harbor Laboratory Announces Collaboration with GSK for Development of Treatment for Obesity, Type 2 Diabetes",2015-03-23 10:36:00-04:00,GSK,neutral
586237.0,"8-K from Theravance Shows Co., Glaxo Introducing REVLAR ELLIPTA in Italy",2015-03-20 07:40:00-04:00,GSK,neutral
586238.0,"Glaxo, Theravance Announce FDA Panel Voted to Support Efficacy, Safety, Voted Against Approval for Proposed Indication in 12-17 Olds",2015-03-19 17:58:00-04:00,GSK,positive
586239.0,"Hearing FDA Panel Has Said Glaxo, Theravance's BREO ELLIPTA In Need of Larger Safety Trial for Both Adults, Children",2015-03-19 16:55:00-04:00,GSK,positive
586240.0,"FDA Panel Has Voted Glaxo, Theravance's BREO ELLIPTA Failed to Win Backing for Asthma Treatment",2015-03-19 16:24:00-04:00,GSK,positive
586241.0,Hearing Glaxo May Sell About Half of ~12% STake in Aspen,2015-03-12 11:16:00-04:00,GSK,neutral
586242.0,Pernix Therapeutics Says GlaxoSmithKline Claimed That Co Owes Damages Relating to Alleged Breach of Covenant Contained in Asset Purchase Agreement; Pernix Says Booked Reserve of $3.5M for 2014 for Legal Settlement Related the Matter,2015-02-25 08:48:00-05:00,GSK,positive
586243.0,Canada Competition Bureau Says Won't Block Glaxosmithkline-Novartis Deal,2015-02-23 11:58:00-05:00,GSK,positive
586244.0,"Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices",2015-02-20 13:10:00-05:00,GSK,positive
586245.0,New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys,2015-02-20 07:22:00-05:00,GSK,positive
586246.0,"Lupin, Celon Announce Strategic Development, Licensing Agreement for Generic Advair Diskus",2015-02-17 06:38:00-05:00,GSK,positive
586247.0,"Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4",2015-02-13 14:19:00-05:00,GSK,neutral
586248.0,What's GlaxoSmithKline Doing In The E.U.?,2015-02-09 21:13:00-05:00,GSK,neutral
586249.0,"After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?",2015-02-06 15:28:00-05:00,GSK,positive
586250.0,"Glaxo Shares Up ~3% Following Q4 EPS $0.342, Diluted EPS $0.339, Sales $9.871B",2015-02-04 07:33:00-05:00,GSK,positive
586251.0,"GlaxoSmithKline Hires Citi, Goldman Sachs, Morgan Stanley as Advisors for Proposed ViiV Healthcare IPO, According to Sources -Reuters",2015-02-04 05:40:00-05:00,GSK,neutral
586252.0,"First Results from Human Trial of GlaxoSmithKline Ebola Vaccine, Show it is Safe, Generates Immune Response, Scientists Say Larger Trials are Needed Regarding Efficacy -Reuters",2015-01-28 17:04:00-05:00,GSK,positive
586253.0,GlaxoSmithKline Expands Its Portfolio Of Medicines In The US For Patients With Asthma And COPD,2015-01-26 09:21:00-05:00,GSK,positive
586254.0,Benzinga's Weekend M&A Chatter,2015-01-25 18:50:00-05:00,GSK,neutral
586255.0,Novartis CEO: Supporting Affordable Care Act Supports Insuring Americans,2015-01-23 06:55:00-05:00,GSK,positive
586256.0,GSK Announces First Batch of Candidate Ebola Vaccine being Shipped to W. Africa,2015-01-23 04:45:00-05:00,GSK,neutral
586257.0,New Street Research Downgrades GlaxoSmithKline to Reduce,2015-01-22 09:20:00-05:00,GSK,neutral
586258.0,Mylan Reports Launch of Generic of Glaxo's Epivir-HBV Tablets,2015-01-15 14:31:00-05:00,GSK,neutral
586259.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2,2015-01-12 11:03:00-05:00,GSK,neutral
586260.0,Hearing Boutique Firm Cautious on GlaxoSmithKline,2014-12-19 10:21:00-05:00,GSK,negative
586261.0,Phase 3 Study of GSK Shingles Vaccine Containing Agenus Adjuvant Met Primary Endpoint; Agenus Shares +8.5% Premarket,2014-12-18 08:19:00-05:00,GSK,positive
586262.0,Fitch Affirms GlaxoSmithKline PLC at 'A+'; Revises Outlook to Negative,2014-12-17 11:15:00-05:00,GSK,negative
586263.0,Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines,2014-12-11 14:14:00-05:00,GSK,neutral
586264.0,"#PreMarket Primer: Thursday, December 4: Beige Book Paints Positive Picture Of U.S. Economy",2014-12-04 08:34:00-05:00,GSK,positive
586265.0,"Glaxo to Cut Headcount in US Commercial, Research Operations, Will Eliminate 'Several Hundred' Positions",2014-12-03 12:58:00-05:00,GSK,negative
586266.0,GlaxoSmithKline's Move A Testament That Pharma Companies Are Turning Focus Away From U.S.,2014-12-01 11:58:00-05:00,GSK,neutral
586267.0,GlaxoSmithKline Shares Rise 1% Premarket Following Weekend Rumor of Hundreds of US Layoffs Coming,2014-12-01 07:42:00-05:00,GSK,positive
586268.0,"GlaxoSmithKline to Cut Hundreds of US Jobs, According to Sources -Reuters",2014-11-30 11:37:00-05:00,GSK,negative
586269.0,Dynavax Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of Collaboration With GlaxoSmithKline,2014-11-28 06:05:00-05:00,GSK,negative
586270.0,"National Institute of Allergy, Infectious Diseases Issues: GlaxoSmithKline 'Experimental Ebola Vaccine Appears Safe, Prompts Immune Response'",2014-11-26 17:03:00-05:00,GSK,positive
586271.0,"FTC Places Conditions on JV Between GlaxoSmithKline, Novartis",2014-11-26 13:09:00-05:00,GSK,neutral
586272.0,Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization,2014-11-17 04:56:00-05:00,GSK,positive
586273.0,"Reuters Reports Apollo Global Management to Bid for GSK's Mature Drugs Portfolio, According to Sources",2014-11-13 12:49:00-05:00,GSK,positive
586274.0,Ligand Reports Partner GSK Has EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade,2014-11-12 09:17:00-05:00,GSK,negative
586275.0,Reuters Reports Group of Scientists Proposes US Health Officials Find Ebola Treatment in Survivor's Antibodies -Reuters,2014-11-07 09:27:00-05:00,GSK,neutral
586276.0,"Galapagos, GSK Announce Good Efficacy in Psoriasis with GSK2856184 ",2014-11-06 05:08:00-05:00,GSK,positive
586277.0,GSK Announces Regulatory Submissions for Mepolizumab in Severe Eosinophilic Asthma,2014-11-05 06:27:00-05:00,GSK,negative
586278.0,"GlaxoSmithKline Buys 832,456 Shares of Theravance @ $15.36/Share -Form 4",2014-11-04 13:52:00-05:00,GSK,positive
586279.0,Ebola Vaccine Contenders,2014-10-30 10:44:00-04:00,GSK,neutral
586280.0,EMA Says Given Scientific Advice to GlaxoSmithKline on Ebola Vaccine Development Plan -Reuters,2014-10-29 10:13:00-04:00,GSK,neutral
586281.0,"Amended 13G Filing from GlaxoSmithKline on Amicus Therapeutics Shows Liquidated Position; Had Shown 14.38% Stake as of Dec. 31st, 2013",2014-10-28 14:13:00-04:00,GSK,neutral
586282.0,"WHO Says Ebola Death Toll Rises to 4,922 from 10,141 Cases in Eight Countries Through October 23",2014-10-25 07:13:00-04:00,GSK,negative
586283.0,"Report Mali's First Ebola Case, A 2-Year Old Girl has Died, According to Health Official -Reuters",2014-10-24 15:33:00-04:00,GSK,negative
586284.0,"Ebola Related Stocks Move Off Lows on Report of Potential New Ebola Case in Houston, TX",2014-10-24 15:14:00-04:00,GSK,positive
586285.0,CDC Spokesperson Says a Number of Options for Returnees from Africa are on the Table; Changes to Policy Likely,2014-10-24 15:01:00-04:00,GSK,positive
586286.0,NIH Says Did Not Administer Experimental Drugs to Nina Pham While She Was in Maryland Hospital,2014-10-24 12:06:00-04:00,GSK,neutral
586287.0,"Dallas Nurse Nina Pham Declared Virus Free, Being Discharged -DJ",2014-10-24 10:49:00-04:00,GSK,positive
586288.0,UPDATE: WHO Expects First Data on Efficacy of Ebola Vaccines By April 2015,2014-10-24 08:40:00-04:00,GSK,neutral
586289.0,WHO Says at Least Five More Experimental Ebola Vaccines Scheduled to Begin Clinical Trials Soon; Says 100K Does of Vaccine Should be Ready in H1 2015 -Reuters,2014-10-24 08:17:00-04:00,GSK,positive
586290.0,Glaxosmithkline CEO Says Expects to be First Company to Have Ebola Vaccine in Late 2014 -Reuters,2014-10-22 07:30:00-04:00,GSK,neutral
586291.0,FDA AccessData Site Showing GlaxoSmithKline Has Received Orphan Drug Designation for Tafinlar in Lung Cancer,2014-10-21 11:03:00-04:00,GSK,negative
586292.0,Benzinga Weekly Preview: Earnings Season Is In Full Swing,2014-10-19 10:19:00-04:00,GSK,neutral
586293.0,GlaxoSmithKline Says Development of Ebola Vaccine Candidate Progressing at Unprecedented Rate,2014-10-18 14:52:00-04:00,GSK,neutral
586294.0,Sarepta Therapeutics Shares Up On Ebola Drug Safety Study,2014-10-17 10:58:00-04:00,GSK,positive
586295.0,"GlaxoSmithKline Seeking Binding Bids by Next Month for Range of Older Drugs Worth $3B+, According to Sources -Reuters",2014-10-14 13:29:00-04:00,GSK,positive
586296.0,Codexis Shares Spike Higher on Mention as Ebola Play,2014-10-13 15:41:00-04:00,GSK,positive
586297.0," Bavarian Nordic's Shares Rise 8% in Copenhagen on CEO Comments its MVA Technology Can be Used to Improve Ebola Vaccines from JNJ, GSK, Create Biodefense Business",2014-10-13 05:57:00-04:00,GSK,positive
586298.0,"UPDATE: WHO Says Phase One Safety Trials of Experimental Ebola Vaccines from GSK, Newlink Planned or Underway at 10+ Sites",2014-10-01 12:06:00-04:00,GSK,positive
586299.0,"WHO Says GSK, Newlink Working to Boost Capacity to Make Ebola Vaccines",2014-10-01 12:04:00-04:00,GSK,positive
586300.0,Isis Pharma Reports $1.5M Earn from GlaxoSmithKline Related to Advancement of ISIS-GSK4 Rx,2014-10-01 07:02:00-04:00,GSK,neutral
586301.0,Could European Funds Offer An Opportunity Now?,2014-09-23 10:04:00-04:00,GSK,positive
586302.0,3 Partnerships Pushing The Pharmaceutical Sector Forward,2014-09-22 12:59:00-04:00,GSK,neutral
586303.0,GlaxoSmithKline China Found Guilty of Bribing Non-Government Personnel; To Pay £297M Fine ,2014-09-19 05:20:00-04:00,GSK,negative
586304.0,GlaxoSmithKline Shares Spike Higher,2014-09-10 12:59:00-04:00,GSK,positive
586305.0,GlaxoSmithKline Announces £5M Collaboration With UK; South African Medical Research Councils to Support Research Into Non-communicable Diseases in Africa,2014-09-09 09:40:00-04:00,GSK,positive
586306.0,GlaxoSmithKline Publishes Positive Study Results from Mepolizumab - Bloomberg,2014-09-08 08:45:00-04:00,GSK,positive
586307.0,WHO Says Available Supply of Ebola Drugs Will Be Used in the Field,2014-09-05 12:30:00-04:00,GSK,neutral
586308.0,"WHO Says Two Promising Ebola Vaccines Identified; Safety Results from Clinical Trials May be Available in Nov 2015, Paving Way for Use",2014-09-05 12:11:00-04:00,GSK,positive
586309.0,"Theravance, Glaxosmithkline Announce Japan Launch Of Anoro Ellipta, Theravance to Make $10M Milestone Payment to GSK Following Launch",2014-09-04 06:11:00-04:00,GSK,neutral
586310.0,GlaxoSmithKline Announces Viiv Healthcare Wins EU Marketing Authorization for Triumeq - Bloomberg,2014-09-03 08:24:00-04:00,GSK,positive
586311.0,Markets Reverse Early Morning Losses; Still Lower On The Day,2014-08-28 16:40:00-04:00,GSK,negative
586312.0,GSK Spokesperson Declines Comment on Rumor of Potential Deal with Tekmira,2014-08-28 08:53:00-04:00,GSK,neutral
586313.0,"GlaxoSmithKline Ebola Vaccine Trials Fast-Tracked by International Consortium, 10,000 Additional Doses to be Manufactured",2014-08-28 05:50:00-04:00,GSK,neutral
586314.0,"Benzinga's M&A Chatter for Wednesday August 27, 2014",2014-08-27 20:45:00-04:00,GSK,neutral
586315.0,"Tekmira Shares Rise 8% After Hours on Daily Mail Report of Potential Offer of $40/Share from GSK, Shire",2014-08-27 20:27:00-04:00,GSK,positive
586316.0,Ligand Announces Partner GlaxoSmithKline Has Received FDA Approval for Promacta/Revolade,2014-08-27 08:00:00-04:00,GSK,positive
586317.0,GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia,2014-08-26 15:56:00-04:00,GSK,positive
586318.0,GlaxoSmithKline's VIIV Units Receives FDA Approval For Triumeq,2014-08-22 14:12:00-04:00,GSK,positive
586319.0,UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma,2014-08-20 15:36:00-04:00,GSK,positive
586320.0,GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma,2014-08-20 15:35:00-04:00,GSK,positive
586321.0,EPA Reports ~$317.55K Settlement with GlaxoSmithKline Related to Waste Violations,2014-08-11 14:57:00-04:00,GSK,negative
586322.0,Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives,2014-08-05 09:16:00-04:00,GSK,positive
586323.0,"Glaxo, Sanofi Trend Up On Potential Deal For Established Brands",2014-08-04 12:55:00-04:00,GSK,neutral
586324.0,Express Scripts Has Reinstated GSK's Advair - Reuters,2014-08-04 11:40:00-04:00,GSK,neutral
586325.0,PREVIEW: Pernix Therapeutics to Resume Trading at 9:50 AM ET,2014-08-04 09:33:00-04:00,GSK,neutral
586326.0,"Glaxo, Genmab Report Positive Interim Result for Phase III Study of Ofatumumab",2014-07-31 14:30:00-04:00,GSK,positive
586327.0,Markets Little Changed Ahead Of The Federal Reserve's Policy Decision,2014-07-28 16:36:00-04:00,GSK,neutral
586328.0,GSK Reports FDA OKs Flonase Allergy Relief for Sale Over-The-Counter In US,2014-07-24 12:42:00-04:00,GSK,positive
586329.0,GlaxoSmithKline Shares Fall 5% Premarket as H1 Revenue Drops 3%,2014-07-23 08:58:00-04:00,GSK,positive
586330.0,Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR Yo Apotex; Apotex Can No Longer Supply Authorized Generic Product,2014-07-17 07:02:00-04:00,GSK,positive
586331.0,Isis Pharma Reports Earning of $1M from GSK Related to Advancing of Isis-TTR RX,2014-07-16 07:06:00-04:00,GSK,neutral
586332.0,Morning Market Movers ,2014-07-15 09:46:00-04:00,GSK,neutral
586333.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield,2014-07-11 04:14:00-04:00,GSK,positive
586334.0,Glaxo Announces Anoro(R) Ellipta (R) Has Gained Approval in Japan for Treatment of COPD,2014-07-07 08:04:00-04:00,GSK,positive
586335.0,"GSK, Genmab Receive EU Authorization for Arzerra as First-Line Treatment for Chronic Lymphocytic Leukemia in Combination with Chlorambucil or Bendamustine for Patients Ineligible for Fludarabine-based Therapy ",2014-07-03 09:40:00-04:00,GSK,neutral
586336.0,"Release from Genmab Shows Co., Glaxo Received EU Authorization for Arzerra as First-Line Treatment for CLL in Combo with Chlorambucil, Bendamustine",2014-07-03 09:17:00-04:00,GSK,neutral
586337.0,Glaxosmithkline Says Issues Relating to China Business are Very Difficult and Complicated; GSK Cooperating with Investigation by Chinese Authorities ,2014-06-30 09:04:00-04:00,GSK,negative
586338.0,"GSK, Theravance Announce Submission to US Regulatory Authorities for Fluticasone Furoate/Vilanterol in Asthma",2014-06-30 08:12:00-04:00,GSK,neutral
586339.0,"GSK, Genmab Announce Phase III Study of Ofatumumab Did Not Meet Primary Endpoint ",2014-06-27 14:31:00-04:00,GSK,neutral
586340.0,Glaxosmithkline Reports Triumeq Receives Positive ChMP Opinion,2014-06-27 07:51:00-04:00,GSK,positive
586341.0,FDA Sends Warning Letter to Glaxosmithkline Unit D Biomedical Corp Citing Deviations from Good Manufacturing Practice for Flulaval Vaccine,2014-06-24 09:44:00-04:00,GSK,positive
586342.0,Isis Pharma Wins $1M from Glaxo for Advancing ISIS-TTR Rx,2014-06-24 07:01:00-04:00,GSK,positive
586343.0,ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug,2014-06-19 10:27:00-04:00,GSK,negative
586344.0,"Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks",2014-06-18 09:38:00-04:00,GSK,positive
586345.0,"Ligand Announces Glaxo Has Presented Results from Phase 3 PETIT2 Study on Eltrombopag, Met Primary Endpoint",2014-06-13 07:31:00-04:00,GSK,neutral
586346.0,UPDATE: Viiv Healthcare Collaborates With Janssen to Investigate Single-Tablet Regimen for Maintenance Treatment Of HIV-1,2014-06-12 06:31:00-04:00,GSK,neutral
586347.0,"UPDATE: Glaxo, Theravance Report Positive Data from Two Studies Considering Efficacy, Safety of Incruse(TM) Ellipta(R) Plus Relvar(R)/Breo(R) Ellipta(R) for COPD",2014-06-11 07:44:00-04:00,GSK,positive
586348.0,"Glaxo, Theravance Report Positive Data from Two Studies Considering Efficacy, Safety of Incruse(TM) Ellipta(R) Plus Relvar(R)/Breo(R) Ellipta(R) for COPD",2014-06-11 07:44:00-04:00,GSK,positive
586349.0,ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?,2014-06-04 13:58:00-04:00,GSK,neutral
586350.0,"UPDATE: GSK Settlement with 44 US States, DC",2014-06-04 12:15:00-04:00,GSK,neutral
586351.0,GlaxoSmithKline in $105M Settlement With Most US States Regarding Prescription Drug Marketing -Reuters,2014-06-04 12:14:00-04:00,GSK,neutral
586352.0,ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy,2014-06-04 10:32:00-04:00,GSK,neutral
586353.0,"Adaptimmune Announces Deal With GlaxoSmithKline to Develop, Commercialize Clinical Cancer Program ",2014-06-02 05:50:00-04:00,GSK,negative
586354.0,GSK Rumor Helps Offset News Of Criminal Probe,2014-05-29 12:13:00-04:00,GSK,negative
586355.0,"Reuters Reports GSK Seekng Private Equity Bids for Portfolio of Older Drugs, According to Source",2014-05-29 10:53:00-04:00,GSK,neutral
586356.0,Bloomberg Highlighting Tweet from Sky News: 'Glaxo Tempts Bidders With £7.5bn Drugs Sale http://news.sky.com/story/1271423/glaxo-tempts-bidders-with-7-5bn-drugs-sale …',2014-05-29 09:40:00-04:00,GSK,neutral
586357.0,Mylan Reports Launch of Generic Malarone Tablets,2014-05-29 07:30:00-04:00,GSK,neutral
586358.0,GlaxoSmithKline Says Been Informed By UK's Serious Fraud Office They have Opened Formal Criminal Investigation Into Company's Commercial Practices,2014-05-27 14:00:00-04:00,GSK,negative
586359.0,"Glaxo, Genmab A/S Report CHMP's Positive Opinion for Marketing Authorization for Arzerra",2014-05-23 09:25:00-04:00,GSK,positive
586360.0,"Glaxo, Genmab Report Topline Results from Pivotal Head to Head Study of Ofatumumab, Says Trial Did Not Meet Primary Endpoint",2014-05-19 14:04:00-04:00,GSK,neutral
586361.0,Aura Of Light Shines On Pernix Shares Following Treximet Acquisition,2014-05-14 12:36:00-04:00,GSK,positive
586362.0,"UPDATE: Pernix Shares Rise 55% Premarket Following Report of Acquisition of US Rights for Treximet Tablets, Warrants to Purchase 500K Shares of Pozen Stock",2014-05-14 08:44:00-04:00,GSK,positive
586363.0,"Theravance Shareholder Glaxosmithkline Buys 317,770 Shares @$26.89/Share -Form 4",2014-05-13 16:46:00-04:00,GSK,positive
586364.0,Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry,2014-05-12 16:27:00-04:00,GSK,positive
586365.0,"UPDATE: Allergan Rumored to Contact Glaxo, Novartis About Possible Interest",2014-05-09 14:04:00-04:00,GSK,positive
586366.0,"Glaxo Receives EU Marketing Authorization for Anoro, Says Theravance Obligated to Make Milestone Payment of $15M",2014-05-08 11:01:00-04:00,GSK,neutral
586367.0,GlaxoSmithKline Announces EU Marketing Authorisation for Anoro,2014-05-08 11:00:00-04:00,GSK,neutral
586368.0,"#PreMarket Primer: Thursday, May 1: Fed Brushes Off Disappointing GDP And Moves Forward With Taper",2014-05-01 07:23:00-04:00,GSK,negative
586369.0,"#PreMarket Primer: Wednesday, April 30: No BOJ Stimulus On The Horizon ",2014-04-30 09:12:00-04:00,GSK,negative
586370.0,"GlaxoSmithKline Reports in Email Statement: Has Commenced Phase 3 Study of Mepolizumab, Will Include ~1.5K Patients - Bloomberg",2014-04-29 10:53:00-04:00,GSK,neutral
586371.0,"Glaxo Has Received EU Marketing Authorisation for Incruse, Expecting First Launch in Europe by End of 2014 - Bloomberg",2014-04-28 11:19:00-04:00,GSK,neutral
586372.0,"GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine for Plasmodium Vivax Malaria",2014-04-28 06:43:00-04:00,GSK,neutral
586373.0,Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report,2014-04-25 16:41:00-04:00,GSK,neutral
586374.0,UPDATE: Glaxosmithkline Receives Positive Chmp Opinion for Mekinist in Metastatic Melanoma With Braf V600 Mutation,2014-04-25 10:41:00-04:00,GSK,positive
586375.0,EMA Reports Positive Recommendation for Glaxo's Mekinist,2014-04-25 10:34:00-04:00,GSK,positive
586376.0,Argus Research Upgrades GlaxoSmithKline PLC to Buy,2014-04-23 08:20:00-04:00,GSK,neutral
586377.0,"Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive",2014-04-22 16:52:00-04:00,GSK,positive
586378.0,"Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)",2014-04-22 13:24:00-04:00,GSK,neutral
586379.0,"Form 8-K from Glaxo, Theravance Shows TGA Approval Breo Ellipta in Australia",2014-04-22 08:35:00-04:00,GSK,positive
586380.0,Panmure Upgrades GlaxoSmithKline PLC to Buy,2014-04-22 08:24:00-04:00,GSK,neutral
586381.0,"Epizyme Reports Has Achieved Lead Candidate Milestone for Third Target in GSK Collab, Receives $4M in Milestone, License Payments",2014-04-22 08:12:00-04:00,GSK,neutral
586382.0,US Stock Futures Edge Higher Ahead Of McDonald's Earnings,2014-04-22 07:31:00-04:00,GSK,neutral
586383.0,Novartis Acquires GSK Oncology Products Business for $14.5B,2014-04-22 06:03:00-04:00,GSK,neutral
586384.0,"Pharmaceutical Stocks For Income, Value And Growth Investors",2014-04-17 10:12:00-04:00,GSK,positive
586385.0,GlaxoSmithKline Release Confirms US Approval for Once-Weekly Tanzeum,2014-04-15 14:28:00-04:00,GSK,positive
586386.0,FDA Says Approved Tanzeum for Treatment of Type 2 Diabetes,2014-04-15 10:12:00-04:00,GSK,positive
586387.0,"Race for Vaccines, Treatments as West Africa Ebola Death Toll Tops 100",2014-04-08 13:47:00-04:00,GSK,negative
586388.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield ,2014-04-08 04:50:00-04:00,GSK,positive
586389.0,"Amgen's Amgen Manufacturing Limited, Glaxo End Pact Related to Commercialization of Denosumab, Will Pay Glaxo Total of $275M for Early Termination, Will Reimburse $15M for Costs During Transition Period",2014-04-03 09:25:00-04:00,GSK,negative
586390.0,Market Wrap For April 2: Markets On Four-Day Winning Streak,2014-04-02 16:40:00-04:00,GSK,positive
586391.0," Glaxosmithkline Buys 103,762 Shares of Applied Genetic Technologies at $12.00 -Form 4",2014-04-02 12:44:00-04:00,GSK,positive
586392.0,Agenus Provides Update on GSK'S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in NSCLC,2014-04-02 05:42:00-04:00,GSK,negative
586393.0,"Glaxosmithkline Confirms Warning Letter Received from FDA o March 19, 2014 Regarding Inspection Carried October 2013 Inspection; Company is Reviewing Contents of Letter -Reuters",2014-04-01 13:07:00-04:00,GSK,negative
586394.0,FDA Issues Warning Letter on Glaxo's Cork Facility,2014-04-01 09:26:00-04:00,GSK,negative
586395.0,GSK Withdraws Application to EMA for Variation to Marketing Authorisation for Votrient,2014-03-31 07:10:00-04:00,GSK,neutral
586396.0,"GlaxoSmithKline Voluntarily Recalling All Alli® Weight Loss Products from US, Puerto Rico Retailers",2014-03-27 09:02:00-04:00,GSK,negative
586397.0,"Mylan Wins Breach of Contract Litigation Against Glaxo, Receives $106.7M in Damages",2014-03-27 07:01:00-04:00,GSK,neutral
586398.0,GlaxoSmithKline Announces EMA Approval for Eperzan,2014-03-26 09:08:00-04:00,GSK,positive
586399.0,"UPDATE: GlaxoSmithKline  to Re-Submit Marketing Application For Combined Tafinlar, Mekinist; to Re-Submit Marketing Application When Phase 3 Data is Available",2014-03-26 06:17:00-04:00,GSK,neutral
586400.0,GlaxoSmithKline Pulls Marketing Authorization Application eith EMA for Mekinist,2014-03-26 06:11:00-04:00,GSK,neutral
586401.0,GlaxoSmithKline Files Debt Securities Shelf,2014-03-21 17:20:00-04:00,GSK,negative
586402.0,Glaxo Shares Volatile But Largely Unch Following WSJ Report Co. Has Received a Prelim. Injunction Related to Advair in Germany,2014-03-21 13:02:00-04:00,GSK,positive
586403.0,Market Wrap For March 20: Investors Showing No Post-Fed Decision Hangover,2014-03-20 16:44:00-04:00,GSK,negative
586404.0,Morning Market Losers ,2014-03-20 09:46:00-04:00,GSK,negative
586405.0,US Stock Futures Drop Ahead Of Jobless Claims Report,2014-03-20 07:25:00-04:00,GSK,negative
586406.0,Agenus Therapeutics Reports GlaxoSmithKline's Magrit Study Does Not Meet First or Second Primary Endpoint,2014-03-20 06:12:00-04:00,GSK,neutral
586407.0,GlaxoSmithKline Study Of Mepolizumab Met Its Primary Endpoint,2014-03-12 13:09:00-04:00,GSK,neutral
586408.0,Market Wrap For March 10: Markets Slightly Lower On Chinese Growth Concerns,2014-03-10 16:56:00-04:00,GSK,positive
586409.0,Glaxosmithkline Increases Stake In Indian Pharmaceuticals Subsidiary to 75%,2014-03-09 20:01:00-04:00,GSK,neutral
586410.0,"Theravance Issues Update on Planned Separation of Late-Stage Partnered Respiratory Assets from Biopharma Operations, Sees Closing in Q2 Compared to Early 2014 Previously",2014-03-03 16:59:00-05:00,GSK,positive
586411.0,"GlaxoSmithKline, Kinder Morgan And Others Insiders Have Been Buying",2014-02-23 08:59:00-05:00,GSK,positive
586412.0,Market Wrap For Febuary 20: S&P 500 Inches Closer To New Highs,2014-02-20 16:46:00-05:00,GSK,neutral
586413.0,GlaxoSmithKline Wins Positive CHMP Opinion for INCRUSE for COPD,2014-02-20 14:29:00-05:00,GSK,positive
586414.0,"Glaxo, Theravance's ANORO Gets Positive Opinion from the CHMP in Europe ",2014-02-20 08:04:00-05:00,GSK,positive
586415.0,Berkshire Hathaway Files SEC 13F,2014-02-18 11:27:00-05:00,GSK,neutral
586416.0,GlaxoSmithKline Raises Q4 Interim Dividend to 23p Vs 22p,2014-02-05 07:08:00-05:00,GSK,neutral
586417.0,GlaxoSmithKline Reports Q4 EPS 50.4p,2014-02-05 07:07:00-05:00,GSK,neutral
586418.0,Market Wrap For February 3: Bears In Complete and Absolute Control,2014-02-03 16:45:00-05:00,GSK,neutral
586419.0,Ligand Partner GlaxoSmithKline Receives FDA Breakthrough Therapy Designation for Promacta/Revolade for Severe Aplastic Anemia,2014-02-03 07:30:00-05:00,GSK,negative
586420.0,Benzinga Weekly Preview: Twitter To Release Earnings For The First Time Since Going Public,2014-01-31 16:19:00-05:00,GSK,neutral
586421.0,S&P Capital IQ Upgrades GlaxoSmithKline PLC to Hold,2014-01-27 10:14:00-05:00,GSK,neutral
586422.0,Ariad Shares Continue to Surge Amidst Buyout Rumors,2014-01-24 16:06:00-05:00,GSK,positive
586423.0,Berenberg Downgrades GlaxoSmithKline PLC to Hold,2014-01-24 08:51:00-05:00,GSK,neutral
586424.0, GlaxoSmithKline Diabetes Treatment Eperzan Receives Positive EMA Opinion,2014-01-24 06:17:00-05:00,GSK,positive
586425.0,Agenus Spikes on CNBC Mention,2014-01-23 13:19:00-05:00,GSK,neutral
586426.0,Top Trending Tickers On StockTwits For January 23,2014-01-23 11:15:00-05:00,GSK,positive
586427.0,Cowen & Company Downgrades GlaxoSmithKline PLC to Market Perform,2014-01-22 08:12:00-05:00,GSK,neutral
586428.0,"Abbott, Glaxo Shares Relatively Quiet Following Headlines Glaxo's Suit Against Abbott Related to AIDS Drug Will Get New Trial",2014-01-21 13:02:00-05:00,GSK,positive
586429.0,GlaxoSmithKline Announces Tivicay Gets EU Approval,2014-01-21 06:44:00-05:00,GSK,positive
586430.0, FDA Granted Breakthrough Therapy Designation for GlaxoSmithKline's Tafinlar,2014-01-13 10:23:00-05:00,GSK,positive
586431.0,Morning Market Losers ,2014-01-13 10:01:00-05:00,GSK,negative
586432.0,Benzinga's Top #PreMarket Losers,2014-01-13 08:30:00-05:00,GSK,negative
586433.0,GlaxoSmithKline Announces ANORO ELLIPTA Approved for COPD Treatment in Canada,2014-01-09 08:14:00-05:00,GSK,positive
586434.0,Market Wrap For January 7: Markets Reverse 3-Day Slump,2014-01-07 16:39:00-05:00,GSK,neutral
586435.0,"Epizyme, Celgene Advance EPZ-5676 DOT1L Inhibitor Clinical Program, Achieve $25M Milestone, $4M Milestone with GlaxoSmithKline",2014-01-06 17:31:00-05:00,GSK,negative
586436.0,Prosensa Comments on Drisapersen Program Update ,2013-12-19 11:09:00-05:00,GSK,neutral
586437.0,Glaxo Confirms ANORO ELLIPTA Approved for First Once-Daily Dual Bronchodilator for Treatment of COPD in US,2013-12-18 12:43:00-05:00,GSK,positive
586438.0,UPDATE: GlaxoSmithKline Anoro Ellipta Approved for Treatment of COPD In US,2013-12-18 12:04:00-05:00,GSK,positive
586439.0,"Glaxo, Theravance's Anoro Ellipta Approved by FDA",2013-12-18 11:45:00-05:00,GSK,positive
586440.0,Merck Collaborates with GlaxoSmithKline on MK-3475,2013-12-18 07:51:00-05:00,GSK,neutral
586441.0,Market Wrap For December 17: Markets Relatively Calm Before The Potential Storm,2013-12-17 16:51:00-05:00,GSK,positive
586442.0,Deutsche Bank Downgrades GlaxoSmithKline PLC to Hold,2013-12-17 08:17:00-05:00,GSK,neutral
586443.0,GlaxoSmithKline to Stop Paying Doctors to Promote Drugs,2013-12-17 06:09:00-05:00,GSK,positive
586444.0,"Glaxo, Theravance Announce Results of PIVOTAL Phase III Study for Fluticasone Furoate/Vilanterol in Asthma, Says Met Primary Efficacy Endpoint",2013-12-06 08:03:00-05:00,GSK,neutral
586445.0,Isis Pharmaceuticals Earns $2M Milestone Payment from GSK for Advancement of ISIS-TTR Rx ,2013-12-02 07:02:00-05:00,GSK,neutral
586446.0,"Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-GSK3 Rx, Earns $3M Milestone Payment From GSK ",2013-11-26 07:07:00-05:00,GSK,neutral
586447.0,"UPDATE: FDA Says Trial Results on Avandia Showed No Elevated Risk of Heart Attack/Death, FDA is Releasing Glaxo from Trial of Avandia Versus Actos",2013-11-25 14:17:00-05:00,GSK,negative
586448.0,FDA requires removal of certain restrictions on the diabetes drug Avandia,2013-11-25 14:15:00-05:00,GSK,positive
586449.0,Glaxo Wins FDA Approval for First Adjuvanted Bird Flu Vaccine,2013-11-22 15:57:00-05:00,GSK,positive
586450.0,Glaxo's Tivicay Receives Positive CHMP Opinion,2013-11-22 08:45:00-05:00,GSK,positive
586451.0,"Pfizer, Glaxo Initiate Study of Novel Combo Therapy in Melanoma",2013-11-21 08:02:00-05:00,GSK,positive
586452.0,"Amicus Therapeutics, Glaxo Revise Fabry Deal, GSK Will Receive No Upfront Payment from Amicus, Glaxo Will Further Invest $3M in Amicus",2013-11-20 16:02:00-05:00,GSK,negative
586453.0,BofA Merrill Adds GlaxoSmithKline to 'Europe 1' List,2013-11-19 07:43:00-05:00,GSK,neutral
586454.0,2013 3Q 13F Roundup,2013-11-18 13:27:00-05:00,GSK,neutral
586455.0,UPDATE: Glaxo Confirms Relvar Ellipta Wins European Marketing Authorization,2013-11-18 08:25:00-05:00,GSK,positive
586456.0,Glaxo Says Theravance Obligated to Make Payment of $15M to Follow Relvar Ellipta Launch in Europe,2013-11-18 08:25:00-05:00,GSK,neutral
586457.0,Isis Pharma Wins $5M in Milestone Payment from Glaxo for Advancement of ISIS-GSK4 Rx,2013-11-15 07:01:00-05:00,GSK,positive
586458.0,Isis Earns $5M Milestone Payment from GSK,2013-11-15 07:01:00-05:00,GSK,neutral
586459.0,"13F from Buffett's Berkshire Shows Lowered Stakes in GlaxoSmithKline, Sanofi, ConocoPhilips, DirecTV, Raised Stakes in Suncor Energy, VeriSign, Bank of NY Mellon, US Bancorp",2013-11-14 16:34:00-05:00,GSK,positive
586460.0,Gilead Sciences Leads In Rising Short Interest Among Biotechs ,2013-11-12 16:41:00-05:00,GSK,positive
586461.0,Panmure Downgrades GlaxoSmithKline PLC to Hold,2013-11-12 07:30:00-05:00,GSK,neutral
586462.0,GSK Pivotal Phase III Study of Darapladib in Chronic Coronary Heart Disease Gid Not Meet Primary Endpoint,2013-11-12 06:11:00-05:00,GSK,neutral
586463.0,"Benzinga's M&A Chatter for Wednesday November 6, 2013",2013-11-06 17:20:00-05:00,GSK,neutral
586464.0,Sarepta Spokesperson Declines Comment on Chatter of GSK Bid,2013-11-06 10:06:00-05:00,GSK,neutral
586465.0,Hearing Unconfirmed Marker Chatter of GlaxoSmithKline Interest in Sarepta,2013-11-06 10:03:00-05:00,GSK,positive
586466.0,"GlaxoSmithKline PLC Reports Q3 EPS of GBP28.90, Up 3.6% YOY; Revenue of GBP6.51B vs GBP6.64B Est; Reaffirms Outlook",2013-10-23 07:02:00-04:00,GSK,neutral
586467.0,GlaxoSmithKline Says Tivicay Submitted for US Approval,2013-10-22 12:21:00-04:00,GSK,positive
586468.0,Credit Suisse Downgrades GlaxoSmithKline PLC to Underperform,2013-10-10 06:28:00-04:00,GSK,positive
586469.0,Benzinga's Top Initiations,2013-10-09 07:42:00-04:00,GSK,positive
586470.0,MainFirst Initiates Coverage on GlaxoSmithKline PLC at Outperform,2013-10-09 06:55:00-04:00,GSK,neutral
586471.0,J&J's Janssen Buys Investigational NS5A Inhibitor from Glaxo,2013-10-08 08:03:00-04:00,GSK,negative
586472.0,Ligand Partner GSK Receives Marketing Authorization from EC for Additional Revolade Indication as Treatment for Chronic Hepatitis C-Associated Thrombocytopenia ,2013-09-24 07:06:00-04:00,GSK,neutral
586473.0,Benzinga's Top Pre-Market Losers,2013-09-20 08:18:00-04:00,GSK,negative
586474.0,"UPDATE: Prosensa Shares Fall 68% Pre-Market on Failed Duchenne Muscular Dystrophy Study, Sarepta Falls 8%",2013-09-20 07:43:00-04:00,GSK,negative
586475.0,US Stock Futures Signal Flat Start On Wall Street,2013-09-20 07:16:00-04:00,GSK,neutral
586476.0,Prosensa Shares Fall 23% on Light Volume on Phase III Duchenne Muscular Dystrophy Results,2013-09-20 07:15:00-04:00,GSK,positive
586477.0,"Sarepta Shares Rise 15% Pre-Market on Failure of Glaxo, Prosensa Duchenne Muscular Dystrophy Treatment",2013-09-20 07:11:00-04:00,GSK,negative
586478.0,GSK Prosensa Announce Primary Endpoint Not Met in Phase III Duchenne Muscular Dystrophy Study of Drisapersen,2013-09-20 07:04:00-04:00,GSK,neutral
586479.0,Relvar Ellipta Approved in Japan for Treatment of Asthma,2013-09-20 06:21:00-04:00,GSK,positive
586480.0,"Glaxo, Theravance Confirm Positive CHMP Opinion for Relvar Ellipta",2013-09-19 13:32:00-04:00,GSK,positive
586481.0,Glaxo Says Relvar Ellipta Receives CHMP Position Opinion,2013-09-19 13:27:00-04:00,GSK,neutral
586482.0,"GlaxoSmithKline Announces Multi-Year Deal with Barda in US for Anthrax Treatment, Valued at ~$196M",2013-09-19 09:24:00-04:00,GSK,positive
586483.0,Write A Prescription For Health Care ETFs,2013-09-19 08:06:00-04:00,GSK,positive
586484.0,"ChemoCentryx Will Regain Global Rights for Vercirnon from Glaxo, Will Assess If Drug Maintains Remission in Crohn's Disease",2013-09-18 08:39:00-04:00,GSK,neutral
586485.0,GlaxoSmithKline Terminates Crohn's Drug Program Following ChemoCentryx Trial Failure -FierceBiotech,2013-09-17 11:49:00-04:00,GSK,negative
586486.0,Dumex China Denies Allegations of Inciting Corruption ,2013-09-16 14:15:00-04:00,GSK,negative
586487.0,Benzinga's Top Downgrades,2013-09-16 08:26:00-04:00,GSK,positive
586488.0,Barclays Downgrades GlaxoSmithKline PLC to Equalweight,2013-09-16 07:43:00-04:00,GSK,neutral
586489.0,"FDA Grants Glaxo, Genmab's Arzerra Breakthrough Therapy Designation",2013-09-13 15:52:00-04:00,GSK,positive
586490.0,"Glaxo, Theravance Confirms FDA Panel Has Recommended Approval for UMEC/VI 62.5/25mcg Dose for COPD",2013-09-10 15:55:00-04:00,GSK,positive
586491.0,"FDA Panel Votes 11-2 Data Supports Theravance, Glaxo's Anoro for Approval",2013-09-10 14:31:00-04:00,GSK,positive
586492.0,"UPDATE: FDA Panel Voted 10-3 in Favor of Safety for Theravance, Glaxo's Anoro",2013-09-10 14:21:00-04:00,GSK,positive
586493.0,"FDA Panel Shows Theravance, Glaxo's Anoro Demonstrated Safety",2013-09-10 14:16:00-04:00,GSK,positive
586495.0,GlaxoSmithKline to Sell Lucozade and Ribena to Suntory $2.1B in Cash,2013-09-09 06:00:00-04:00,GSK,neutral
586496.0,ChemoCentryx Says Glaxo's Top-Line Results from SHIELD-1 Phase III Study of Vercirnon Did Not Meet Primary Endpoint,2013-08-23 09:25:00-04:00,GSK,neutral
586497.0,Eli Lilly Accused of Bribing Doctors in China -WantChinaTimes,2013-08-22 06:20:00-04:00,GSK,negative
586498.0,"Cowen & Company Upgrades GlaxoSmithKline PLC to Outperform, Raises PT to $59.00",2013-08-21 09:18:00-04:00,GSK,neutral
586499.0,Morgan Stanley Downgrades GlaxoSmithKline PLC to Underweight,2013-08-15 08:35:00-04:00,GSK,neutral
586500.0,"UPDATE: Berkshire Hathaway Shows Increased Stakes In American Express, ConocoPhillips, Costco, Davita Healthcare, Deere, DirecTV, GE, GM, GlaxoSmithKline, J&J, Liberty Media, M&T Bank",2013-08-15 07:14:00-04:00,GSK,positive
586501.0,JP Morgan Upgrades GlaxoSmithKline PLC to Neutral,2013-08-14 07:43:00-04:00,GSK,positive
586502.0,JP Morgan Upgrades GlaxoSmithKline PLC to Neutral,2013-08-14 07:28:00-04:00,GSK,positive
586503.0,Shares of Glaxo Edge Higher as FDA Approves Tivicay for Treatment of HIV-Related Infection,2013-08-12 16:59:00-04:00,GSK,positive
586504.0,Bloomberg Reporting GlaxoSmithKline Issues Application for Cervarix 2 Dosing Schedule in EU,2013-08-07 07:19:00-04:00,GSK,neutral
586505.0,Citigroup Downgraded GlaxoSmithKline PLC to Neutral,2013-08-06 09:31:00-04:00,GSK,neutral
586506.0,"Apple, Wal-Mart And Other Companies With Monster Share Buyback (AAPL, WMT)",2013-08-05 13:10:00-04:00,GSK,positive
586507.0,UPDATE: GlaxoSmithKline Receives FDA Approval To Ship Four-Strain (Quadrivalent) Influenza Vaccine To Healthcare Providers ,2013-08-05 13:08:00-04:00,GSK,positive
586508.0,Glaxo Wins FDA Approval to Ship 2013-2014 Flu Vaccine,2013-08-05 12:52:00-04:00,GSK,positive
586509.0,"Amended 13D Filing from Glaxo on Theravance Showing 26.96% Stake, Had Show 26.87% Stake as of Apr. 30th",2013-08-01 09:22:00-04:00,GSK,neutral
586510.0,Form 8-K from Theravance Shows Co. to Sell 3.06M Unregistered Shares at $36.50/Share to Glaxo,2013-07-30 17:31:00-04:00,GSK,positive
586511.0,Ligand Announces GlaxoSmithKline Wins Positive CHMP Opinion for REVLOADE,2013-07-26 08:45:00-04:00,GSK,positive
586512.0,GlaxoSmithKline Names Herve Gisserot New Head of China Operations,2013-07-25 14:01:00-04:00,GSK,neutral
586513.0,Dow Jones Reporting Glaxo Smith Kline to Pay $229M to Settle Lawsuits Over Avandia in US,2013-07-24 17:26:00-04:00,GSK,negative
586514.0,"Glaxo Reported Q2 Core EPS 26.3 pence, Inline with the Street, Sales £6.6B, Also Inline",2013-07-24 07:16:00-04:00,GSK,neutral
586515.0,"Third Circuit Rules in Mylan's Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylan's Breach of Contract Claim Against GSK to Trial",2013-07-23 07:32:00-04:00,GSK,positive
586516.0,Citron Research Tweet: 'Glaxo held accountable in China – but a US company breaking multiple Chinese laws may be at far greater risk – major report tommorow',2013-07-22 14:02:00-04:00,GSK,positive
586517.0,GlaxoSmithKline CEO to Address China Bribery Allegations at Q2 Earnings Presentation on July 24 -Reuters,2013-07-21 17:56:00-04:00,GSK,neutral
586518.0,Four GlaxoSmithKline China Executives Detained on Bribery Charges -WantChinaTimes,2013-07-16 06:25:00-04:00,GSK,negative
586519.0,GlaxoSmithKline Under Investigation in China for Bribery Charges -WantChinaTimes,2013-07-15 06:12:00-04:00,GSK,negative
586520.0,GlaxoSmithKline China Under Investigation for Bribing Doctors -WantChinaTimes,2013-07-12 06:22:00-04:00,GSK,neutral
586521.0,"Short Interest Rises in Gilead Sciences, Onyx Pharmaceuticals (BIIB, GILD, ONXX)",2013-07-11 12:47:00-04:00,GSK,positive
586522.0,Central Banks Lift Currency Hedged ETFs,2013-07-05 12:36:00-04:00,GSK,neutral
586523.0,Financial Times Reporting That China Is Investigating 33 Foreign Pharmaceutical Companies For Pricing Irregularities,2013-07-04 07:27:00-04:00,GSK,neutral
586524.0,Big Pharma's Next Blockbuster is Fish Oil?,2013-06-28 11:42:00-04:00,GSK,positive
586525.0,"Glaxo's Drisapersen to get FDA Breakthrough Therapy Designation, Glaxo Says Received Verbal Notification Yesterday",2013-06-27 11:08:00-04:00,GSK,neutral
586526.0,"AstraZeneca to Acquire Pearl Therapeutics to Gain Foothold into Lucrative Market (AZN, GSK, NVS)",2013-06-10 09:18:00-04:00,GSK,positive
586527.0,Liberum Upgrades GlaxoSmithKline PLC to Hold,2013-06-07 07:36:00-04:00,GSK,neutral
586528.0,FDA Revoting on Glaxo's Avandia,2013-06-06 15:20:00-04:00,GSK,neutral
586529.0,"FDA Staff Review of Duke Data Similar to Prior Avandia Findings, Reanalysis of Data Supports Overall Glaxo Findings",2013-06-03 08:43:00-04:00,GSK,positive
586530.0,FDA Approves Two Skin Cancer Treatments for GlaxoSmithKline,2013-05-29 14:45:00-04:00,GSK,negative
586531.0,"Glaxo, Genmab Offer Positive Top-Line Results from Pivotal Study of ARZERRA, Chlorabucil Combo",2013-05-29 13:17:00-04:00,GSK,positive
586532.0,UPDATE: Deutsche Bank Upgrades GlaxoSmithKline to a Buy on Risk/Reward Move to Positive ,2013-05-28 09:33:00-04:00,GSK,positive
586533.0,Credit Suisse Downgrades GlaxoSmithKline PLC to Neutral,2013-05-28 08:42:00-04:00,GSK,positive
586534.0,Benzinga's Top Upgrades,2013-05-28 07:38:00-04:00,GSK,positive
586535.0,Deutsche Bank Upgrades GlaxoSmithKline PLC to Buy,2013-05-28 07:03:00-04:00,GSK,neutral
586536.0,UPDATE: Theravance to Make $30M Milestone Payment to Glaxo,2013-05-10 12:39:00-04:00,GSK,neutral
586537.0,"Glaxo, Theravance Confirm BREO ELLIPTA Gained US FDA Approval for Treatment of COPD",2013-05-10 12:38:00-04:00,GSK,positive
586538.0,Glaxo Confirming FDA Approval for Breo Ellipta,2013-05-10 12:04:00-04:00,GSK,positive
586539.0,Theravance Shares Spike Higher as FDA Approves Breo Ellipta,2013-05-10 11:29:00-04:00,GSK,positive
586540.0,"Merck, Glaxo Reduce Prices 95% for HPV Vaccine in Poor Nations",2013-05-09 07:16:00-04:00,GSK,negative
586541.0,"Impax, Glaxo Terminate Collaboration for IPX066",2013-04-29 08:03:00-04:00,GSK,neutral
586542.0,A Peek Into The Market Before The Trading Starts,2013-04-29 07:23:00-04:00,GSK,neutral
586543.0,WNS Signs Contract Extension with GlaxoSmithKline Services Unlimited,2013-04-29 06:51:00-04:00,GSK,neutral
586544.0,"FDA Says Valeant's, Glaxo's Potiga Linked to Retinal Abnormalities",2013-04-26 16:59:00-04:00,GSK,neutral
586545.0,"GlaxoSmithKline Posts Ill EPS, Healthy Revenue",2013-04-24 10:34:00-04:00,GSK,neutral
586546.0,"GlaxoSmithKline, Avalon Ventures in $495M Biotech Deal",2013-04-23 06:43:00-04:00,GSK,neutral
586547.0, Intel Expands Its Pharmaceutical R&D ,2013-04-22 08:55:00-04:00,GSK,positive
586548.0,Glaxo Confirms FDA Panel Recommended Approval of BREO ELLIPTA for COPD,2013-04-17 17:19:00-04:00,GSK,positive
586549.0,PREVIEW: Theravance to Resume Trading at 4:25 PM ET,2013-04-17 16:10:00-04:00,GSK,neutral
586550.0,This New ETF Gets Defensive With Global Dividends,2013-04-17 14:28:00-04:00,GSK,neutral
586551.0,"FDA Panel Votes 10-3 for Safety of Glaxo, Theravance Breo",2013-04-17 14:21:00-04:00,GSK,positive
586552.0,"FDA Panel Votes 8-5 Theravance's, Glaxo's Breo Helps Reduce Lung Disease Severity",2013-04-17 13:53:00-04:00,GSK,positive
586553.0,"UPDATE: Glaxo, Theravance's Breo Reduces Lung Disease Exacerbations",2013-04-17 13:51:00-04:00,GSK,neutral
586554.0,"FDA Panel Votes 12-1 for Efficacy of Glaxo, Theravance's Breo ",2013-04-17 13:42:00-04:00,GSK,neutral
586555.0,Intel Expands Its Pharmaceutical R&D ,2013-04-17 09:32:00-04:00,GSK,positive
586556.0,A New International Dividend ETF Comes to Town,2013-04-16 17:18:00-04:00,GSK,neutral
586557.0,Biogen Loses Appeal in Arzerra Patent Case Against Glaxo,2013-04-16 11:40:00-04:00,GSK,negative
586558.0,"Theravance Shares Surge Higher as FDA Issues Staff Report on Breo Ellipta, Report Says Safety Similar to Other Drugs",2013-04-15 10:09:00-04:00,GSK,positive
586559.0,Likely Winners and Losers in Obama's 2014 Budget,2013-04-11 10:21:00-04:00,GSK,negative
586560.0,"Market Wrap for Tuesday, April 9: Stocks Climb Along With Euro",2013-04-09 16:10:00-04:00,GSK,neutral
586561.0,"Benzinga's M&A Chatter for Tuesday April 2, 2013",2013-04-02 17:57:00-04:00,GSK,neutral
586562.0,Hearing Chatter Optimer Draws Interest from Glaxo and Astellas,2013-04-02 09:34:00-04:00,GSK,positive
586563.0,"Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences",2013-03-28 08:18:00-04:00,GSK,negative
586564.0,13 Drugs Pending FDA Approval in 2013,2013-03-26 13:19:00-04:00,GSK,positive
586565.0,"GlaxoSmithKline Receives CRL from FDA Related to Q-Pan H5N1 App, Glaxo Says Working with FDA to Complete Review",2013-03-25 08:57:00-04:00,GSK,neutral
586566.0,Report of 14 Adults 'Cured' of HIV -NewScientist,2013-03-15 06:27:00-04:00,GSK,neutral
586567.0,Blackstone Reportedly Bidding to Acquire Lucozade and Ribena Soft Drink Brands from GlaxoSmithKline -Sky News,2013-03-11 08:05:00-04:00,GSK,neutral
586568.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield,2013-03-08 06:15:00-05:00,GSK,positive
586569.0,"Hearing Glaxo, VIIV Got Request from EC on Tyverb, Combivir",2013-03-06 11:24:00-05:00,GSK,neutral
586570.0,Theravance Announces Postponement of March 7 PDAC Meeting Due to Weather -8K,2013-03-06 09:28:00-05:00,GSK,neutral
586571.0,3 ADR ETFs Your Broker Forgot to Mention,2013-03-05 14:42:00-05:00,GSK,neutral
586572.0,Theravance Spokesperson Says GlaxoSmithKline is Waiting to Hear Back from FDA. Weather is a Factor on the Delay of the Posting of the Briefing Documents,2013-03-05 14:09:00-05:00,GSK,negative
586573.0,Theravance Shares Rally as Analyst Highlights Co. as Possible Takeover Target If FDA Panel Outcome Positive,2013-03-04 15:53:00-05:00,GSK,positive
586574.0,An HIV Cure Is Great News For These Drug Manufacturers,2013-03-04 15:22:00-05:00,GSK,positive
586575.0,Spokesperson for GlaxoSmithKline and Pfizer HIV Company ViiV Healthcare Comments on First Case of Functional Cure of HIV in an Infant,2013-03-04 11:24:00-05:00,GSK,neutral
586576.0,HIV Infected Baby 'Cured' with Aggressive Drug Treatment -NYT,2013-03-03 17:50:00-05:00,GSK,negative
586577.0,"Benzinga's M&A Chatter for Friday March 1, 2013",2013-03-02 10:36:00-05:00,GSK,neutral
586578.0,"UPDATE: Morgan Stanley Downgrades GlaxoSmithKline to Underweight on Growth, Pricing Policy Headwinds",2013-02-28 07:27:00-05:00,GSK,positive
586579.0,Morgan Stanley Downgrades GlaxoSmithKline PLC to Underweight,2013-02-28 06:12:00-05:00,GSK,neutral
586580.0,These ETFs Have Moving Average Problems,2013-02-27 15:23:00-05:00,GSK,negative
586581.0,"Sarepta Therapeutics Shares Jump Over $31, May Be Related to Glaxo Headline",2013-02-27 13:40:00-05:00,GSK,positive
586582.0,"TheStreet.com Reporting Glaxo's DMD Drug Said Tied to Side Effects, Hospitalizations",2013-02-27 13:38:00-05:00,GSK,neutral
586583.0,"Hearing Kentucky Has Sued GlaxoSmithKline Related to Avandia, Alleging Deceptive Advertising on Avandia Effectiveness",2013-02-21 10:43:00-05:00,GSK,neutral
586584.0,Barclays Upgrades GlaxoSmithKline PLC to Overweight,2013-01-29 08:25:00-05:00,GSK,negative
586585.0,2 Attractively Valued Blue Chips,2013-01-27 19:19:00-05:00,GSK,positive
586586.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2013-01-26 12:17:00-05:00,GSK,positive
586587.0,Genpact Awarded Five-Year Contract Extension by GlaxoSmithKline,2013-01-15 07:11:00-05:00,GSK,positive
586588.0,4 Health Care ETFs Your Broker Forgot to Mention,2013-01-07 15:52:00-05:00,GSK,positive
586589.0,"GlaxoSmithKline to Pay ~$3.62M to Maryland Medicaid Program Related to Marketing, Pricing",2013-01-03 13:41:00-05:00,GSK,negative
586590.0,Benzinga's Top Pre-Market Losers,2012-12-20 08:20:00-05:00,GSK,negative
586591.0,"Amicus, Glaxo Release Top-Line Six-Month Primary Treatment Period Results from First Phase 3 Fabry Monotherapy Study",2012-12-19 16:06:00-05:00,GSK,neutral
586592.0,Glaxo's Influenza Vaccine Fluarix Quadrivalent Receives FDA Approval,2012-12-17 10:12:00-05:00,GSK,positive
586593.0,FDA Approves Raxibacumab to Treat Inhalational Anthrax ,2012-12-14 15:49:00-05:00,GSK,positive
586594.0,UPDATE: Credit Suisse Upgrades GlaxoSmithKline to Neutral; Pricing Policy Impact Priced In  ,2012-12-13 13:21:00-05:00,GSK,positive
586595.0,Credit Suisse Upgrades GlaxoSmithKline PLC to Neutral,2012-12-12 16:08:00-05:00,GSK,positive
586596.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2012-12-12 12:57:00-05:00,GSK,positive
586597.0,From Earlier: Panmure Upgrades GlaxoSmithKline PLC to Buy,2012-12-12 10:01:00-05:00,GSK,neutral
586598.0,"Benzinga's M&A Chatter for Tuesday December 11, 2012",2012-12-11 17:23:00-05:00,GSK,neutral
586599.0,"Warburg Pincus Said to Hire Goldman Sachs to Sell Bausch & Lomb, Seeking At Least $10B; Abbott, Glaxo, Merck, Sanofi Said to Be Contacted - Bloomberg",2012-12-11 16:56:00-05:00,GSK,neutral
586600.0,"Three More Defensive Stock Picks for 2013 (LLY, PFE, VTR)",2012-12-10 15:12:00-05:00,GSK,positive
586601.0,"A Look at Fortune's Health Care Picks for 2013 (ALGN, FMS, GILD)",2012-12-08 23:17:00-05:00,GSK,positive
586602.0,GlaxoSmithKline Says Bought Back 742k Shares,2012-11-29 12:50:00-05:00,GSK,positive
586603.0,"Theravance, GlaxoSmithKline to Advance GSK961081 to Phase 3 in 2013",2012-11-27 12:07:00-05:00,GSK,neutral
586604.0,Benzinga's Volume Movers,2012-11-19 10:46:00-05:00,GSK,neutral
586605.0,"Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication",2012-11-19 09:11:00-05:00,GSK,positive
586606.0,UPDATE: FDA Says Dynavax's HEPLISAV Does Not Have Any Clinically Significant Differences in Safety vs Glaxo's Engerix-B,2012-11-13 12:42:00-05:00,GSK,positive
586607.0,GlaxoSmithKline's Phase 3 Malaria Vaccine Study Meets Primary Endpoint,2012-11-09 06:07:00-05:00,GSK,neutral
586608.0,"Vertex,  GlaxoSmithKline Enter Agreement for Phase 2 Hepatitis C Study",2012-11-01 07:36:00-04:00,GSK,positive
586609.0,"On Glaxo Q3 Conference Call, CEO Says M&A Interest 'Lower Than Recent Years,' But Won't Rule Out 'Occasional' Bolt-Ons",2012-10-31 10:28:00-04:00,GSK,positive
586610.0,GlaxoSmithKline Reports Q3 EPS $26.5P vs $28P Est; Revenues $6.53BGBP,2012-10-31 08:03:00-04:00,GSK,neutral
586611.0,"Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)",2012-10-25 14:09:00-04:00,GSK,positive
586612.0,NuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of Directors ,2012-10-23 17:00:00-04:00,GSK,neutral
586613.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)",2012-10-15 06:59:00-04:00,GSK,positive
586614.0,Aeras Signs Agreement with GSK to Jointly Develop TB Vaccine ,2012-10-10 06:18:00-04:00,GSK,positive
586615.0,FDA Says Teva's Wellburton XL Not as Effective as Brand Drug,2012-10-03 15:06:00-04:00,GSK,negative
586616.0,Glaxosmithkline Buys Back 450K Shares at 1430P/Share,2012-10-01 12:41:00-04:00,GSK,positive
586617.0,"Benzinga's Microcap Movers for Thursday September 13, 2012",2012-09-13 19:27:00-04:00,GSK,neutral
586618.0,Seven Cheap Large-Caps Yielding Over 4% ,2012-09-06 14:07:00-04:00,GSK,neutral
586619.0,Pharma Companies Switch Drugs to OTC Market,2012-08-30 16:15:00-04:00,GSK,neutral
586620.0,Benzinga's Top Downgrades,2012-08-28 07:16:00-04:00,GSK,positive
586621.0,GSK and Theravance Announce Completion of the Phase III Programme for Once-Daily LAMA/LABA (UMEC/VI) in COPD ,2012-08-24 07:05:00-04:00,GSK,neutral
586622.0,Benzinga's Top Downgrades,2012-08-22 07:41:00-04:00,GSK,positive
586623.0,A Peek Into The Market Before The Trading Starts,2012-08-22 07:14:00-04:00,GSK,neutral
586624.0,UPDATE: JP Morgan Downgrades GlaxoSmithKline to Underweight; Investments Risk Earnings  ,2012-08-22 07:03:00-04:00,GSK,positive
586625.0,JP Morgan Downgrades GlaxoSmithKline from Neutral to Underweight,2012-08-22 06:30:00-04:00,GSK,positive
586626.0,GlaxoSmithKline Spokesperson Would Not Comment on Rumored Theravance Takeover Talks,2012-08-16 15:34:00-04:00,GSK,neutral
586627.0,Hearing DealReporter Says Theravance Faces Wait on Possible GlaxoSmithKline Buyout,2012-08-16 15:14:00-04:00,GSK,neutral
586628.0,"Benzinga'a M&A Chatter for Tuesday August 14, 2012",2012-08-14 17:23:00-04:00,GSK,neutral
586629.0,GlaxoSmithKline Spokesperson Declines Comment on Arena Pharmaceuticals Takeover Chatter,2012-08-14 14:29:00-04:00,GSK,neutral
586630.0,Hearing Unconfirmed Takeover Chatter in Arena Pharmaceuticals,2012-08-14 14:02:00-04:00,GSK,negative
586631.0,"FDA Approves Vaccine Formula for 2012-2013 Season; Medimmune, Novartis, Sanofi, Diagnostics Limited Manufacture",2012-08-13 15:45:00-04:00,GSK,positive
586632.0,UPDATE: Jefferies Downgrades GlaxoSmithKline to Hold on Margin Expansion Visibility  ,2012-08-13 09:50:00-04:00,GSK,neutral
586633.0,Jefferies & Company  Downgrades GlaxoSmithKline from Buy to Hold,2012-08-13 05:54:00-04:00,GSK,neutral
586634.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield,2012-08-13 00:25:00-04:00,GSK,positive
586635.0,"Benzinga's M&A Chatter for Wednesday August 1, 2012",2012-08-01 17:17:00-04:00,GSK,neutral
586636.0,Seeking Alpha Article on Possible GSK Buyout of Amarin,2012-08-01 13:29:00-04:00,GSK,neutral
586637.0,Seeking Alpha Article on Possible GSK Buyout of Amarin,2012-08-01 12:56:00-04:00,GSK,neutral
586638.0,GlaxoSmithKline Will Pay $14.25/Share to Remaining Human Genome Sciences Holders,2012-07-30 08:34:00-04:00,GSK,negative
586639.0,Alnylam Earns $3.2M Milestone Payment from GlaxoSmithKline in VaxiRNA Collaboration on Flu Vaccine Production   ,2012-07-30 08:05:00-04:00,GSK,negative
586640.0,"GlaxoSmithKline Says Will Be Engaged with Human Genome in Open Mindset, Can't Rule Out Job Cuts",2012-07-25 07:40:00-04:00,GSK,positive
586641.0,Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental New Drug Application for Promacta® for the Treatment of Thrombocytopenia in Adult Patients with Chronic Hepatitis C Infection   ,2012-07-25 07:16:00-04:00,GSK,neutral
586642.0,Agenus Announces Phase 3 Clinical Trial of GSK's Herpes Zoster Vaccine Candidate Containing Agenus' QS-21 Commences in Immunocompromised Patients  ,2012-07-18 07:07:00-04:00,GSK,neutral
586643.0,Amicus Therapeutics and GlaxoSmithKline Expand Fabry Disease Collaboration; GSK to Increase Ownership in Amicus to 19.9% with $18.6M Investment in Common Stock Priced at $6.30 Per Share ,2012-07-17 16:03:00-04:00,GSK,positive
586644.0,Human Genome Finally Agrees to GlaxoSmithKline Buyout,2012-07-17 07:52:00-04:00,GSK,positive
586645.0,"Benzinga's M&A Chatter for Monday July 16, 2012",2012-07-16 17:19:00-04:00,GSK,neutral
586646.0,Monday Market Movers,2012-07-16 11:31:00-04:00,GSK,neutral
586647.0,PREVIEW: Human Genome Sciences to Resume Trading at 9:45am ,2012-07-16 09:22:00-04:00,GSK,neutral
586648.0,GSK to Acquire Human Genome Sciences for US$14.25 per share in cash,2012-07-16 09:15:00-04:00,GSK,positive
586649.0,GlaxoSmithKline Ready for Human Genome Takeover,2012-07-16 08:22:00-04:00,GSK,positive
586650.0,Benzinga's Top Pre-Market Gainers,2012-07-16 08:15:00-04:00,GSK,positive
586651.0,Human Genome Sciences Rises Over $14/Share Pre-Market on Speculation of Deal with GlaxoSmithKline,2012-07-16 07:31:00-04:00,GSK,neutral
586652.0,UPDATE: Glaxo Nears Deal for Human Genome Sciences; Glaxo Expected to Pay Between $14 and $14.25 a Share for Human Genome Sciences,2012-07-16 07:02:00-04:00,GSK,positive
586653.0,Spokesperson for GlaxoSmithKline Declines Comment on Rumored Deal with Human Genome Sciences,2012-07-16 06:35:00-04:00,GSK,neutral
586654.0,UPDATE: Human Genome Sciences Agrees to be Acquired by GlaxoSmithKiline for $14/Share -Reuters,2012-07-15 23:09:00-04:00,GSK,positive
586655.0,GlaxoSmithKline in Talks with Human Genome Sciences -Sources,2012-07-15 21:12:00-04:00,GSK,neutral
586656.0,3 New Bets by a Biotech Hedge Fund,2012-07-13 17:32:00-04:00,GSK,neutral
586657.0,A Peek Into The Market Before The Trading Starts,2012-07-13 07:24:00-04:00,GSK,neutral
586658.0,GlaxoSmithKline Withdraws FDA Application for Tykerb With Trastuzumab,2012-07-12 10:07:00-04:00,GSK,neutral
586659.0,Glaxo HIV Drug Beats Gilead's Atripla In Study -IBD,2012-07-11 12:34:00-04:00,GSK,neutral
586660.0,"Dendreon, Pharmacyclics and Other Biotech Takeover Targets",2012-07-10 14:07:00-04:00,GSK,neutral
586661.0,GlaxoSmithKline Announces Final Settlement of $3B Covered by Existing Legal Provisions Announced in November 2011 ,2012-07-02 10:53:00-04:00,GSK,positive
586662.0,"GlaxoSmithKline Reaches Agreement Over Drug Labeling, Will Pay $3B to Resolve Probe",2012-07-02 09:44:00-04:00,GSK,positive
586663.0,GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for Once-Daily LAMA/LABA (UMEC/VI) in COPD  ,2012-07-02 08:24:00-04:00,GSK,positive
586664.0,BioMarin Pharmaceutical Hits New 52-Week High on Continued Takeover Chatter,2012-06-29 12:03:00-04:00,GSK,neutral
586665.0,GlaxoSmithKline Spokesperson Says Way too Early to Speculate on Higher Offer for Human Genome Sciences,2012-06-29 12:01:00-04:00,GSK,neutral
586666.0,Human Genome Sciences Responds To GSK Extension of Unsolicited Tender Offer; Board of Directors Reject Offer    ,2012-06-29 08:56:00-04:00,GSK,negative
586667.0,"Benzinga's M&A Chatter for Thursday June 28, 2012",2012-06-28 18:20:00-04:00,GSK,neutral
586668.0,GlaxoSmithKline Must Face Humana Suit Over Avandia Costs -Bloomberg,2012-06-28 17:10:00-04:00,GSK,neutral
586669.0,Spokesperson for BioMarin Pharmaceutical Won't Comment on Guardian Report on Takeover Bids,2012-06-28 13:45:00-04:00,GSK,neutral
586670.0,Editor of Little Bear Blog is Long BioMarin Pharmaceutical on Takeover Chatter,2012-06-28 12:26:00-04:00,GSK,neutral
586671.0,"UPDATE: BioMarin Spikes Higher on Report GlaxoSmithKline, Sanofi, Biogen Could Bid $60/Share -Guardian",2012-06-28 12:10:00-04:00,GSK,neutral
586672.0,Ultimate Stock Watch List for The Supreme Court's Health Care Ruling,2012-06-28 09:51:00-04:00,GSK,positive
586673.0,GlaxoSmithKline Buys Back 1.3M Shares,2012-06-27 12:46:00-04:00,GSK,positive
586674.0,"GlaxoSmithKline Says European Market Much More Difficult Than Previously Expected, Higher Pricing Pressure is Top Concern",2012-06-27 09:37:00-04:00,GSK,negative
586675.0,"UPDATE: Option Alert: Theravance 4,691 July 17.50 Put Contracts Traded; Currently $21.21",2012-06-26 15:48:00-04:00,GSK,positive
586676.0,GlaxoSmithKline Buys Back 1.2M Shares,2012-06-26 12:58:00-04:00,GSK,positive
586677.0,"Benzinga's M&A Chatter for Tuesday June 19, 2012",2012-06-19 17:21:00-04:00,GSK,neutral
586678.0,"Benzinga's M&A Chatter for Friday June 15, 2012",2012-06-16 12:31:00-04:00,GSK,neutral
586679.0,GlaxoSmithKline Plc GSK Continues With Tender Offer To Acquire HGSI,2012-06-15 10:05:00-04:00,GSK,neutral
586680.0,From Earlier: GSK Receives FDA Approval for MenHibrix,2012-06-15 07:47:00-04:00,GSK,positive
586681.0,FDA Approves GlaxoSmithKline's Combination Vaccine Menhibrix ,2012-06-14 16:46:00-04:00,GSK,positive
586682.0,Johnson & Johnson to Complete Synthes Acquisition ,2012-06-14 08:25:00-04:00,GSK,neutral
586683.0,"Benzinga's M&A Chatter for Tuesday June 12, 2012",2012-06-12 17:32:00-04:00,GSK,neutral
586684.0,"Benzinga's M&A Chatter for Friday June 8, 2012",2012-06-09 22:52:00-04:00,GSK,neutral
586685.0,GlaxoSmithKline buys for treasury 1.6 million shares - DJ,2012-06-08 12:52:00-04:00,GSK,positive
586686.0,"Spokesperson for Human Genome Sciences Says They Are Exploring a Potential Sale of the Company, But Declined Comment on Potential Buyers",2012-06-08 10:25:00-04:00,GSK,neutral
586687.0,Spokesperson for GlaxoSmithKline Declines Comment When Asked if They Will Raise Offer for Human Genome,2012-06-08 10:13:00-04:00,GSK,neutral
586688.0,HGS Again Rejects GSK Extension of Tender Offer,2012-06-08 10:06:00-04:00,GSK,negative
586689.0,Human Genome Sciences Rises 2% Pre-Market as GlaxoSmithKline Extends Tender Offer Deadline to June 29 ,2012-06-08 08:49:00-04:00,GSK,positive
586691.0,"From Earlier, GSK and XenoPort Receive FDA Approval for Horizant® for Postherpetic Neuralgia   ",2012-06-07 07:54:00-04:00,GSK,positive
586692.0,GlaxoSmithKline Announces 1.8M Share Buyback,2012-06-06 13:04:00-04:00,GSK,positive
586693.0,Mylan Launches Generic Version of GSK's Epivir in the UK and Italy,2012-06-06 09:38:00-04:00,GSK,neutral
586694.0,GSK Presents Positive results for investigational BRAF and MEK Inhibitors dabrafenib and trametinib at ASCO,2012-06-04 10:36:00-04:00,GSK,positive
586695.0,Human Genome Sciences Rejects GlaxoSmithKline's $13/Share Offer,2012-06-01 13:40:00-04:00,GSK,negative
586696.0,"Human Genome Sciences Rejects GSK $13 Offer, Calls It Inadequate",2012-06-01 13:39:00-04:00,GSK,negative
586697.0,GlaxoSmithKline Buys Back 1.85M Shares,2012-05-31 12:55:00-04:00,GSK,positive
586698.0,"Stiefel, GSK Company, to Acquire Novel Topical Agent for Psoriasis and Atopic Dermatis from Welichem Biotech for C$35M ",2012-05-30 15:21:00-04:00,GSK,positive
586699.0,GlaxoSmithKline Plans to Launch Campaign to Replace Entire Board of Human Genome Sciences -Reuters Citing Sources ,2012-05-30 10:16:00-04:00,GSK,neutral
586700.0,"Par Pharma, Teva Lose Bid to Sell Generic Lovaza",2012-05-29 15:21:00-04:00,GSK,negative
586701.0,UPDATE: Citi Raises GlaxoSmithKline's PT,2012-05-29 09:22:00-04:00,GSK,neutral
586702.0,"Benzinga's M&A Chatter for Wednesday May 23, 2012",2012-05-23 18:03:00-04:00,GSK,neutral
586703.0,"GlaxoSmithKline Amends HGS Tender Offer to Address Poison Pill, Requires HGS to Redeem Pill",2012-05-23 08:37:00-04:00,GSK,negative
586704.0,"Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim® in the U.S. ",2012-05-21 07:01:00-04:00,GSK,positive
586705.0,Human Genome is in Talks with Potential Suitors Amid Glaxo Bid -Bloomberg,2012-05-17 17:25:00-04:00,GSK,neutral
586706.0,Human Genome Looks to Anyone but GlaxoSmithKline,2012-05-17 10:43:00-04:00,GSK,neutral
586707.0,The Shorts Report: 10 Mega-Caps With Increased Short Selling,2012-05-11 11:12:00-04:00,GSK,positive
586708.0,GlaxoSmithKline Buys Back 1.35M Shares,2012-05-10 12:36:00-04:00,GSK,positive
586709.0,Glaco Buys Back 1.5M Shares,2012-05-09 12:40:00-04:00,GSK,positive
586710.0,Human Genome Sciences Board of Directors to Review Unsolicited Tender Offer From GlaxoSmithKline   ,2012-05-09 10:06:00-04:00,GSK,neutral
586711.0,Bank of America Likes GlaxoSmithKline's HGSI Tender Offer,2012-05-09 09:21:00-04:00,GSK,positive
586712.0,GlaxoSmithKline to Get Hostile with Offer for Human Genome,2012-05-09 09:15:00-04:00,GSK,negative
586713.0,FDA Considering Letting Patients Purchase Drugs Without Prescriptions,2012-04-30 12:09:00-04:00,GSK,neutral
586714.0,Amarin Soars on JP Morgan Initiation,2012-04-20 15:25:00-04:00,GSK,positive
586715.0,Human Genome Sciences Spokesperson Has No Comment on dealReporter Article,2012-04-20 14:29:00-04:00,GSK,negative
586716.0,Negative Rumors Circulate About Human Genome Sciences,2012-04-20 13:45:00-04:00,GSK,negative
586717.0,"Benzinga's M&A Chatter for Thursday April 19, 2012",2012-04-19 18:03:00-04:00,GSK,neutral
586718.0,Human Genome Said to Have Told Glaxo of Bid Rejection Today -Bloomberg,2012-04-19 17:19:00-04:00,GSK,negative
586719.0,Option Alert: Human Genome Sciences Call Volume at 693% of Average ,2012-04-19 11:30:00-04:00,GSK,positive
586720.0,Hearing Berstein Saying Human Genome Sciences Should Take GlaxoSmithKline Offer,2012-04-19 10:38:00-04:00,GSK,neutral
586721.0,Human Genome Sciences Doubles Its Market Cap After Rejecting GSK Offer ,2012-04-19 10:33:00-04:00,GSK,negative
586722.0,GlaxoSmithKline Bids for Human Genome Sciences,2012-04-19 10:19:00-04:00,GSK,neutral
586723.0,"Option Alert: Human Genome Sciences April 8 Call Rises 62,900% on GlaxoSmithKline Bid",2012-04-19 09:57:00-04:00,GSK,positive
586724.0,"Financial Breakfast: Morning News Summary for April 19, 2012",2012-04-19 07:38:00-04:00,GSK,neutral
586725.0,"Human Genome Rises 100% on Rejected $13 Per Share Offer from GlaxoSmithKline, Currently $14.50; Dendreon Also Trading Higher",2012-04-19 07:12:00-04:00,GSK,negative
586726.0,Human Genome Sciences Announces Rejects Offer from GlaxoSmithKline; HGS Board of Directors Authorizes Exploration of Strategic Alternatives   ,2012-04-19 06:29:00-04:00,GSK,negative
586727.0,UPDATE: Supreme Court Sides With Generic Drug Makers In Legal Tactics Case,2012-04-17 10:49:00-04:00,GSK,positive
586728.0,"VVUS Analyst: Wouldn't Be Surprised GSK is Interested in Possible Acquisition, it is Clearly an Acquisition Target",2012-04-03 13:25:00-04:00,GSK,positive
586729.0,Glaxo SmithKline Spokesperson Says Company Does Not Comment on Speculation or Rumor with Regard to Chatter of Vivus Offer,2012-04-03 11:21:00-04:00,GSK,neutral
586730.0,Positive Rumors Circulate About Vivus,2012-04-03 10:31:00-04:00,GSK,positive
586731.0,"From Earlier, Human Genome Sciences: GlaxoSmithKline Announces Further Data from Phase 3 Trials of Albiglutide ",2012-04-03 09:19:00-04:00,GSK,neutral
586732.0,Brean Murray Carret Discusses Gilead's Potential Competitor,2012-04-03 09:09:00-04:00,GSK,neutral
586733.0,Market Roundup,2012-04-02 11:36:00-04:00,GSK,neutral
586734.0,Theravance up 22% After GlaxoSmithKline Increases Stake in Company ,2012-04-02 10:48:00-04:00,GSK,neutral
586735.0,GlaxoSmithKline Lifts Stake In Theravance,2012-04-02 07:57:00-04:00,GSK,neutral
586736.0,UPDATE: GlaxoSmithKline to Increase Its Ownership in Theravance ,2012-04-02 07:34:00-04:00,GSK,positive
586737.0,GlaxoSmithKline PLC GSK To Increase Its Ownership In Theravance; Will Own 26.8% Of Theravance After The Investment,2012-04-02 07:32:00-04:00,GSK,positive
586738.0,Positive Rumors Circulate About Dendreon,2012-03-27 10:47:00-04:00,GSK,positive
586739.0,GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme and Topline Results From Relovair vs. Advair Phase III Studies in COPD  ,2012-03-23 08:01:00-04:00,GSK,neutral
586740.0,"Benzinga's M&A Chatter for Wednesday March 21, 2012",2012-03-21 19:21:00-04:00,GSK,neutral
586741.0,"St. Jude, Novo Nordisk and Other Health Care Stocks Worth a Look Now",2012-03-21 07:20:00-04:00,GSK,positive
586742.0,FDA Panel Votes 11-2 To Recommend Glaxosmithkline's Votrient For Soft-tissue Sarcoma,2012-03-20 11:46:00-04:00,GSK,positive
586743.0,Hearing Renewed Takeover Chatter in Human Genome Sciences,2012-03-19 11:13:00-04:00,GSK,neutral
586744.0,FDA Staff Says Glaxo's Votrient Doesn't Increase Survival; Questions Whether Drug is Beneficial for Patients,2012-03-16 08:14:00-04:00,GSK,positive
586745.0,"Briefing Information for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",2012-03-16 08:12:00-04:00,GSK,neutral
586746.0,"Benzinga's M&A Chatter for Tuesday March 13, 2012",2012-03-13 21:26:00-04:00,GSK,neutral
586747.0,GlaxoSmithKline Spokesperson Won't Comment on Earlier Rumor of Offer for Dendreon,2012-03-13 12:04:00-04:00,GSK,neutral
586748.0,Editor of Little Bear Research Blog is Long Dendreon on Takeover Chatter,2012-03-13 09:57:00-04:00,GSK,neutral
586749.0,Positive Rumors Circulate About Dendreon,2012-03-13 09:54:00-04:00,GSK,positive
586750.0,Infosys and Fabric Worldwide Chosen by GlaxoSmithKline to Support the Delivery of Digital Strategy  ,2012-03-13 07:43:00-04:00,GSK,positive
586751.0,Epistem Announces a Three Year Collaboration with GlaxoSmithKline in Fibrosis Research  ,2012-03-13 07:35:00-04:00,GSK,neutral
586752.0,"Benzinga's M&A Chatter for Wednesday March 7, 2012",2012-03-08 00:15:00-05:00,GSK,neutral
586753.0,Hearing Rodman & Renshaw Saying Agenus Could Be Takeover Target of GlaxoSmithKline,2012-03-07 11:01:00-05:00,GSK,neutral
586754.0,Glaxo SmithKline Spokesperson Would Not Comment on Earlier Chatter of Bid for Human Genome Sciences,2012-03-07 10:57:00-05:00,GSK,neutral
586755.0,Human Genome Sciences Spokesperson Would Not Comment on Earlier Chatter of Takeover Bid by Glaxo SmithKline,2012-03-07 10:08:00-05:00,GSK,neutral
586756.0,Positive Rumors Circulate About Human Genome Sciences,2012-03-07 09:56:00-05:00,GSK,positive
586757.0,Agenus Expands QS-21 License and Grants Right of First Negotiation to GlaxoSmithKline,2012-03-05 08:31:00-05:00,GSK,positive
586758.0,LadaTech announces Illumina Found to Infringe Patent,2012-03-01 11:51:00-05:00,GSK,neutral
586759.0,FDA Accepts Impax Pharmaceuticals NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson's Disease   ,2012-02-23 07:02:00-05:00,GSK,positive
586760.0,"Benzinga's M&A Chatter for Thursday February 9, 2012",2012-02-09 17:58:00-05:00,GSK,neutral
586761.0,Glaxo SmithKline Spokesperson Says Company Does Not Comment on Speculation or Rumor with Regard to Chatter of Human Genome Takeover,2012-02-09 15:51:00-05:00,GSK,neutral
586762.0,UPDATE: GlaxoSmithKline Rumored Buyer for Human Genome Sciences $15 to $17/Share,2012-02-09 10:58:00-05:00,GSK,neutral
586763.0,Hearing Renewed Takeover Chatter in Human Genome Sciences,2012-02-09 10:54:00-05:00,GSK,neutral
586764.0,Positive Rumors Circulate About Human Genome Sciences,2012-02-09 10:54:00-05:00,GSK,positive
586765.0,"Financial Breakfast: Morning News Summary for February 07, 2012",2012-02-07 07:19:00-05:00,GSK,neutral
586766.0,GlaxoSmithKline Reports Q4 EPS 28.4 Pence vs 28.3 Pence Est,2012-02-07 07:02:00-05:00,GSK,neutral
586767.0,Anacor Pharma Analyst: We Remain Buyers of Shares Based on Positive View of 4 Mid to Late Stage Novel Oxaborole Compounds Positioned to Address Large Anti-Infective Markets,2012-02-06 14:38:00-05:00,GSK,positive
586768.0,Anacor Pharmaceuticals Down 14.4% After GlaxoSmithKline Pauses Ongoing Trials ,2012-02-06 09:20:00-05:00,GSK,neutral
586769.0,Verastem IPO Launch Captures Investors Attention,2012-02-01 22:54:00-05:00,GSK,neutral
586770.0,"Benzinga's M&A Chatter for Tuesday January 31, 2012",2012-01-31 19:13:00-05:00,GSK,neutral
586771.0,Intermune Spokesperson Says No Comment on Glaxo Takeover Rumor,2012-01-31 11:39:00-05:00,GSK,negative
586772.0,Hearing Takeover Chatter in Intermune; Glaxo Rumored Buyer for $35/Share,2012-01-31 09:54:00-05:00,GSK,neutral
586773.0,"Benzinga's M&A Chatter for Wednesday January 25, 2012",2012-01-25 20:04:00-05:00,GSK,neutral
586774.0,Taking a Closer Look at Investing in Singapore,2012-01-17 13:52:00-05:00,GSK,neutral
586775.0,"Fast Money Picks For January 13th (JPM, RBS, CHS, GSK, BBBY, CCL)",2012-01-12 19:42:00-05:00,GSK,neutral
586776.0,India's Wockhardt to Launch Generic Version of Flonase Nasal Spray;  Hi-Tech Pharmacal Currently Manufactures Generic Version,2012-01-10 10:40:00-05:00,GSK,neutral
586777.0,Notable Put Options Activity in GlaxoSmithKline,2012-01-09 12:15:00-05:00,GSK,neutral
586778.0,From Earlier: GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair in COPD and Asthma  ,2012-01-09 07:16:00-05:00,GSK,neutral
586779.0,"Benzinga's M&A Chatter for Friday January 6, 2012",2012-01-06 16:51:00-05:00,GSK,neutral
586780.0,Human Genome Sciences Spokesperson Would Not Comment on Earlier Chatter of Takeover Bid by Glaxo SmithKline,2012-01-06 12:31:00-05:00,GSK,neutral
586781.0,Human Genome Sciences Spiking Higher; May be Attributed to Takeover Chatter; Hearing Glaxo SmithKline has Offered $14/Share,2012-01-06 10:08:00-05:00,GSK,neutral
586782.0,Glaxo SmithKline Spokesperson Says Company Does Not Comment on Speculation or Rumor with Regard to Chatter of Celgene Takeover,2012-01-05 12:06:00-05:00,GSK,neutral
586783.0,Celgene Spokesperson Unaware of Rumor of Glaxo SmithKline Offer; Has No Other Comment,2012-01-05 11:08:00-05:00,GSK,negative
586784.0,Celgene Spiking Higher; May be Attributed to Takeover Chatter; GlaxoSmithKline Rumored Buyer at $85/Share,2012-01-05 10:17:00-05:00,GSK,neutral
586785.0,ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein ,2012-01-05 08:07:00-05:00,GSK,positive
586786.0,GlaxoSmithKline  Hits 52-Week High of $46.06,2012-01-03 10:00:00-05:00,GSK,neutral
586787.0,GlaxoSmithKline  Hits 52-Week High of $45.85,2011-12-30 11:44:00-05:00,GSK,neutral
586788.0,GlaxoSmithKline  Hits 52-Week High of $45.83,2011-12-27 10:27:00-05:00,GSK,neutral
586789.0,GlaxoSmithKline  Hits 52-Week High of $45.68,2011-12-23 09:50:00-05:00,GSK,neutral
586790.0,Merck Hands Exelixis $12 Million Up Front For a Preclinical Compound Program,2011-12-21 11:28:00-05:00,GSK,neutral
586791.0,Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson's Disease   ,2011-12-21 08:32:00-05:00,GSK,neutral
586792.0,Dynavax Initiates Proof of Mechanism Trial in Lupus Patients  ,2011-12-20 09:06:00-05:00,GSK,neutral
586793.0,"Fast Money Picks For December 20th (SVU, CLWR, AA, GSK, TLT, V)",2011-12-19 19:26:00-05:00,GSK,neutral
586794.0,Key Phase IIb Clinical Trial Results Await Smoking Cessation Player This Week,2011-12-19 11:45:00-05:00,GSK,positive
586795.0,A Peek Into The Market Before The Trading Starts,2011-12-19 07:30:00-05:00,GSK,neutral
586796.0,Galapagos Achieves Clinical Proof-of-Mechanism Milestone in GSK Alliance  ,2011-12-19 06:56:00-05:00,GSK,neutral
586797.0,Thomas H Lee Said to be in Lead for Glaxo Consumer Assets,2011-12-13 12:20:00-05:00,GSK,positive
586798.0,Glaxo's Tykerb Misses Goal In Breast Cancer Trial -DJ,2011-12-09 07:52:00-05:00,GSK,negative
586799.0,Citigroup Initiates GlaxoSmithKline at Buy,2011-11-29 12:52:00-05:00,GSK,neutral
586800.0,Abbott Expands Agreement with GlaxoSmithKline to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen ,2011-11-28 09:01:00-05:00,GSK,negative
586801.0,FDA Approves Erwinaze To Treat A Form Of Leukemia,2011-11-18 09:34:00-05:00,GSK,positive
586802.0,Glaxo Presents Phase III Results of Eltrombopag; Says Significant Improvement in Endpoint in Enable 1,2011-11-07 17:22:00-05:00,GSK,positive
586803.0,Are Upcoming Study Results Spurring Insider Buying at Ligand Pharmaceuticals?,2011-11-02 08:46:00-04:00,GSK,neutral
586804.0,Human Genome Sciences Inc. Overview,2011-11-01 21:14:00-04:00,GSK,neutral
586805.0,Alnylam and GlaxoSmithKline Form Collaboration on RNAi Technology for Vaccine Production   ,2011-11-01 08:02:00-04:00,GSK,neutral
586806.0,"GlaxoSmithKline Hits New 52-Week High, $45.50",2011-10-31 11:55:00-04:00,GSK,neutral
586807.0,Human Genome Sciences Moves Higher; May be Attributable to Takeover Chatter,2011-10-28 09:46:00-04:00,GSK,neutral
586808.0,"Pfizer Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-27 09:37:00-04:00,GSK,neutral
586810.0,GlaxoSmithKline Reports Q3 EPS $0.285P vs $0.285P Est,2011-10-26 07:06:00-04:00,GSK,neutral
586811.0,"Allergan Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-25 18:02:00-04:00,GSK,neutral
586812.0,"Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into",2011-10-25 16:10:00-04:00,GSK,positive
586813.0,Life Technologies Signs Agreement with GlaxoSmithKline Biologicals Seeking Expanded Use of Platform Technologies into Companion Diagnostics ,2011-10-25 16:01:00-04:00,GSK,positive
586814.0,"Earnings Preview: Vertex Pharmaceuticals' EPS, Revenue Expected to Rise",2011-10-25 13:50:00-04:00,GSK,neutral
586815.0,"Merck Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-25 12:10:00-04:00,GSK,neutral
586816.0,"Celgene Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-25 12:10:00-04:00,GSK,neutral
586817.0,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-24 10:16:00-04:00,GSK,negative
586818.0,"Gilead Sciences Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-24 08:46:00-04:00,GSK,neutral
586819.0,Dynavax and GlaxoSmithKline Expand Their Worldwide Strategic Alliance  ,2011-10-21 09:02:00-04:00,GSK,positive
586820.0,Theravance Announces Presentation of GSK Phase 2 Data for LAMA at CHEST 2011  ,2011-10-19 16:32:00-04:00,GSK,neutral
586821.0,Human Genome Sciences Soaring on Rumors,2011-10-19 12:12:00-04:00,GSK,neutral
586822.0,Human Genome Sciences Spokesperson Comments on Recent Rumors,2011-10-19 12:09:00-04:00,GSK,neutral
586823.0,Human Genome Sciences Spokesperson Comments on Recent Rumors,2011-10-19 12:07:00-04:00,GSK,neutral
586824.0,Amicus Therapeutics Announces Close of Patient Recruitment in First Phase 3 Study of Amigal for Fabry Disease  ,2011-10-19 07:31:00-04:00,GSK,neutral
586825.0,Positive Results Shown With Agenus' QS-21 Stimulon Adjuvant in Phase 3 Trial of GlaxoSmithKline's Malaria Vaccine,2011-10-18 13:00:00-04:00,GSK,positive
586826.0,Hearing Cowen Says GlaxoSmithKline Not Likely to Bid for Human Genome Sciences,2011-10-18 12:11:00-04:00,GSK,neutral
586827.0,Piper Jaffray Believes Timing is Right for GSK to Buy Human Genome Sciences,2011-10-18 11:22:00-04:00,GSK,neutral
586828.0,FDA Warns GlaxoSmithKline On Manufacturing Violations At U.K. Plant,2011-10-18 10:13:00-04:00,GSK,negative
586829.0,Flamel Technologies Announces Multi-Year Supply Agreement with GlaxoSmithKline for Coreg CR™ Microparticles   ,2011-10-18 08:31:00-04:00,GSK,positive
586830.0,Hearing Chatter GlaxoSmithKline May Launch $25/Share Bid for Human Genome Sciences,2011-10-18 07:36:00-04:00,GSK,neutral
586831.0,"Abbott Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-14 17:54:00-04:00,GSK,neutral
586832.0,"Johnson & Johnson Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-14 10:19:00-04:00,GSK,negative
586833.0,Top 4 Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield,2011-10-14 04:31:00-04:00,GSK,positive
586834.0,"ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry versus Truvada, in combination with a Protease Inhibitor in people living with HIV ",2011-10-11 09:04:00-04:00,GSK,negative
586835.0,POZEN Provides Patent Litigation Update; Sees 2011 Revenue of $18.-19M vs   ,2011-10-04 07:35:00-04:00,GSK,negative
586836.0,Deus Ex Machina for the World: In Search of Global Salvation,2011-09-26 13:04:00-04:00,GSK,neutral
586837.0,China Hit with Polio Outbreak ,2011-09-21 07:10:00-04:00,GSK,neutral
586838.0,FDA Says Glaxo's Zofran May Cause Abnormal Heart Rhythms - Bloomberg,2011-09-15 15:20:00-04:00,GSK,neutral
586839.0,Amicus Therapeutics and GlaxoSmithKline Commence Second Phase 3 Study of Amigal for Fabry Disease ,2011-09-12 07:31:00-04:00,GSK,neutral
586840.0,Anacor's Partner GlaxoSmithKline Awarded up to $94 Million in U.S. Government Funding to Support Development of GSK '052,2011-09-07 06:43:00-04:00,GSK,positive
586841.0,From Earlier: Dendreon Terminates Provenge Supply Agreement With GlaxoSmithKline Due to Implementation Difficulties,2011-09-06 08:43:00-04:00,GSK,positive
586842.0,"Benzinga's Top ETF Decliners, August 31st (EDZ, DPK, EPV, FXP)",2011-08-31 19:39:00-04:00,GSK,positive
586843.0,"Goldman Sachs CEO Shows Signs of Fear, Hires High-Profile Defense Attorney",2011-08-22 17:22:00-04:00,GSK,negative
586844.0,GlaxoSmithKline Buys Back 2M Shares,2011-08-22 12:22:00-04:00,GSK,positive
586845.0,Glaxo SmithKline Purchases 2.3M of its Shares,2011-08-19 12:45:00-04:00,GSK,positive
586846.0,Friday's Biotech/Pharma Stocks Trading,2011-08-15 11:48:00-04:00,GSK,neutral
586847.0,Benzinga's Volume Movers,2011-08-15 10:26:00-04:00,GSK,neutral
586848.0,Impax and GSK Announce Positive Topline Results of ASCEND-PD Phase III Study of IPX066 in Advanced Parkinson's Disease ,2011-08-15 07:03:00-04:00,GSK,positive
586849.0,GlaxoSmithKline and XenoPort Submit Supplemental New Drug Application to FDA for Horizant™ in Postherpetic Neuralgia  ,2011-08-09 16:05:00-04:00,GSK,neutral
586850.0,Pozen Patents Upheld in Treximet Patent Litigation   ,2011-08-08 06:32:00-04:00,GSK,negative
586851.0,NPS Pharmaceuticals Announces New Calcilytics Agreement with GlaxoSmithKline ,2011-08-02 16:00:00-04:00,GSK,positive
586852.0,Mad Money Lightning Round: Cramer Likes PPL Corp,2011-08-01 03:05:00-04:00,GSK,negative
586853.0,"Earnings Preview: Allergan's EPS, Revenue Expected to Rise",2011-07-29 10:05:00-04:00,GSK,neutral
586854.0,Pfizer Earnings Preview: Analysts Expect Falling EPS,2011-07-28 15:40:00-04:00,GSK,negative
586855.0,Stocks to Watch for Wednesday 7/27/2011: Fresh 52 Week Highs and Lows,2011-07-27 04:37:00-04:00,GSK,positive
586856.0,"Earnings Preview: Merck EPS, Revenue Expected to Rise from Previous Quarter",2011-07-26 13:00:00-04:00,GSK,neutral
586857.0,"Amgen Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",2011-07-26 12:29:00-04:00,GSK,negative
586858.0,GlaxoSmithKline Hits New 52-Week High at $45.10 after Earnings this Morning,2011-07-26 09:34:00-04:00,GSK,neutral
586859.0,Earnings Roundup,2011-07-26 09:32:00-04:00,GSK,neutral
586860.0,Impax Pharmaceuticals Completes Enrollment in ASCEND-PD Phase III Trial of IPX066 in Parkinson's Disease   ,2011-07-26 08:31:00-04:00,GSK,neutral
586861.0,UPDATE: GlaxoSmithKline Swings To Q2 Profit; Shares Rise In Pre-Market,2011-07-26 08:21:00-04:00,GSK,positive
586862.0,GlaxoSmithKline Reports EPS 25P vs 25P Est; Revenues 6.72B PNDS vs 6.7B PNDS Est,2011-07-26 07:14:00-04:00,GSK,neutral
586863.0,GlaxoSmithKline Raises Dividend by 7%,2011-07-26 07:04:00-04:00,GSK,neutral
586864.0,"Celgene Earnings Preview: Analysts Expect Falling Revenue, Rising EPS Over Last Quarter",2011-07-25 14:20:00-04:00,GSK,negative
586865.0,"Vertex Pharmaceuticals Earnings Preview: Analysts Expect Falling Revenue, Rising EPS Over Last Quarter",2011-07-25 13:49:00-04:00,GSK,negative
586866.0,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",2011-07-25 12:45:00-04:00,GSK,negative
586867.0,Citi Comments On GSK,2011-07-25 11:43:00-04:00,GSK,neutral
586868.0,Watson Pharmaceuticals Confirms JALYN™ Patent Challenge,2011-07-22 17:47:00-04:00,GSK,positive
586869.0,"Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter",2011-07-21 13:12:00-04:00,GSK,neutral
586870.0,Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target,2011-07-20 09:05:00-04:00,GSK,neutral
586871.0,Nabi Pharmaceuticals Plunges On Phase III Data,2011-07-18 17:34:00-04:00,GSK,neutral
586872.0,Eli Lilly & Earnings Preview: Analysts Predict Higher Earnings Over Prior Quarter,2011-07-18 14:55:00-04:00,GSK,neutral
586873.0,Twelve ETFs Trading Near 52-Week Highs,2011-07-12 06:56:00-04:00,GSK,neutral
586874.0,Stocks to Watch for Monday 07/11/11: Fresh 52 Week Highs and Lows,2011-07-10 18:15:00-04:00,GSK,positive
586875.0,GlaxoSmithKline Hits New 52-Week High of 44.42,2011-07-08 13:38:00-04:00,GSK,neutral
586876.0,"Q&A with Aethlon Medical CEO, Jim Joyce; The Potential for the Hemopurifier® Medical Device in Cancer Immunotherapy",2011-06-28 12:21:00-04:00,GSK,negative
586877.0,High Yield Big Pharmaceutical Stocks,2011-06-24 01:19:00-04:00,GSK,neutral
586878.0,Forest Labs and Watson Pharma to Open Near 52-Week Highs,2011-06-23 08:44:00-04:00,GSK,neutral
586879.0,Anacor Pharmaceuticals Announces GSK Has Initiated Two Phase 2 Trials of GSK ‘052 in Complicated Urinary Tract Infections and Complicated Intra-Abdominal Infections ,2011-06-22 16:02:00-04:00,GSK,neutral
586880.0,Colgate and Forest Labs to Open Near 52-Week Highs,2011-06-21 08:22:00-04:00,GSK,neutral
586881.0,Biotech/Pharma Stocks; Take A New Approach to Cancer,2011-06-20 13:40:00-04:00,GSK,negative
586882.0,Adolor Corporation Announces Agreement to Acquire Full Ownership of ENTEREG,2011-06-14 16:41:00-04:00,GSK,positive
586883.0,"Benzinga's Political Roundup June 13, 2011",2011-06-13 12:00:00-04:00,GSK,neutral
586884.0,"News Summary for June 13, 2011",2011-06-13 08:15:00-04:00,GSK,neutral
586885.0,"Earlier, Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga",2011-06-13 07:43:00-04:00,GSK,positive
586886.0,CIGNA and Forest Laboratories Open Near 52-Week Highs,2011-06-10 09:48:00-04:00,GSK,neutral
586887.0,GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD  ,2011-06-02 07:04:00-04:00,GSK,neutral
586888.0,GlaxoSmithKline: Results Support Continuation Of Relovair Development Program -Dow Jones,2011-06-02 07:02:00-04:00,GSK,positive
586889.0,Europe's sovereign-debt crisis Effects on Drug Stocks,2011-05-23 14:27:00-04:00,GSK,negative
586890.0,Top Healthcare and Major Drugs stocks to watch- Sector Performance,2011-05-22 14:55:00-04:00,GSK,positive
586891.0,GlaxoSmithKline and Human Genome Sciences Receive Positive Opinion in Europe from the CHMP for BENLYSTA,2011-05-20 07:05:00-04:00,GSK,positive
586892.0,Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From GlaxoSmithKline,2011-05-19 07:02:00-04:00,GSK,neutral
586893.0,"Glaxo's Avandia For Diabetes To Be Pulled From U.S. Pharmacies; Glaxosmithkline's Avandia To Be Restricted Nov. 18, FDA Says, Announces Avandia Restriction In Posting On Website -Bloomberg",2011-05-18 15:50:00-04:00,GSK,negative
586894.0,GlaxoSmithKline and Isis Pharmaceuticals partnership shouldn't be overlooked as a long-term,2011-05-18 06:29:00-04:00,GSK,neutral
586895.0,"UPDATE: FDA Approves New Treatment for Rare Type of Pancreatic Cancer (PFE, MRK, GSK)",2011-05-06 09:58:00-04:00,GSK,negative
586896.0,"Top 4 Large-Cap Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio (GSK, ABT, MRK, JNJ)",2011-05-03 00:38:00-04:00,GSK,negative
586897.0,Using Zignals Stock Screener to Search for UK Stocks,2011-04-28 07:41:00-04:00,GSK,neutral
586898.0,"Top 5 S&P 500 worst performers for the week – IRM, GILD, HOG, KEY and DV",2011-04-24 06:21:00-04:00,GSK,negative
586899.0,4-21-11 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com,2011-04-21 12:27:00-04:00,GSK,neutral
586900.0,Dynavax Initiates First Human Trial in Lupus Program  ,2011-04-20 12:31:00-04:00,GSK,neutral
586901.0,"CEOWORLD Daily Business Roundup- China, GOOG, ZIP, BAC, MAT, HAS, GPC, KNL, SCHW, JPM, WFC…",2011-04-15 07:25:00-04:00,GSK,neutral
586902.0,GSK Says Announces Non-Core OTC Products To Be Divested -Bloomberg (GSK),2011-04-14 10:10:00-04:00,GSK,neutral
586903.0,"Current Top Percentage Gainers And Losers (XNPT, DGW, IMGN, TPCG, DBLE, GSK, QXM, QTWW, RT, SUPG, NLST)",2011-04-07 12:29:00-04:00,GSK,negative
586904.0,"Morning Top Percentage Gainers And Losers (XNPT, GSK, XOMA, BKE, TPCG, BBBY, QXM, RT, NLST, MDRX, BID) ",2011-04-07 10:28:00-04:00,GSK,negative
586905.0,"Benzinga's Volume Movers (XNPT, BBBY, BLUD, IMGN)",2011-04-07 10:19:00-04:00,GSK,neutral
586906.0,"Morning Market Movers (XNPT, AXN, OLCB, MOV)",2011-04-07 09:49:00-04:00,GSK,neutral
586907.0,"Pre-Market Top Percentage Gainers and Losers (XNPT, GSK, ZAGG, LOGI, BBBY, PRXL, BLUD, INHX, PWER, INTC, TZOO, KERX) ",2011-04-07 09:11:00-04:00,GSK,negative
586908.0,Piper Jaffray Comments On XenoPort Following FDA Approval,2011-04-07 08:28:00-04:00,GSK,positive
586909.0,"Benzinga's Top Pre-Market NASDAQ Gainers (XNPT, ZAGG, BBBY, BLUD)",2011-04-07 08:16:00-04:00,GSK,positive
586910.0,"GlaxoSmithKline and XenoPort: FDA Approval for Restless Leg Syndrome Drug Horizant (XNPT, GSK)",2011-04-07 07:21:00-04:00,GSK,positive
586911.0,Unconfirmed Rumors Circulate that (GSK) will acquire (IMMU) at 10.00 a share,2011-04-06 09:54:00-04:00,GSK,positive
586912.0,Unconfirmed Rumors Circulate that (GSK) will acquire (IMMU) at 10.00 a share,2011-04-06 09:54:00-04:00,GSK,positive
586913.0,April Catalysts For Biotech And Drug Stocks,2011-04-01 12:36:00-04:00,GSK,neutral
586914.0,A Peek Into The Market Before The Trading Starts,2011-03-30 07:28:00-04:00,GSK,neutral
586915.0,Dr. Reddy's Announces Completion of the Acquisition of US Penicillin Facility and Products from GlaxoSmithKline   ,2011-03-30 06:57:00-04:00,GSK,neutral
586916.0,GSK and Valeant Receive European Authorisation for Trobalt ,2011-03-29 12:17:00-04:00,GSK,neutral
586917.0,POZEN Announces Licensing Deal with a Division of Johnson & Johnson for Migraine Treatment   ,2011-03-23 07:32:00-04:00,GSK,neutral
586918.0,Biotech Sector Snapshot HIV Drug Development,2011-03-18 14:13:00-04:00,GSK,neutral
586919.0,"Hearing Late-Night Rumors Of Buyout By GlaxoSmithKline For Human Genome Sciences (GSK, HGSI)",2011-03-18 09:42:00-04:00,GSK,neutral
586920.0,Biotech/Pharma Sector Close-Up;  Drug Resistance Potential for HIV Drugs; Can Medical Devices take over when drugs fail?,2011-03-17 14:22:00-04:00,GSK,negative
586921.0,Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint ,2011-03-11 09:03:00-05:00,GSK,neutral
586922.0,"Fast Money Pops & Drops, March 10th (IRM, HGSI, NTAP, SFD)",2011-03-10 20:10:00-05:00,GSK,neutral
586923.0,"Benzinga's Volume Movers (HGSI, GMCR, SMTC, SBUX)",2011-03-10 10:47:00-05:00,GSK,neutral
586924.0,Background On Human Genome (HGSI),2011-03-10 10:24:00-05:00,GSK,neutral
586925.0,"Morning Market Movers (GMCR, ATRN, HGSI, XRM)",2011-03-10 09:47:00-05:00,GSK,neutral
586926.0,"Benzinga's Top Pre-Market NASDAQ Gainers (GMCR, HGSI, SBUX, ATRN)",2011-03-10 08:24:00-05:00,GSK,positive
586927.0,One Side of Market May Tip Hand 03-09-11,2011-03-09 18:06:00-05:00,GSK,positive
586928.0,"Stocks To Watch When Human Genome Sciences Reopens After Benlysta Approval (HGSI, GSK, LJPC, ANTH, CEPH)",2011-03-09 17:49:00-05:00,GSK,positive
586929.0,Human Genome Wins Approval For Benlysta (HGSI),2011-03-09 17:26:00-05:00,GSK,positive
586930.0,Pullback in Commodities Takes Pressure Off  03-08-2011,2011-03-08 18:21:00-05:00,GSK,negative
586931.0,Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline ,2011-03-03 08:56:00-05:00,GSK,positive
586932.0,"Benzinga's Top Upgrades (TRN, ANF, CAM, GSK)",2011-02-14 08:22:00-05:00,GSK,positive
586933.0,Exane BNP Paribas Ups GSK To Outperform,2011-02-14 06:04:00-05:00,GSK,neutral
586934.0,Why Is Carl Icahn Interested In Clorox? (CLX),2011-02-11 15:27:00-05:00,GSK,positive
586935.0,Glaxo Set To Pay Out After Diabetes Drug Linked To Heart Attacks (GSK),2011-02-07 12:48:00-05:00,GSK,negative
586936.0,"David Darst Likes ""Global Gorillas"" (PG, KO, DO, RIG, WIP, JNJ)",2011-02-04 16:00:00-05:00,GSK,positive
586937.0,Roche Misses on Tamiflu Decline - Analyst Blog,2011-02-03 08:31:00-05:00,GSK,negative
586938.0,Roche Misses on Tamiflu Decline - Analyst Blog,2011-02-03 08:15:00-05:00,GSK,negative
586939.0,Onyx Makes Headway with Carfilzomib - Analyst Blog,2011-02-01 10:31:00-05:00,GSK,neutral
586940.0,Onyx Makes Headway with Carfilzomib - Analyst Blog,2011-02-01 10:00:00-05:00,GSK,neutral
586941.0,"Actelion, Glaxo Halt Study - Analyst Blog",2011-01-31 12:31:00-05:00,GSK,neutral
586942.0,"Actelion, Glaxo Halt Study - Analyst Blog",2011-01-31 12:00:00-05:00,GSK,neutral
586943.0,Piper Jaffray Defends THRX Following Delayed Sell-Off,2011-01-31 09:15:00-05:00,GSK,negative
586944.0,Divergence Started to Form Midday  01-28-2011,2011-01-28 18:33:00-05:00,GSK,neutral
586945.0,Earnings Preview: Eli Lilly - Analyst Blog,2011-01-25 11:00:00-05:00,GSK,neutral
586946.0,Earnings Preview: Eli Lilly - Analyst Blog,2011-01-25 10:45:00-05:00,GSK,neutral
586947.0,Boost for VRX-GSK Epilepsy Drug - Analyst Blog,2011-01-25 10:01:00-05:00,GSK,positive
586948.0,Boost for VRX-GSK Epilepsy Drug - Analyst Blog,2011-01-25 09:45:00-05:00,GSK,positive
586949.0,Pfizer Inks Deal With Theraclone - Analyst Blog,2011-01-20 11:01:00-05:00,GSK,neutral
586950.0,Pfizer Inks Deal With Theraclone - Analyst Blog,2011-01-20 10:45:00-05:00,GSK,neutral
586951.0,Morgan Stanley Downgrades GlaxoSmithKline to Underweight (GSK),2011-01-19 12:12:00-05:00,GSK,neutral
586952.0,GlaxoSmithKline and Prosensa Start Phase III Study of Investigational Duchenne Muscular Dystrophy Medication ,2011-01-19 08:15:00-05:00,GSK,neutral
586953.0,J&J Issues Tylenol Recalls,2011-01-18 10:05:00-05:00,GSK,neutral
586954.0,"Company News for January 18, 2011 - Corporate Summary",2011-01-18 10:01:00-05:00,GSK,neutral
586955.0,"Company News for January 18, 2011 - Corporate Summary",2011-01-18 09:09:00-05:00,GSK,neutral
586956.0,Glaxo Announces $3.4B Legal Charge,2011-01-17 14:20:00-05:00,GSK,positive
586957.0,Top 10 Warren Buffett Dividend Stocks,2011-01-14 07:30:00-05:00,GSK,positive
586958.0,"Jefferies Upgrades GSK To Buy, Anticipates Positive Earnings Momentum",2011-01-11 10:09:00-05:00,GSK,positive
586959.0,"Hewlett-Packard: Upgrades, Downgrades",2011-01-11 09:27:00-05:00,GSK,neutral
586960.0,Jefferies Upgrades GlaxoSmithKline (GSK),2011-01-11 08:50:00-05:00,GSK,neutral
586961.0,"Benzinga's Top Upgrades (HPQ, FLR, GSK, M)",2011-01-11 08:29:00-05:00,GSK,positive
586962.0,"DENTSPLY, Glaxo in Co-branding Pact - Analyst Blog",2011-01-10 11:01:00-05:00,GSK,neutral
586963.0,"DENTSPLY, Glaxo in Co-branding Pact - Analyst Blog",2011-01-10 10:30:00-05:00,GSK,neutral
586964.0,Valeant's 2011 Outlook Impresses - Analyst Blog,2011-01-07 11:06:00-05:00,GSK,positive
586965.0,Valeant's 2011 Outlook Impresses - Analyst Blog,2011-01-07 10:45:00-05:00,GSK,positive
586966.0,Label Expansion for Roche's Actemra - Analyst Blog,2011-01-06 17:00:00-05:00,GSK,neutral
586967.0,Label Expansion for Roche's Actemra - Analyst Blog,2011-01-06 16:38:00-05:00,GSK,neutral
586968.0,Pfizer Expands Santaris Agreement - Analyst Blog,2011-01-05 17:33:00-05:00,GSK,positive
586969.0,Pfizer Expands Santaris Agreement - Analyst Blog,2011-01-05 16:58:00-05:00,GSK,positive
586970.0,"FDA's Drug Approval Down In 2010(AMGN, DNDN, WPI, GSK)",2010-12-31 08:34:00-05:00,GSK,positive
586971.0,Top 10 Emerging Markets Stocks in 2010,2010-12-30 11:13:00-05:00,GSK,positive
586972.0,Theravance Evenly Poised  - Analyst Blog,2010-12-29 16:33:00-05:00,GSK,positive
586973.0,Theravance Evenly Poised  - Analyst Blog,2010-12-29 16:09:00-05:00,GSK,positive
586974.0,Vivus Seeks EU Nod for Qnexa - Analyst Blog,2010-12-27 09:30:00-05:00,GSK,neutral
586975.0,Vivus Seeks EU Nod for Qnexa - Analyst Blog,2010-12-27 08:45:00-05:00,GSK,neutral
586976.0,"Impax Laboratories Up 6.4% After Deal With GlaxoSmithKline (IPXL, GSK)",2010-12-16 15:07:00-05:00,GSK,neutral
586977.0,GlaxoSmithKline and Impax Pharmaceuticals AnnounceGlobal Development Agreement ,2010-12-16 08:04:00-05:00,GSK,positive
586978.0,UCB Commences Patient Enrolment - Analyst Blog,2010-12-15 12:30:00-05:00,GSK,neutral
586979.0,UCB Commences Patient Enrolment - Analyst Blog,2010-12-15 12:00:00-05:00,GSK,neutral
586980.0,Unconfirmed Rumors circulate that GlaxoSmithKline plc (GSK) will acquire Human Genome Sciences Inc. (HGSI) at $42.00 a share,2010-12-15 09:50:00-05:00,GSK,positive
586981.0,Clinical Data: The FDA Bear Thesis Explained,2010-12-14 10:28:00-05:00,GSK,neutral
586982.0,Glaxo on Acquisition Spree - Analyst Blog,2010-12-14 10:03:00-05:00,GSK,neutral
586983.0,Glaxo on Acquisition Spree - Analyst Blog,2010-12-14 09:15:00-05:00,GSK,neutral
586984.0,Roche's Herceptin Impresses - Analyst Blog,2010-12-13 17:33:00-05:00,GSK,positive
586985.0,Roche's Herceptin Impresses - Analyst Blog,2010-12-13 17:10:00-05:00,GSK,positive
586986.0,ED Drug Could Support Vivus - Analyst Blog,2010-12-09 12:18:00-05:00,GSK,positive
586987.0,ED Drug Could Support Vivus - Analyst Blog,2010-12-09 11:48:00-05:00,GSK,positive
586988.0,Best Stocks For Creating A Passive Income Stream,2010-12-09 11:00:00-05:00,GSK,positive
586989.0,Some Good News for Onyx Pharma - Analyst Blog,2010-12-08 14:03:00-05:00,GSK,positive
586990.0,Some Good News for Onyx Pharma - Analyst Blog,2010-12-08 13:19:00-05:00,GSK,positive
586991.0,New Target Date for HGSI's Benlysta - Analyst Blog,2010-12-06 16:00:00-05:00,GSK,neutral
586992.0,New Target Date for HGSI's Benlysta - Analyst Blog,2010-12-06 15:39:00-05:00,GSK,neutral
586993.0,Human Genome: After-Hours Trading,2010-12-03 18:00:00-05:00,GSK,neutral
586994.0,Setback for Valeant Epilepsy Drug - Analyst Blog,2010-12-03 18:00:00-05:00,GSK,neutral
586995.0,Setback for Valeant Epilepsy Drug - Analyst Blog,2010-12-03 18:00:00-05:00,GSK,neutral
586996.0,Setback for Valeant Epilepsy Drug - Analyst Blog,2010-12-03 17:28:00-05:00,GSK,neutral
586997.0,Setback for Valeant Epilepsy Drug - Analyst Blog,2010-12-03 17:28:00-05:00,GSK,neutral
586998.0,Merck Strikes Deal with SmartCells  - Analyst Blog,2010-12-03 11:16:00-05:00,GSK,negative
586999.0,Merck Strikes Deal with SmartCells  - Analyst Blog,2010-12-03 10:11:00-05:00,GSK,negative
587000.0,FDA Panel Turns Down Glaxo Drug - Analyst Blog,2010-12-02 09:54:00-05:00,GSK,neutral
587001.0,Goldman Sachs Maintains Valeant Pharmceuticals Rating And PT,2010-12-02 08:36:00-05:00,GSK,neutral
587002.0,FDA Panel Turns Down Glaxo Drug - Analyst Blog,2010-12-02 04:08:00-05:00,GSK,neutral
587003.0,Glaxo Hikes Stake in Theravance - Analyst Blog,2010-11-30 15:30:00-05:00,GSK,neutral
587004.0,Glaxo Hikes Stake in Theravance - Analyst Blog,2010-11-30 10:05:00-05:00,GSK,neutral
587005.0,Merck Halts Isentress Study - Analyst Blog,2010-11-30 10:00:00-05:00,GSK,neutral
587006.0,Bootstrap Like Spanx to Start a Business,2010-11-30 08:00:00-05:00,GSK,positive
587007.0,Merck Halts Isentress Study - Analyst Blog,2010-11-30 04:28:00-05:00,GSK,neutral
587008.0,Amarin: Fish-Oil Pill Delivers Strong Results,2010-11-29 07:51:00-05:00,GSK,positive
587009.0,FDA Approves Axiron  - Analyst Blog,2010-11-24 09:00:00-05:00,GSK,positive
587010.0,FDA Approves Axiron  - Analyst Blog,2010-11-24 03:39:00-05:00,GSK,positive
587011.0,GlaxoSmithKline to Sell US Penicillin Facility and Productst to Dr. Reddy's Agree,2010-11-23 11:40:00-05:00,GSK,positive
587012.0,Accenture to Acquire CAS Computer - Analyst Blog,2010-11-22 15:00:00-05:00,GSK,neutral
587013.0,Accenture to Acquire CAS Computer - Analyst Blog,2010-11-22 09:36:00-05:00,GSK,neutral
587014.0,Label Expansion for Shire's Vyvanse - Analyst Blog,2010-11-19 15:30:00-05:00,GSK,neutral
587015.0,Label Expansion for Shire's Vyvanse - Analyst Blog,2010-11-19 09:56:00-05:00,GSK,neutral
587016.0,"Mad Money Lightning Round OT: Cramer Is A Buyer Of BBY (GLD, EGO, SLW, BIDU, GOOG, BBY, AGN, SMT, GSK, RFMD, AMAT)",2010-11-17 20:03:00-05:00,GSK,negative
587017.0,FDA Panel Backs HGSI's Benlysta - Analyst Blog,2010-11-17 14:03:00-05:00,GSK,negative
587018.0,"Company News for November 17, 2010 - Corporate Summary",2010-11-17 09:33:00-05:00,GSK,neutral
587019.0,FDA Panel Backs HGSI's Benlysta - Analyst Blog,2010-11-17 08:33:00-05:00,GSK,negative
587020.0,"Company News for November 17, 2010 - Corporate Summary",2010-11-17 04:23:00-05:00,GSK,neutral
587021.0,Market Focused on Interest Rate Moves  11-16-2010,2010-11-16 18:52:00-05:00,GSK,positive
587022.0,"GlaxoSmithKline Moving Higher On Benlysta Panel (GSK, HGSI)",2010-11-16 16:52:00-05:00,GSK,neutral
587023.0,GlaxoSmithKline Higher On FDA Decision (GSK),2010-11-16 16:49:00-05:00,GSK,neutral
587024.0,"Zacks Analyst Blog Highlights: Isis Pharmaceuticals, GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson and Genzyme      - Press Releases",2010-11-16 10:36:00-05:00,GSK,neutral
587025.0,GlaxoSmithKline Pharma 2QFY2011 Performance Highlights and Results Update ,2010-11-16 07:57:00-05:00,GSK,neutral
587026.0,Pharma & Biotech Industry Outlook - Nov. 2010 - Zacks Analyst Interviews,2010-11-09 17:03:00-05:00,GSK,neutral
587027.0,Pharma & Biotech Industry Outlook - Nov. 2010 - Industry Outlook,2010-11-09 17:03:00-05:00,GSK,neutral
587028.0,Pharma and Biotech Industry Outlook - Nov. 2010 - Industry Outlook,2010-11-09 17:03:00-05:00,GSK,neutral
587029.0,Put Spread Sold on GlaxoSmithKline (GSK),2010-11-09 13:25:00-05:00,GSK,neutral
587030.0,10-29-10 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com,2010-10-29 11:53:00-04:00,GSK,neutral
587031.0,GlaxoSmithKline Settles Lawsuit for $750M,2010-10-26 14:32:00-04:00,GSK,negative
587032.0,Theravance Loss Wider Than Expected - Analyst Blog,2010-10-25 14:48:00-04:00,GSK,negative
587033.0,Glaxo Misses by a Penny - Analyst Blog,2010-10-22 09:33:00-04:00,GSK,negative
587034.0,Unconfirmed rumor that GlaxoSmithKline plc (GSK) will acquire Immunomedics Inc. (IMMU) at $12.00,2010-10-21 10:23:00-04:00,GSK,negative
587035.0,Viagra Treatment for Muscular Dystrophy,2010-10-20 12:11:00-04:00,GSK,neutral
587036.0,Mylan To Appeal Court Hearing In GSK Case,2010-10-19 09:58:00-04:00,GSK,neutral
587037.0,"Top 4 NYSE Stocks In The Healthcare Sector With The Highest Dividend Yield (LLY, BMY, GSK, PFE)",2010-10-12 04:16:00-04:00,GSK,positive
587038.0,"Star Scientific ""Wins"" US Patent Office Ruling - Game on! (CIGX)",2010-10-05 09:44:00-04:00,GSK,neutral
587039.0,Unconfirmed Rumors that GlaxoSmithKline plc (GSK) will make a bid for Human Genome Sciences Inc. (HGSI) at $45.00 a share,2010-10-05 09:30:00-04:00,GSK,positive
587040.0,J&J-Galapagos in Anti-Cancer Deal - Analyst Blog,2010-10-04 23:21:00-04:00,GSK,neutral
587041.0,Colgate-Palmolive Expected To Raise Promo Spending By $150-200M,2010-09-30 07:45:00-04:00,GSK,neutral
587042.0,FDA Restricts Use of Glaxo Drug - Analyst Blog,2010-09-24 21:51:00-04:00,GSK,negative
587043.0,Travelers Mad As Hell ,2010-09-23 12:48:00-04:00,GSK,negative
587044.0,FDA Restricts GlaxoSmithKline's Avandia (GSK),2010-09-23 11:28:00-04:00,GSK,negative
587045.0,"Benzinga's Volume Movers (THRX, TPCG, PRGS, ALXN)",2010-09-22 13:46:00-04:00,GSK,neutral
587046.0,"Top 4 Large-Cap Stocks In The Drug Manufacturers–Major Industry With The Highest EPS Estimates (AZN, NVS, ABT, GSK)",2010-09-22 05:24:00-04:00,GSK,positive
587047.0,"Zacks Analyst Blog Highlights: Johnson & Johnson, Crucell NV, GlaxoSmithKline, Merck and Sanofi-Aventis    - Press Releases",2010-09-21 07:34:00-04:00,GSK,neutral
587048.0,Goldman Sachs Color On CROs,2010-09-20 10:15:00-04:00,GSK,neutral
587049.0,J&J Makes a Pitch for Crucell - Analyst Blog,2010-09-18 11:06:00-04:00,GSK,neutral
587050.0,Pharmaceutical Stocks Worth Owning For The Dividend Alone,2010-09-15 20:06:00-04:00,GSK,neutral
587051.0,Pharmaceutical Stocks Worth Owning For The Dividend Alone,2010-09-15 20:06:00-04:00,GSK,neutral
587052.0,"Benzinga's Top Downgrades (NOK, AIV, MU, GSK)",2010-09-15 07:58:00-04:00,GSK,positive
587053.0,Jefferies Downgrades GSK To Hold,2010-09-15 06:33:00-04:00,GSK,neutral
587054.0,Jefferies Downgrades GSK On Avandia's Removal Risk,2010-09-15 06:17:00-04:00,GSK,negative
587055.0,Top Domain Names are Owned by Publicly Traded Companies,2010-09-13 15:50:00-04:00,GSK,positive
587056.0,Avandia Off The Market; GSK Falls,2010-09-07 14:48:00-04:00,GSK,neutral
587057.0,"Benzinga's Top Upgrades (GSK, SI, VE, CM)",2010-09-07 06:44:00-04:00,GSK,positive
587058.0,BofA/Merrill Upgrades GSK To Buy,2010-09-07 06:32:00-04:00,GSK,neutral
587059.0,Top British Companies That Trade On the New York Stock Exchange,2010-09-01 01:47:00-04:00,GSK,positive
587060.0,New Action Date for Epilepsy Drug - Analyst Blog,2010-08-31 19:15:00-04:00,GSK,neutral
587061.0,Johnson Wins German Contract - Analyst Blog,2010-08-30 13:03:00-04:00,GSK,positive
587062.0,Roche Cancer Drug Hits Roadblock - Analyst Blog,2010-08-30 12:45:00-04:00,GSK,negative
587063.0,8-26-10 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com,2010-08-26 11:51:00-04:00,GSK,neutral
587064.0,Priority Review for HGSI's Benlysta  - Analyst Blog,2010-08-20 12:13:00-04:00,GSK,neutral
587065.0,Unconfirmed Chatter (GSK) Will Buy (HGSI) $40.00 Plus Range,2010-08-20 10:07:00-04:00,GSK,negative
587066.0,Nabi Biopharma Pops On Patent Rights Approval (NABI),2010-08-17 11:44:00-04:00,GSK,positive
587067.0,"Top 4 Large-Cap Stocks In The Healthcare Sector With The Highest Dividend Yield (LLY, BMY, GSK, PFE)",2010-08-17 04:57:00-04:00,GSK,positive
587068.0,Isis Loss Widens  - Analyst Blog,2010-08-16 15:46:00-04:00,GSK,negative
587069.0,All Is Not Well In The Pharmaceutical Industry,2010-08-13 14:14:00-04:00,GSK,negative
587070.0,FDA Warning for Glaxo Drug  - Analyst Blog,2010-08-13 13:37:00-04:00,GSK,negative
587071.0,"U.S. Probing Pharmaceutical Corruption (GSK, PFE, BMY, LLY)",2010-08-13 10:57:00-04:00,GSK,neutral
587072.0,FDA Panel Backs Anti-Epileptic Drug - Analyst Blog,2010-08-12 15:37:00-04:00,GSK,negative
587073.0,"Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield (LLY, GSK, BMY, PFE)",2010-08-11 05:58:00-04:00,GSK,positive
587074.0,Revenues Dip at Alkermes - Analyst Blog,2010-08-09 17:52:00-04:00,GSK,neutral
587075.0,Santarus Beats on Higher Revs - Analyst Blog,2010-08-04 13:34:00-04:00,GSK,neutral
587076.0,GlaxoSmithKline (GSK) Suing Colgate-Palmolive ,2010-07-29 15:57:00-04:00,GSK,negative
587077.0,"Stock Market News for July 27, 2010 - Market News",2010-07-27 09:49:00-04:00,GSK,neutral
587078.0,Glaxo to Perform Well: Barron’s (GSK),2010-07-26 13:39:00-04:00,GSK,positive
587079.0,"Company News for July 26, 2010 - Corporate Summary",2010-07-26 10:20:00-04:00,GSK,neutral
587080.0,US Stock Futures Flattish As Investors Await Housing Data ,2010-07-26 08:41:00-04:00,GSK,positive
587081.0,Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program (GSK),2010-07-19 10:04:00-04:00,GSK,negative
587082.0,Glaxo Plans $2.36 Billion Legal Charge (GSK),2010-07-15 09:52:00-04:00,GSK,positive
587083.0,FDA Panel Narrowly Allows Avandia to Remain on the U.S. Market (GSK),2010-07-14 15:50:00-04:00,GSK,neutral
587084.0,"Roark, Rearden & Hamot",2010-07-14 06:36:00-04:00,GSK,neutral
587085.0,"Company News for July 13, 2010 - Corporate Summary",2010-07-13 12:41:00-04:00,GSK,neutral
587086.0,Puts Sold on Glaxosmithkline (GSK),2010-07-13 12:30:00-04:00,GSK,neutral
587087.0,GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth ,2010-07-13 07:20:00-04:00,GSK,positive
587088.0,"News Summary (BA, EAD, GSK)",2010-07-09 11:03:00-04:00,GSK,neutral
587089.0,US Stock Futures Indicate Troubled Day For Broader Market ,2010-07-09 08:25:00-04:00,GSK,negative
587090.0,XenoPort Shares Plunge On Negative Phase IIb Study,2010-07-07 09:49:00-04:00,GSK,negative
587091.0,7-6-10 The Small Cap Market Update from Express IR,2010-07-06 17:40:00-04:00,GSK,neutral
587092.0,7-6-10 The Small Cap Market Update from Express IR,2010-07-06 12:17:00-04:00,GSK,neutral
587093.0,"GlaxoSmithKline's Avadia Risks Have Dissapated, Says Jefferies (GSK)",2010-07-02 10:33:00-04:00,GSK,negative
587094.0,"Top 4 Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield (AZN, LLY, GSK, BMY)",2010-06-30 05:58:00-04:00,GSK,positive
587095.0,"Low Yields, Consumer Confidence, Income Impact 06-28-2010",2010-06-28 18:45:00-04:00,GSK,positive
587096.0,GlaxoSmithKline Declines After Studies Show Heart Risk in Diabetes Drug (GSK),2010-06-28 13:09:00-04:00,GSK,negative
587097.0,Puts Purchased on GlaxoSmithKline (GSK),2010-06-28 10:55:00-04:00,GSK,neutral
587098.0,"Benzinga’s Top Upgrades (AEO, GSK, IP, PKG)",2010-06-11 07:43:00-04:00,GSK,positive
587099.0,Barclays Upgrades GSK To Overweight,2010-06-11 06:34:00-04:00,GSK,negative
587100.0,"Company News for June 10, 2010 - Corporate Summary",2010-06-10 10:04:00-04:00,GSK,neutral
587101.0,"Top 5 Large-Cap NYSE Stocks In The Healthcare Sector With The Highest Return On Equity (GSK, LLY, AZN, ACL, NVO)",2010-06-07 06:26:00-04:00,GSK,positive
587102.0,"Benzinga’s Top Upgrades (VQ, JOYG, TIBX, GSK, SYT)",2010-06-02 07:49:00-04:00,GSK,positive
587103.0,Jefferies Upgrades GSK To Buy,2010-06-02 06:10:00-04:00,GSK,neutral
587104.0,"Afternoon Market Update (AAPL, AMGN, GSK)",2010-05-28 15:01:00-04:00,GSK,neutral
587105.0,Weight Loss Pill Alli May Cause Severe Liver Damage,2010-05-26 14:51:00-04:00,GSK,negative
587106.0,"Abbott Laboratories To Buy Piramal (ABT, SNY, PFE, GSK)   ",2010-05-21 10:36:00-04:00,GSK,neutral
587107.0,"Mid Market Movers (ZANE, RGDX, AEY, AGEN)",2010-05-11 15:14:00-04:00,GSK,neutral
587108.0,Glaxo’s “Red Wine” Drug Trial On Hold (GSK),2010-05-04 18:07:00-04:00,GSK,neutral
587109.0,US Stock Futures Indicate Turn In Tide,2010-04-28 09:09:00-04:00,GSK,neutral
587110.0,ISIS Collaboration With GlaxoSmithKline Not Favorable,2010-03-31 15:25:00-04:00,GSK,negative
587111.0,"Benzinga’s Volume Movers (ISIS, KMGB, CLNE, SYNA, GIVN)",2010-03-31 14:34:00-04:00,GSK,neutral
587112.0,"Benzinga’s Top Pre-Market Gainers (ARQL, AIXG, ISIS, ORCT)",2010-03-31 08:11:00-04:00,GSK,positive
587113.0,FDA Asks Doctors To Suspend Use Of GlaxoSmithKline (GSK) Rotavirus Vaccine,2010-03-22 15:37:00-04:00,GSK,negative
587114.0,"European Markets Have A Mixed Day (GSK, SNN, IRE, CS, AIB)",2010-03-22 14:27:00-04:00,GSK,neutral
587115.0,US Stock Futures Slip; Focus Shifts To Pharmaceutical Stocks,2010-03-22 08:41:00-04:00,GSK,neutral
587116.0,"Mad Money Lightning Round! (RTN, NABI, PALM, GSK, FLEX, MDRX, COH, FLIR)",2010-03-18 18:56:00-04:00,GSK,negative
587117.0,"US Stock Futures Mixed (PFE, TEVA, GSK, NKE, NVS, FDX)",2010-03-18 09:04:00-04:00,GSK,neutral
587118.0,"Top 5 NYSE Stocks In The Healthcare Sector With The Highest Dividend (ACL, AZN, GSK, NVS, JNJ)",2010-03-03 07:55:00-05:00,GSK,positive
587119.0,Human Genome Sciences (HGSI) CFO TO Quit In March,2010-03-01 15:23:00-05:00,GSK,neutral
587120.0,"Company News for February 26, 2010 - Corporate Summary",2010-02-26 09:27:00-05:00,GSK,neutral
587121.0,"U.S. Equity Movers & Shakers: (HS, HUM, UNH, ENDP, AIG)",2010-02-22 13:55:00-05:00,GSK,positive
587122.0,Glaxo’s Drug Avandia Under Increased Scrutiny (GSK),2010-02-22 12:15:00-05:00,GSK,positive
587123.0,"Unusual Movements Expected In These Shares (ES, GSK, HOLX, USB, WAG)",2010-02-22 09:46:00-05:00,GSK,positive
587124.0,"Benzinga’s Top Pre-Market Losers (RIGL, FSLR, GILD, STP, GSK)",2010-02-22 08:52:00-05:00,GSK,negative
587125.0,Glaxo Was Aware Of Avandia Risk: Senate Report (GSK),2010-02-20 20:45:00-05:00,GSK,negative
587126.0,XenoPort (XNPT) Shares Fall 65% After FDA Rejection,2010-02-18 19:56:00-05:00,GSK,negative
587127.0,"Market Roundup (ZNT, TIF, NVDA, AMD, XNPT, GSK, KO)",2010-02-18 13:14:00-05:00,GSK,neutral
587128.0,"Xenoport, Glaxo RLS Drug Denied By US FDA",2010-02-18 12:59:00-05:00,GSK,negative
587129.0,"FDA Rejects XNPT, GSK Gabapentin Prodrug, Horizant",2010-02-18 10:41:00-05:00,GSK,negative
587130.0,"XenoPort, Inc. (NASDAQ: XNPT) And GlaxoSmithKline (NYSE: GSK) Declines After FDA’s Response Letter",2010-02-18 08:48:00-05:00,GSK,neutral
587131.0,"XenoPort Falls Fast (XNPT, GSK)",2010-02-18 08:16:00-05:00,GSK,neutral
587132.0,GlaxoSmithKline (GSK) Shares Rise With Upgrade,2010-02-16 11:28:00-05:00,GSK,positive
587133.0,"Market Roundup (HA, LUV, UAUA, CHL, TSM, GSK, BP, DEO, MSFT, YHOO, GOOG, AAPL, RIMM)",2010-02-12 14:50:00-05:00,GSK,neutral
587134.0,"For Higher Dividends Go For Foreign Companies: Barron’s (BP, CHL, DEO, TSM, GSK)",2010-02-12 11:56:00-05:00,GSK,neutral
587135.0,"A Look At How Different Sectors Will Behave In 2010 (PG, KO, WMT, GSK, GILD, AZN, EXC, D, DUK)",2010-02-09 14:58:00-05:00,GSK,neutral
587136.0,Glaxo SmithKline Quarterly Profit Up By 66% (GSK),2010-02-04 12:31:00-05:00,GSK,positive
587137.0,"Top 5 Stocks For February 4, 2010 (DNB, TM, CLX, GSK, K)",2010-02-04 08:30:00-05:00,GSK,positive
587138.0,"Benzinga's Top Pre-Market Losers (LZ, SYY, CEPH, GSK, MIR, M)",2010-02-01 08:51:00-05:00,GSK,negative
587139.0,Smokers Respond To Glaxo (GSK) Ads,2010-01-26 08:39:00-05:00,GSK,neutral
587140.0,"Market Round-up (GM, IDC, MHP, PSO, TRI, GSK, VZ, VOD, JNJ, OCR)   ",2010-01-15 14:43:00-05:00,GSK,neutral
587141.0,"Top 5 Large-Cap Stocks In The Healthcare Sector With The Highest ROE (GSK, GILD, AZN, ACL, MRK) ",2010-01-14 09:02:00-05:00,GSK,positive
587142.0,GlaxoSmithKline plc (GSK) Sees Little Threat To Advair From Generic Competition,2010-01-13 15:13:00-05:00,GSK,negative
587143.0,Human Genome Sciences (HGSI) Looks Forward To A Promising Year,2010-01-13 04:10:00-05:00,GSK,positive
587144.0,Human Genome Sciences CEO On CNBC (HGSI),2010-01-12 13:51:00-05:00,GSK,neutral
587145.0,"Benzinga’s Top Pre- Market Gainers (CHTT, BUCY, SGEN, INCY, MAIL, ATHX)",2009-12-21 08:25:00-05:00,GSK,positive
587146.0,"James Altucher's Top 10 Picks (AGO, WCG, POT, CSH, BDX)",2009-12-10 12:06:00-05:00,GSK,positive
587147.0,Barron's Report: Valeant Pharma (VRT) Bets Big On New Epilepsy Drug ,2009-11-23 12:49:00-05:00,GSK,neutral
587148.0,"Benzinga’s Top News Update (CEL, LNMIY, GSK, CAJ)",2009-11-16 07:07:00-05:00,GSK,positive
587149.0,Swine Flu Appears To Be Slowing,2009-11-14 08:44:00-05:00,GSK,negative
587150.0,Cutting Edge Biotech Companies Human Genome Sciences (HGSI) and Dendreon Corp. (DNDN) Are Poised To Go Higher,2009-11-05 12:00:00-05:00,GSK,positive
587151.0,"Black And Decker and Avis Up As US Stocks Rise (BDK, SWK, HGSI, CAR, F, CIT)",2009-11-02 18:21:00-05:00,GSK,neutral
587152.0,Human Genome Sciences Up 22% In The Pre-Market,2009-11-02 06:54:00-05:00,GSK,neutral
587153.0,Human Genome Sciences and GlaxoSmithKline Announce Human Genome Lupus Drug Succeeds In BLISS-76 trial,2009-11-02 02:32:00-05:00,GSK,positive
587154.0,Human Genome Sciences Discusses The Company's Products (HGSI),2009-10-29 08:05:00-04:00,GSK,neutral
587155.0,GlaxoSmithKline (GSK) Very Active Looking For Acquisition Targets,2009-10-28 08:39:00-04:00,GSK,positive
587156.0,Looking To Europe For A Long ETF Play (IEV),2009-10-26 21:15:00-04:00,GSK,positive
587157.0,SuperGen (SUPG) and GSK Announce $375 Million Collaboration,2009-10-26 06:22:00-04:00,GSK,neutral
587158.0,"Tim Seymour Picks Brazilian Stocks For You (ERJ, ITUB, RDY)",2009-10-23 18:33:00-04:00,GSK,neutral
587159.0,"Benzinga’s Top Downgrades (CB, POT, GSK, SPWRA)",2009-10-23 11:33:00-04:00,GSK,positive
587160.0,GlaxoSmithKline (GSK) Says H1N1 Vaccine Worked Really Well In Kids,2009-10-23 08:55:00-04:00,GSK,positive
587161.0,US Listed Chinese Bio-Tech firms Soar in Market,2009-09-08 10:00:00-04:00,GSK,neutral
587162.0,UBS Raises Human Genome Price Target to $25 Based on Acquisition Potential ,2009-09-04 08:36:00-04:00,GSK,neutral
587163.0,Crucell Receives NIH Award for the Development of Influenza Monoclonal Antibodies,2009-08-18 01:52:00-04:00,GSK,positive
587164.0,"Trends in the U.K. and Irish Pharmaceutical and Biotechnology Industry, an Industrial Info News Alert",2009-08-17 05:01:00-04:00,GSK,positive
587165.0,New awards of $300 million for Quinvaxem(R) bringing total value up to $800 million,2009-08-17 01:53:00-04:00,GSK,positive
587166.0,Two Life Science Companies Manage to Pry Open IPO Window,2009-08-16 06:45:00-04:00,GSK,neutral
587167.0,Galapagos reports revenue growth and improved net result in 1H 2009,2009-08-07 11:04:00-04:00,GSK,positive
